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1Summary
Several screens performed in Saccharomyces cerevisiae have
led to the isolation of a large number of endocytic mutants.
Interestingly, the majority of these mutants were shown to be
defective in the internalization step. In this PhD thesis we have
started to dissect the internalization step of endocytosis on a
molecular level by looking for protein-protein interactions
among the proteins required for this step. We found that
Rvs167p, one of the two yeast amphiphysin homologs, is a
central player in this interaction network and therefore focused
the following studies on Rvs167p and its binding partners.
In a first series of experiments, we demonstrated that Rvs167p
and Rvs161p, the two yeast amphiphysin homologs, function
together in vivo. The interaction of these proteins is relevant and
required for their stability.
We next found that Rvs167p interacts with Sla2p/End4p and
Myo5p, two proteins involved in the internalization step, and
that these three proteins are part of an approximately 600 kDa
protein complex most likely involved in regulating the actin
cytoskeleton.
In a next series of experiments, we showed that Myo5p, a type I
myosin, has a second ATP-independent actin binding site via the
SH3-domain in its tail. We show that the interaction with actin
requires Vrp1p/End5p and is physiologically relevant.
Furthermore, we have identified the two protein kinases Pkh1p
and Pkh2p, the yeast PDK1 homologs, to be part of a sphingoid
base-mediated signaling pathway required for the internalization
step of endocytosis. We found that Rvs167p is a substrate for
Pkh2p in vitro and show that mutating the phosphorylation site
leads to an endocytic defect in vivo suggesting that Rvs167p is
one of the downstream effectors of this signaling cascade.
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Introduction
The first part of the introduction is a manuscript published in ‘Frontiers in Molecular
Biology: Endocytosis’. The second part summarizes recent findings published since the first
part was written.
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1. Introduction
All eukaryotic cells are able to internalize
extracellular material together with
portions of their plasma membrane through
a mechanism called endocytosis. The
budding yeast Saccharomyces cerevisiae
(further referred to as yeast) is an organism
well suited for the study of cell biological
processes like endocytosis. It is an
unicellular eukaryote with a membrane
organization and organelles similar to
higher eukaryotes (see Figure 1), and it
offers well developed genetic manipulation
techniques that enable the identification of
conditional mutants defective in the
process of interest. Indeed, several studies
have led to the isolation of endocytosis-
deficient mutants in yeast based on three
major approaches, defective accumulation
of fluorescent dyes in their vacuole
(Chvatchko et al., 1986; Wendland et al.,
1996), defective pheromone receptor
endocytosis (Davis et al., 1993; Raths et
al., 1993) and their synthetic lethality with
a mutation in the vacuolar H+-ATPase
(Munn and Riezman, 1994).
Figure 1. Membrane trafficking in yeast
A schematic overview of a budding yeast cell with
internal organelles is drawn showing the major
membrane trafficking pathways in yeast.
end, endocytic mutants; sec, secretory mutants;
vps, vacuolar protein sorting mutants.
Yeast can exist in three different cell types,
two haploids with opposite mating types a
or  and a diploid a/. The haploid a or 
cells can either grow by mitotic cell
division or they can mate with a cell of the
opposite mating type thus forming an a/
diploid cell. The diploid cell is no longer
competent for mating. It also grows by
mitotic cell division and upon starvation
for nutrients (especially nitrogen) the
diploid yeast undergoes meiosis and
produces four haploid spores, two of each
mating type (see Herskowitz, 1988, and
references therein). The differences
between a,  and a/ cells are determined
by the mating type locus. Two different
alleles encode for different regulatory
proteins causing cell-specific expression or
repression of a subset of genes ultimately
generating the respective cell type
(Herskowitz, 1989). In contrast to the
diploid cells, both haploid mating types
secrete and recognize short peptides called
pheromones which bind to receptors on the
cell surface of cells of the opposite mating
type. Both the -factor receptor Ste2p and
the a-factor receptor Ste3p are plasma
membrane proteins with seven membrane-
spanning segments and are coupled to a
heterotrimeric G protein that is involved in
the mating-specific signal transduction
pathway (Marsh et al., 1991).  cells
secrete -factor but recognize a-factor
which is secreted by a cells and vice versa.
Binding of either ligand to its receptor
leads to several striking changes, including
transcriptional induction of a variety of
genes required for mating, arrest in the
G1 phase of the cell cycle, clearance of
pheromone binding sites, and formation of
cell surface projections which are the sites
of cell-cell fusion (Kurjan, 1992; Marsh et
al., 1991). Cells displaying these
morphological changes have been termed
‘shmoos’. Thus the mating pheromone
system function in cell to cell
communication to synchronize the cell
cycles of the mating partners and to allow
the appropriate fusion events.
Receptor-mediated endocytosis was shown
to occur in yeast by using radioactively
labeled -factor pheromone (Chvatchko et
al., 1986; Jenness and Spatrick, 1986). The
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study of the pheromone receptors,
especially the -factor receptor Ste2p, has
shed light on the sequence of events
resulting in receptor down-regulation. It
was shown that Mat a cells are competent
to respond to -factor and internalize it
throughout the cell cycle (Zanolari and
Riezman, 1991). The pheromone receptors
undergo constitutive endocytosis at a slow
rate, and upon ligand binding the
internalization rate is greatly stimulated
and hyperphosphorylation and ubiquiti-
nation of the cytoplasmic tail of the
receptors are induced (for review see
Riezman, 1998). Multiple internalization
signals have been identified in the
cytoplasmic tail of Ste2p. The most
membrane proximal signal, SINNDAKSS,
was shown to be necessary and sufficient
for internalization of a truncated receptor.
The crucial residue is the lysine that when
mutated to arginine completely blocks
receptor internalization (Rohrer et al.,
1993). The lysine was shown to be an
acceptor site for ubiquitination and this
ubiquitination signals the internalization of
the receptor (Hicke and Riezman, 1996).
Several other yeast and mammalian plasma
membrane proteins have been shown to be
ubiquitinated and internalized suggesting a
general role of ubiquitination not only in
yeast but also in higher eukaryotes (for
review see Hicke, 1997, and Hicke, 1999).
Another internalization signal in yeast,
NPFXD, was found in Kex2p and a similar
NPF-sequence was shown to be necessary
for the pheromone dependent internali-
zation of a truncated a-factor receptor (Tan
et al., 1996).
The endocytic pathway in mammalian cells
has been well characterized at the
morphological level (see Gruenberg and
Maxfield, 1995; Mellman, 1996, and
references therein) while, until very
recently, the characterization of this
pathway in yeast was quite poor.
Biochemical evidence for two endocytic
intermediates between the plasma
membrane and the vacuole in yeast came
from studies following the internalization
of radioactively labeled -factor.
Internalized -factor travels successively
and transiently through two biochemically
distinct membrane-bound compartments to
the vacuole (Singer-Krüger et al., 1993).
Based on the kinetics of -factor
movement through those compartments
and by analogy to the mammalian pathway,
the two intermediates were termed early
endosomes and late endosomes.
Immunofluorescence studies following the
internalization and delivery of the -factor
receptor Ste2p have revealed a peripheral
early endocytic compartment and a late
endocytic compartment near the vacuole.
The formation of the early endocytic
compartment was dependent upon SEC18
gene function (yeast homolog of the
mammalian N-ethylmaleimide-sensitive
fusion protein) which is essential for
multiple vesicular fusion events (see Hicke
et al., 1997, and references therein).
Recently, an electron microscopy study has
allowed the yeast cell endocytic pathway to
be seen at an ultrastructural level by
following the internalization and delivery
of positively charged NanogoldTM
(Nanoprobes, Stony Brook, NY, USA) to
the vacuole (Prescianotto-Baschong and
Riezman, 1998). In agreement with the
previous reports, the first endocytic
intermediates seen are small vesicles of
approximately 50 nm in diameter which
also accumulate at non-permissive
temperature in the sec18 mutant. These
vesicles are likely to be the primary
endocytic vesicles. In wild-type cells, the
NanogoldTM is next found in a peripheral
compartment with a tubular-vesicular
structure. Later the NanogoldTM is found in
a large oval structure with internal
membranes located near the vacuole and
finally in the vacuole. Taken together,
these data suggest a very similar
organization of the endocytic pathways in
mammalian cells and yeast. In yeast, the
first detected intermediates are endocytic
vesicles that either generate an early
peripheral endocytic intermediate by
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homotypic fusion or fuse with a pre-
existing endocytic compartment. These
tubular-vesicular structures at the cell
periphery were termed early endosomes.
The next clearly defined intermediate is a
large oval structure with internal
membranes located near the vacuole, called
late endosome. Finally, the endocytosed
material is delivered to the vacuole.
It has been previously shown that vacuolar
and endocytosed proteins accumulate in an
aberrant compartment in a subset of
vacuolar protein sorting (vps) mutants
(Piper et al., 1995). This compartment,
termed ‘class E compartment’, has been
proposed to be an exaggerated form of a
prevacuolar compartment where the
endocytic and vacuole biogenesis pathways
intersect (Piper et al., 1995). The
prevacuolar compartment could be an
intermediate between the early and late
endosomes as defined above. Transport
between the endosomal compartments and
the vacuole has been shown to require two
small GTP-binding proteins of the Rab/Ypt
family. Ypt51p functions in the early to
late endosome transport step while Ypt7p
is involved in late endosome to vacuole
trafficking and in homotypic vacuolar
fusion (Schimmöller and Riezman, 1993;
Singer-Krüger et al., 1994; Singer-Krüger
et al., 1995; Wichmann et al., 1992).
Several t-SNARES are involved in the
endocytic pathway. Vam3p has been
localized to the vacuole and shown to be
important for several trafficking pathways
leading to the vacuole (Nichols et al.,
1997; Wada et al., 1997), while Pep12p
has been localized to a prevacuolar
compartment and functions in the traffic
from the Golgi to this prevacuolar
compartment (Becherer et al., 1996).
Recently, two other members of the yeast
syntaxin family of t-SNARES, Tlg1p and
Tlg2p, have been identified. Both have
been implicated in the TGN/endosomal
system but there is controversy as to their
localization in the cell and on their exact
function (Abeliovich et al., 1998; Coe et
al., 1999; Holthuis et al., 1998a; Holthuis
et al., 1998b; Seron et al., 1998).
Nevertheless, not only the morphology of
the endocytic pathway but also the
components involved in regulating and
mediating the trafficking steps appear to be
conserved from yeast to mammals.
In this review, we will focus on the
internalization step of receptor-mediated
endocytosis. Different studies have led to
the identification of a great number of
mutants impaired in this step (see Table 1).
Analysis of these mutants revealed two
fundamental aspects of the internalization
process: The requirement for actin and a
subset of actin-associated proteins, and the
importance of certain lipids. Both aspects
will be discussed together with the role of
clathrin and an overview of the techniques
available to study endocytosis in yeast.
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Table 1. Yeast genes required for the uptake step of receptor-mediated endocytosis
Yeast Gene Homologies/Comments Motifs/Domains
ACT1/END7 Actin
AKR1 Ankyrin repeat
ARC35/END9 Subunit ARP2/3-complex
ARP2 Actin related protein
ARP3 Actin related protein
CHC1 Clathrin heavy chain
CLC1 Clathrin light chain
CMD1 Calmodulin Four EF hands
END3 Eps15 EH domain
ERG2/END11 Ergosterol biosynthesis enzyme
LAS17/ BEE1 Human WASP
LCB1/END8 Ceramide biosynthesis enzyme
MYO5 Type I myosin SH3
PAN1/DIM2 Eps15 EH domains
RSP5/NPI1 Ubiquitin protein ligase HECT domain
RVS161/END6 Amphiphysin
RVS167 Amphiphysin SH3
SAC6 Fimbrin
SJL1, SJL2, SJL3 Synaptojanin
SLA2/END4 Talin 
SRV2/END14
VRP1/END5 Proline rich
2. Techniques used to study
endocytosis in yeast
Several reporter systems have been
developed to study endocytosis in yeast.
Fluid phase endocytosis can be followed
by using fluorescent dyes like lucifer
yellow (Riezman, 1985) or FM 4-64 (Vida
and Emr, 1995), or by internalization of
electron dense particles and analysis by
electron microscopy (Prescianotto-
Baschong and Riezman, 1998; Wendland
et al., 1996). Receptor-mediated
endocytosis can be assayed by following
a-factor receptor Ste3p (Davis et al., 1993)
and -factor pheromone (Chvatchko et al.,
1986) or by measuring the clearance of
transporters from the plasma membrane
(Berkower et al., 1994; Lai et al., 1995;
Riballo et al., 1995; Volland et al., 1994).
In the present chapter we will present and
detail these different methods to follow
endocytosis in yeast.
2.1. Fluid-phase endocytosis
2.1.1. Fluorescent dye uptake
Two fluorescent dyes are commonly used
to study fluid-phase endocytosis in yeast,
lucifer yellow-carbohydrazide (LY), a
fluid-phase marker, and FM 4-64, a
membrane probe.
LY is a small hydrophilic fluorescent
molecule that is incapable of diffusion
across biological membranes. It is non-
toxic, highly fluorescent and resistant to
bleaching. Uptake of LY is time-, energy-,
and temperature-dependent and it is
nonsaturable. The rate of endocytic
accumulation has been estimated as
27 nl/mg of cellular protein/hour at 30°C
for yeast cells (Riezman, 1985), compared
to 250 nl/mg/h in murine peritoneal
macrophages (Swanson et al., 1985).
Internalized LY accumulates in the vacuole
and can be visualized by fluorescence
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microscopy using FITC optics. The
vacuole in each cell is visible as an
indentation when observed with Nomarski
optics. LY has been used to screen for
mutants that are defective in endocytosis,
since the assay is simple to perform
(Chvatchko et al., 1986). Unfortunately,
due to the limitations in the resolution of
yeast organelles by light microscopy, it has
not been possible to visualize internalized
LY in any intermediate compartment.
Recently, the lipophilic styryl dye FM 4-64
(N- (3-thiethylammoniumpropyl) -4-
(p-diethyl-aminophenylhexatrienyl) pyridi-
nium dibromide) has been shown to enter
yeast cells by an endocytic mechanism
(Vida and Emr, 1995). This dye selectively
labels the membrane of the intracellular
organelles along the endocytic pathway
since it is fluorescent only when inserted
into membranes. During a time-course of
FM 4-64 staining, the dye initially stains
the yeast plasma membrane, then the
cytoplasmic intermediate endosomal
compartments and finally the vacuolar
membrane (Vida and Emr, 1995). FM 4-64
has the advantage that it can be used to
visualize intermediates between the plasma
membrane and the vacuole during
endocytosis.
2.1.2. Electron dense endocytic markers
Positively charged NanogoldTM
(Nanoprobes, Stony Brook, NY) is a new
marker used to follow the endocytic
pathway in yeast (Prescianotto-Baschong
and Riezman, 1998). NanogoldTM binds to
the plasma membrane of yeast spheroplasts
and its internalization and intracellular
targeting can be followed by electron
microscopy. NanogoldTM cannot be
degraded, and can be used to visualize all
compartments along the endocytic
pathway.
Cationized ferritin was also used to follow
endocytosis in yeast spheroplasts
(Wendland et al., 1996). This marker is
also electron dense and can be visualized
by electron microscopy. Cationized ferritin
has been used to identify structures that
accumulate in endocytic mutants.
2.2. Receptor-mediated endocytosis
2.2.1. -factor pheromone uptake
Receptor-mediated endocytosis can be
followed using the yeast pheromone
-factor. -factor binds to its specific cell
surface receptor, the STE2 gene product
(Jenness et al., 1983). Internalized -factor
is transported through two intermediate
compartments, the early and late
endosomes (Hicke et al., 1997; Singer-
Krüger et al., 1993), on its way to the
vacuole where it is degraded by resident
vacuolar proteases (Schandel and Jenness,
1994; Singer and Riezman, 1990). The best
way to quantitatively assess the earliest
stages of endocytosis in yeast is to follow
the uptake of radioactively labeled -factor
by Mat a cells.
Figure 2. -factor uptake assay
[35S]-factor binds the -factor receptor Ste2p and
is internalized. The internalization rate is
determined by dividing the fraction of radiolabelled
-factor that is internalized and therefore cannot be
removed from the cells by an acid wash protocol
(pH 1-resistant), by the total cell-associated counts
(pH 1-sensitive).
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The -factor pheromone is radioactively
labeled with 35SO4 in vivo, recovered from
the culture supernatant and purified to
obtain 35S-labeled -factor (Dulic et al.,
1991). [35S]-factor uptake assays are
performed on mid-log phase cells using
either the continuous presence or the pulse-
chase protocol (Dulic et al., 1991). The
percentage of internalized -factor at each
time point is calculated by dividing the
internalized counts (pH 1-resistant) by the
total cell-associated counts (pH 6-resistant)
(see Figure 2).
2.2.2. a-factor receptor internalization
Receptor-mediated endocytosis can also be
assayed by following the yeast a-factor
receptor, Ste3p. The a-factor receptor, like
the Ste2p, is subjected to two modes of
endocytosis, a constitutive, ligand-
independent mechanism and a regulated,
ligand-dependent mechanism (Davis et al.,
1993). Both mechanisms result in delivery
of the receptor to the vacuole for
subsequent degradation. The endocytic
assay was developed based on the down-
regulation of the receptor by determining
the rate of degradation of Ste3p. The
ligand-independent turnover of the Ste3p
receptor is rapid, with a t1/2 estimated to be
~15 min. An endocytic defect leads to a
turnover defect of Ste3p and to
accumulation of the receptor at the cell
surface. Ste3p is labeled with
[35S]methionine in a pulse-chase protocol,
at various time points after the initiation of
the non-radioactive chase, aliquots of the
labeled intact cells are taken and subjected
to external protease treatment. This assay
distinguishes surface-localized receptors
(susceptible to external proteases), from
receptors that localize to compartments
inside the cell (resistant to external
proteases). The Ste3p protein is
immunoprecipitated from cell extracts and
subjected to polyacrylamide gel
electrophoresis (Davis et al., 1993).
2.2.3 Permeases and transporters uptake
Another rapid and sensitive way to follow
endocytosis is to measure clearance of
permeases and transporters from the
plasma membrane. A number of stimuli
appear to trigger rapid endocytosis and
subsequent vacuolar degradation of various
permeases when the uptake of their
respective substrate is no longer needed by
the cell. Such a control of permease
stability in response to nutrients has been
demonstrated for inositol, tryptophane and
uracil permeases (Beck et al., 1999; Lai et
al., 1995; Seron et al., 1999; Volland et al.,
1994). Similar mechanisms were also
reported for the Ste6p a-factor pheromone
transporter, the Pdr5p ATP-binding
cassette (ABC) transporter and the maltose
transporter (Berkower et al., 1994; Egner
et al., 1995; Kolling and Hollenberg, 1994;
Riballo et al., 1995).
The best studied among the yeast
permeases is the uracil permease, encoded
by the FUR4 gene (Weber et al., 1986).
Uracil permease is phosphorylated and
ubiquitinated at the plasma membrane and
undergoes rapid internalization followed
by vacuolar degradation in cells submitted
to various stress conditions, such as
inhibition of protein synthesis (Galan et al.,
1996; Volland et al., 1992). The fate of
plasma membrane uracil permease can be
followed in exponentially growing cells
after inhibition of protein synthesis by
cycloheximide. [14C]Uracil uptake is
measured at various time points after
addition of cycloheximide, and protein
extracts are prepared and analyzed for
uracil permease on immunoblots. In wild-
type yeast cells, inhibition of protein
synthesis triggers rapid loss of uracil
uptake, concurrent with permease
degradation, whereas in endocytic mutants
a protection against cycloheximide-induced
loss of uracil uptake is observed (Volland
et al., 1994).
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The yeast maltose transporter is degraded
in the vacuole after internalization by
endocytosis (Riballo et al., 1995). This
internalization occurs under certain
physiological conditions such as impaired
protein synthesis or presence of a
fermentable substrate in the medium.
Endocytosis of this protein is dependent on
the actin network but independent of
microtubules (Penalver et al., 1997). In
addition, the binding of ubiquitin is
required for the internalization step
(Lucero and Lagunas, 1997). By using
yeast mutants defective in the heavy chain
of clathrin and in several subunits of the
COPI and the COPII complexes, it has
recently been shown that clathrin and the
two cytosolic subunits of COPII, Sec23p
and Sec24p, are involved in endocytosis of
the maltose transporter (Penalver et al.,
1999).
3. Actin and actin-associated
proteins
3.1. The actin cytoskeleton
Initial studies in yeast revealed a
fundamental role for the actin cytoskeleton
in the internalization step of endocytosis
(Kübler and Riezman, 1993). Using two
conditional mutations in both actin and
-tubulin, a requirement for actin in the
internalization step but not for post-
internalization trafficking was demon-
strated. Microtubules were not required at
all. An act1-1 strain showed a rapid onset
of the endocytic defect at 37°C, even
without pre-incubation, and internalized
-factor at less than 10% of the rate
detected in wild-type cells suggesting a
direct role of actin in the internalization
step.
The actin cytoskeleton in yeast consists of
cortical patches and actin cables both
composed of F-actin. Patches show a
polarized distribution that changes during
the cell cycle and the cables generally run
along the mother-bud axis (see Amberg,
1998, and references therein). At an ultra-
stuctural level, the actin patches consist of
a finger-like invagination of plasma
membrane around which actin filaments
and actin binding proteins like Abp1p and
cofilin are organized (Mulholland et al.,
1994). These data led to the notion that
actin patches might be the sites of
endocytosis. However, a recent study
following Ste2p internalization by immuno
electron microscopy provided evidence
that the cortical actin patches are not the
sites of receptor internalization
(Mulholland et al., 1999). The authors
showed that Ste2p is not randomly
distributed over the plasma membrane but
is concentrated in furrow-like invagi-
nations. This localization of Ste2p agrees
with previous immunofluorescence studies
showing a spotty distribution of Ste2p on
the cell surface (Hicke et al., 1997).
Using the drug latrunculin A, the actin
filaments in yeast were shown to undergo
rapid cycles of assembly and disassembly
in vivo (Ayscough et al., 1997) suggesting
a very dynamic actin cytoskeleton even in
this nonmotile organism. Using conditional
mutations in the yeast cofilin gene COF1,
rapid turnover of cortical actin structures
was shown to be essential for endocytosis
(Lappalainen and Drubin, 1997). Cells
lacking the yeast homolog of the actin
filament bundling protein fimbrin, Sac6p,
are also defective for internalization
(Kübler and Riezman, 1993). Taken
together, these data strongly support the
central role of an organized dynamic actin
cytoskeleton in the internalization step of
endocytosis in yeast. Further support
comes from the analysis of isolated yeast
mutants defective for endocytosis. One
mutant allele isolated, end7-1, has been
shown to be allelic to ACT1 (Munn et al.,
1995) and several endocytic mutants also
exhibit defects in the actin cytoskeleton
(Riezman et al., 1996). However, it is
important to point out that not all mutants
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with defects in the actin cytoskeleton are
affected in endocytosis. Mutations in myo2,
pfy1 and tpm1 cause actin cytoskeleton
defects similar to those observed in several
endocytic mutants but they endocytose as
well as wild-type yeast cells (Munn et al.,
1995). The involvement of the actin
cytoskeleton in mammalian cells has been
a matter of discussion for a long time (see
Geli and Riezman, 1998, and references
therein). Ambiguous results have been
obtained depending on the cell line and the
actin depolymerizing agent used. A recent
study using latrunculin A provided
evidence that the actin cytoskeleton is
required for receptor-mediated endocytosis
in mammalian cells (Lamaze et al., 1997),
though other studies have suggested it is
not essential (Fujimoto et al., 2000).
Figure 3. Actin-associated protein complexes
Schematic drawing of the four protein complexes described in detail in the text. Proteins that have been shown to
interact biochemically and/or in the two-hybrid system are drawn near each other. Synthetic lethal interactions
are shown by a dashed line, and an arrow marks phosphorylation of a protein by a kinase. Las17p might be part
of three complexes and therefore connections are drawn by double-headded arrows.
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3.2. Actin-associated proteins
As previously mentioned, several
endocytic mutants exhibit defects in the
actin cytoskeleton and some of the proteins
encoded by these genes have been shown
to bind to actin or are associated with
actin-binding proteins. Several protein
complexes have been implicated in the
internalization step of endocytosis and will
be described below (see Figure 3).
3.2.1. Myo5p complex
Type I myosins have been implicated in
actin-dependent membrane motility
processes such as membrane trafficking,
organelle movement, phagocytosis,
pinocytosis and cellular locomotion (see
Mermall et al., 1998, and references
therein). The yeast genome encodes two
type I myosins, MYO3 and MYO5 (Geli
and Riezman, 1996; Goodson et al., 1996).
Single deletions do not lead to any growth
phenotype but deletion of both genes
results in a severe growth defect or
lethality (see Geli and Riezman, 1996, and
references therein). In contrast to a myo3
strain, a myo5 strain is impaired for
-factor internalization at 37°C, suggesting
a more direct role of Myo5p in the
internalization step (Geli and Riezman,
1996). Myo5p contains two IQ motifs that
constitute binding sites for the small
EF-hand containing protein calmodulin
(Cmd1p) and this interaction is required for
endocytosis in vivo (Geli et al., 1998). A
previous study had already implicated
Cmd1p in the internalization step of
endocytosis and this function of Cmd1p
appears to be Ca2+-independent because a
calmodulin allele defective in high-affinity
calcium binding (cmd1-3) shows no
endocytic defect (Kübler et al., 1994). In
addition, evidence suggests that at least
two distinct calmodulin functions are
required for the internalization step. One
target of Cmd1p is Myo5p and this
function is impaired in the cmd1-247
mutant. Another function is impaired in the
cmd1-228 mutant for which the target is
not known (Geli et al., 1998). The actual
function of Myo5p in the internalization
step is unknown. Since none of the
dynamin-homologs in yeast have a role in
the internalization step of endocytosis,
Myo5p was suggested to replace dynamin
in yeast endocytosis if one assumes that
dynamin works as a mechanochemical
enzyme (Geli and Riezman, 1998). Myo5p
has been shown to interact via its SH3-
domain with End5p/Vrp1p and this
interaction is required for polarized
localization of Myo5p (Anderson et al.,
1998). Interestingly, a mutant allele of
END5, end5-1, has been isolated in a
previous screen for endocytic mutants
(Munn et al., 1995). End5p is very rich in
proline residues and contains several
putative SH3-binding sites. End5p interacts
with actin in the two-hybrid system and an
actin-binding domain was mapped to the
first 70 amino acids of End5p (Vaduva et
al., 1997).
In summary, the endocytic function of
Myo5p is regulated at least partially by
Cmd1p and there is a second function of
Cmd1p in the internalization step whose
target is unknown. Polarized localization of
Myo5p depends on End5p and therefore
this interaction might concentrate or
activate Myo5p at the sites of function.
3.2.2. Arp2/3 complex
As already mentioned, a dynamic actin
cytoskeleton is required for the
internalization step of endocytosis.
Recently, a protein complex, the Arp2/3
complex, has been implicated in the
regulation of the actin cytoskeleton and
identified in several organisms. The Arp2/3
complex consists of seven subunits and has
been shown to stimulate actin filament
nucleation and to bind both pointed-ends
and sides of actin filaments (see Machesky
and Gould, 1999, and references therein).
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Interestingly, several subunits of the
complex are required for the internalization
step of endocytosis. Mutations in genes
encoding the actin-related proteins ARP2
(Moreau et al., 1997) and ARP3
(C. Schaerer-Brodbeck and H. Riezman,
unpublished data) block receptor-mediated
endocytosis. A conditional mutant, end9-1,
has been isolated in a screen for endocytic
mutants (Munn and Riezman, 1994) and
subsequently shown to be allelic to ARC35,
the 35 kD subunit of the Arp2/3 complex
(Schaerer-Brodbeck and Riezman, 2000b).
The end9-1 strain is defective for both fluid
phase and receptor-mediated endocytosis at
the restrictive temperature (Munn and
Riezman, 1994). Taken together these data
strongly implicate the Arp2/3 complex in
the internalization step. To our knowledge
no data have been published concerning
the endocytic phenotypes of mutations in
the other subunits of the complex.
Studies from two different laboratories
have implicated the yeast homolog of the
human Wiskott-Aldrich Syndrome protein
(WASP), LAS17/BEE1, in Arp2/3 complex
function (Madania et al., 1999; Winter et
al., 1999). Las17p has been shown to
interact with the Arp2/3 complex by
co-immunoprecipitation. LAS17 is an
allele-specific multicopy suppressor of
ARP2 and ARP3 mutations, and
overexpression restores the endocytic
defect of the arp2-2 mutant allele.
Furthermore, las17 is synthetically lethal
with several ARP2 mutant alleles and with
arp3-14. In addition, Las17p stimulated the
actin nucleation activity of the Arp2/3
complex in vitro. Taken together, these
data support an important functional
interaction of Las17p and the Arp2/3
complex. Las17p interacts with the Arp2/3
complex via its carboxy terminal
WA-domain. Unexpectedly, deletion of
this domain, as opposed to a las17,
caused relatively minor defects suggesting
that Las17p does not function solely via the
Arp2/3 complex and that other cellular
factors act redundantly with Las17p to
activate the Arp2/3 complex (Winter et al.,
1999). Interestingly, a las17 strain
exhibits a strong -factor internalization
defect indicating a role in endocytosis
(Madania et al., 1999).
LAS17 has been isolated as a multicopy
suppressor of the end5-1 temperature
sensitive growth defect and overexpression
of Las17p also restores the endocytic
defect of this mutant allele. Furthermore,
las17 is synthetically lethal with end5
and the two proteins interact in the two-
hybrid system (Naqvi et al., 1998). These
findings suggest a functional relationship
between Las17p and End5p. A similar
interaction has been detected in human
cells between WASP and WIP (WASP
interacting protein), whose yeast homolog
probably is END5 (Ramesh et al., 1997).
In summary, the data presented in the
previous section (Myo5p complex)
together with this data suggest that End5p
can associate with both Myo5p and Las17p
and thus might functionally couple the
Arp2/3 complex to the Myo5p complex.
However, there is no evidence that End5p
interacts with both proteins at the same
time leaving the possibility that End5p
exerts its function in two separate
complexes.
3.2.3. Rvs167p complex
The end6-1 mutant was isolated in a screen
for endocytic mutants and shown to be
allelic to RVS161 (Munn et al., 1995).
Rvs161p shows homologies to a second
yeast protein, Rvs167p, and to the
mammalian protein amphiphysin. In
mammalian cells, amphiphysin interacts
with dynamin, synaptojanin, AP-2 and
clathrin, all proteins implicated in clathrin-
mediated endocytosis, and has been
suggested to act as a scaffold protein (see
Wigge and McMahon, 1998, and
references therein). The entire Rvs161p is
homologous to the N-terminal part of
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Rvs167p and amphiphysin but lacks the
SH3-domain present in Rvs167p and
amphiphysin. Mutations in either RVS161
or RVS167 lead to similar phenotypes
except for a cell fusion defect detected in
rvs161 and not in rvs167 strains (see
Navarro et al., 1997, and references
therein; Brizzio et al., 1998). Both proteins
are required for the internalization step of
endocytosis (Munn et al., 1995) and they
interact with each other (Navarro et al.,
1997) further supporting a joint function.
Surprisingly, their localization in the cell is
different. Rvs161p was shown to be mainly
cytosolic in unbudded cells and upon
appearance of the bud to localize mainly to
the mother-bud-neck (Brizzio et al., 1998).
In contrast, in unbudded cells Rvs167p is
localized mainly in small cortical patches
throughout the cell which polarize at the
bud emergence site and in the small buds
(Balguerie et al., 1999). Taken together,
these data support both overlapping and
unique functions of the proteins in the cell.
Rvs167p interacts with the Pho85 cyclin-
dependent kinase complexes and is a
substrate for this kinase in vitro. The
similarities of the phenotypes associated
with the deletion of PHO85 and RVS167 as
well as the reduced phosphorylation of
Rvs167p in a pho85 strain in vivo suggest
a regulatory function of Pho85 kinases on
Rvs167p activity (Lee et al., 1998). The
SH3-domain of Rvs167p interacts with
Act1p (Amberg et al., 1995) and Las17p
(Colwill et al., 1999; Madania et al., 1999)
in the two-hybrid system and with Abp1p
(Lila and Drubin, 1997) in a binding assay.
Another protein interacting with Rvs167p
is End4p/Sla2p (Wesp et al., 1997), a
protein isolated both in a screen for
endocytic mutants (Raths et al., 1993) and
in a synthetic lethal screen with abp1
(Holtzman et al., 1993). The SH3-domain
of Abp1p interacts with Srv2p (Freeman et
al., 1996). Deletion of either ABP1 or
SRV2 show no endocytic defect (Kübler
and Riezman, 1993; Wesp et al., 1997) but
interestingly, a mutant allele (srv2-14) of
SRV2 has been isolated based on its
endocytic defect (Wesp et al., 1997).
Furthermore, deletion of the central coiled-
coil domain of End4p creates a synthetic
endocytic defect in the absence of Abp1p
or Srv2p suggesting a redundant endocytic
function of both Abp1p and Srv2p with
End4p (Wesp et al., 1997). Several lethal
double mutant combinations have been
shown among disruptions in ABP1, END4,
RVS167 and SRV2 (Lila and Drubin, 1997)
further supporting a functional relationship
of these actin-associated proteins.
As mentioned previously, Rvs167p
interacts with Las17p in the two-hybrid
system. This interaction could link the
Rvs167p complex to the Arp2/3 complex
and/or the Myo5p complex via Las17p.
However, Las17p probably does not
interact with all these complexes at the
same time. Rather a dynamic model can be
envisioned in which Las17p interactions
are tightly regulated and possibly mutually
exclusive to allow a controlled interplay
between the different complexes.
3.2.4. Pan1p complex
The end3-1 allele was isolated in a screen
for endocytic mutants and shown to be
required for the internalization of -factor
and for fluid phase endocytosis (Bénédetti
et al., 1994; Raths et al., 1993). End3p
contains an N-terminal EH-domain (Eps15
homology domain) first identified in the
mammalian protein Eps15 (Wong et al.,
1995). Several EH-domain containing
proteins are present in yeast, and of these
Pan1p has also been shown to be required
for endocytosis (Tang et al., 1997;
Wendland et al., 1996). Interestingly,
END3 was identified as a multicopy
suppressor of pan1-4, and end3 is
synthetically lethal with pan1-4. In
addition, both proteins have been shown to
interact by co-immunoprecipitation and in
the two-hybrid system (Tang et al., 1997).
Loss of function mutations in PRK1
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suppress the growth and actin defect of
pan1-4 (Zeng and Cai, 1999). Prk1p is a
serine/threonine kinase that was shown to
phosphorylate Pan1p in vitro. This
phosphorylation occurs in the Pan1p
domain implicated in End3p binding and
pre-incubation of this Pan1p-domain with
End3p prior to the in vitro kinase assay
reduced the phosphorylation of the Pan1p-
domain (Zeng and Cai, 1999). PRK1 shows
homologies to another putative yeast
kinase, ARK1. Single deletions of either
kinase gene are viable but an ark1 prk1
strain exhibits large cytoplasmic actin
clumps and severe defects in cell growth
implicating both kinases in regulating the
actin cytoskeleton (Cope et al., 1999).
Interestingly, Ark1p was isolated in a two-
hybrid screen using parts of the End4p as
bait, and prk1 is synthetically lethal with
end4 providing a link to the previously
described Rvs167p complex. So far, no
function of either Prk1p or Ark1p in
regulating End4p or the Rvs167p complex
has been shown.
Pan1p also interacts with yAP180A and
yAP180B, the yeast homologs of the
mammalian AP180, via its EH-domain. As
with to their mammalian counterparts, the
two yeast proteins interact with clathrin
and might therefore function as adaptor
proteins (Wendland and Emr, 1998).
However, this interaction might not be
required for endocytosis because the two
yAP180 are not required for endocytosis
(see Huang et al., 1999, and section 4
below).
END3 and PAN1 show genetic interactions
with several proteins involved in
endocytosis. end3-1 is synthetically lethal
with arp2-1, a component of the previously
described Arp2/3 complex (Moreau et al.,
1997) and pan1-20 is synthetically lethal
with sjl1 but not with sjl2 or sjl3, the
yeast homologs of mammalian synapto-
janin (Wendland and Emr, 1998). A
previous study has shown that a strain
lacking SJL1 and SJL2 (sjl1 sjl2)
exhibits a defect in both receptor-mediated
and fluid-phase endocytosis, while a sjl2
sjl3 mutant had only a minor defect, and a
sjl1 sjl3 had no defect, implicating these
proteins in endocytosis like their
mammalian counterpart, synaptojanin
(Singer-Krüger et al., 1998). PAN1 shows
allele-specific synthetic lethality with
RSP5 (Zolladek et al., 1997), an ubiquitin-
ligase involved in the ubiquitination of
several permeases and therefore in their
internalization (see Springael et al., 1999,
and references therein). RSP5 is an
essential gene, and the conserved cysteine
in the HECT domain is required for both
yeast cell viability and ubiquitination of
permeases like Gap1p. Interestingly,
deletion of the N-terminal C2-domain of
Rsp5p does not affect viability but it
impairs internalization of Gap1p without
affecting ubiquitination of the permease
indicating a role of Rsp5p in internalization
in addition to its function in ubiquitination
(Springael et al., 1999).
Recently, two yeast homologs of the
mammalian epsin, Ent1p and Ent2p have
been identified and shown to be required
for FM4-64 internalization. Ent1p interacts
with clathrin via its final eight amino acids
(Wendland et al., 1999). A previous study
had reported a weak interaction of Ent1p
and the EH-domain of Pan1p in the two-
hybrid system (Wendland and Emr, 1998)
providing a possible link between the yeast
epsins and the Pan1p complex.
Taken together, these data suggest that the
two protein kinases Ark1p and Prk1p are
involved in regulating the actin
cytoskeleton and may work, at least
partially, via Pan1p. The genetic
interactions detected link the yeast
homologs of synaptojanin, SJL1-3, and the
ubiquitin ligase RSP5 to the Pan1p
complex.
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4. Involvement of clathrin in
endocytosis
In mammalian cells, the most prominent
and best studied mechanism of receptor-
mediated endocytosis occurs via clathrin-
coated pits and vesicles (see Hirst and
Robinson, 1998; Schmid, 1997, and
references therein). In addition to the
clathrin-mediated endocytic pathway, other
so called clathrin-independent endocytic
pathways are present and function as the
major internalization routes for some
receptors (see Lamaze and Schmid, 1995,
and references therein). Selective inhibition
of clathrin-dependent endocytosis causes
the up-regulation of these clathrin-
independent pathways (Damke et al.,
1995).
The clathrin molecule is a triskelion
formed by three clathrin heavy chain
molecules, each associated with a clathrin
light chain. The yeast genome contains a
single clathrin heavy chain gene (CHC1)
and also a single clathrin light chain gene
(CLC1). Strains with a disruption of either
CHC1 or CLC1, as well as a strain
harboring a chc1-ts allele, show a defect in
-factor internalization. However, these
strains still internalize radioactive -factor
at about 35-50% of the level detected in
wild-type cells (Chu et al., 1996; Huang et
al., 1997; Payne et al., 1988; Tan et al.,
1993). Compared to the strict requirement
of actin and several actin-associated
proteins for -factor internalization (see
section 3 above) this partial effect of
clathrin mutations points to a non-essential
role of clathrin in receptor-mediated
endocytosis in yeast. Several models have
been proposed to explain this partial effect
of clathrin mutations:
1) Clathrin is only required to concentrate
receptors at the sites of internalization
but not for the actual budding of the
vesicles.
2) At least two endocytic pathways exist in
yeast that are actin-dependent but only
one of them is clathrin-dependent.
3) Another protein can partially substitute
for mutations in clathrin and take over
some of its functions.
4) The defect of clathrin mutations is
indirect.
The findings that no other genes with
extended homologies to CHC1 are found in
the yeast genome and the rapid onset of the
endocytic defect in a chc1-ts strain (Tan et
al., 1993) would argue against the later two
models. An interesting recent finding is
that the internalization of the uracil
permease Fur4p is unaffected at restrictive
temperature in a chc1-ts strain (A. Gratias
and R. Haguenauer-Tsapis, unpublished
data). Therefore, the requirement for
clathrin in endocytosis seems to be
dependent on the protein to be internalized.
According to the second model, the two
proteins might be internalized by two
different endocytic pathways. According to
the first model, a cell might need to remove
an actively signaling receptor (Ste2p with
bound -factor) from the plasma
membrane faster than a pyrimidine base
permease (Fur4p) and thus only Ste2p
would normally be concentrated for
internalization.
In mammalian cells, the heterotetrameric
adaptor complexes have been implicated
both in recruiting clathrin to membranes
and in concentrating receptors in clathrin-
coated pits via interactions with their
cytoplasmic tails (Hirst and Robinson,
1998). A recent study demonstrated that
clathrin can function in the absence of both
heterotetrameric adaptors and AP180-
related proteins in yeast (Huang et al.,
1999). A yeast strain with disruptions of all
six heterotetrameric AP large chain genes
(all  chains, // chains removed) as well
as a strain with disruption of the three AP
large chain -subunit genes and the two
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YAP180 genes did not display the
phenotypes of clathrin-deficient cells.
Endocytosis was not affected in these
strains and the authors were able to isolate
clathrin-coated vesicles from them. Taken
together, these data suggest that clathrin
can be recruited to membranes in the
absence of functional adaptors and that
clathrin can function in the absence of
adaptors. There is still the possibility that
other proteins can function as adaptor
molecules and therefore mediate the
membrane association of clathrin and the
concentration of receptors. In mammalian
cells, -arrestin was shown to act as a
clathrin adaptor in the endocytosis of the
2-adrenergic receptor and some other
seven transmembrane domain G protein-
coupled receptors (Goodman et al., 1996).
Taken together, all these data clearly
suggest that a re-evaluation of the
requirements to form a clathrin-coated
vesicle must take place.
Additional support for a non-essential role
for clathrin in the internalization step in
yeast comes from the finding that none of
the dynamin-homologs in yeast are
involved in endocytosis (see Geli and
Riezman, 1998, and references therein). It
is well established in mammalian cells that
dynamin is required for clathrin-mediated
endocytosis (Schmid et al., 1998).
Nevertheless, several proteins involved in
endocytosis in yeast have homologs in
mammalian cells and vice versa pointing to
at least some functional homologies of
endocytosis in both cell types (for a review
see Geli and Riezman, 1998).
5. Role of lipids in the endocytic
pathway
5.1. Lipid requirement in membrane
trafficking in yeast
Recently, not only proteins but also
specific lipids were shown to be required
for the endocytic pathway. Lipids are
responsible for the structural integrity of
biological membranes and confer specific
dynamic properties to the bilayer. Major
lipid components of eukaryotic membranes
are phospholipids, sterols, sphingolipids,
and glycerolipids. Phosphatidic acid,
diacylglycerol (DAG), sphingolipids, and
phosphoinositides (PI) have been
implicated in several stages of membrane
trafficking in yeast.
The vacuolar protein sorting (VPS)
pathway of yeast mediates transport of
vacuolar protein precursors from the late
Golgi to the lysosome-like vacuole (see
Figure 1). Sorting of some vacuolar
proteins occurs via the prevacuolar
endosomal compartment and mutations in a
subset of VPS genes interfere with the
Golgi-to-endosome transport step. The
VPS34 gene encodes a PI 3-kinase  and this
enzyme is required for protein sorting to
the vacuole (Schu et al., 1993).
Inactivation of VPS34 results in impaired
fusion of endosomal transport
intermediates with the vacuole . These data
implicate PI(3)P as a regulator of
membrane traffic (Wurmser and Emr,
1998).
The SEC14 gene product encodes a
phosphatidylinositol/phosphatidylcholine
transfer protein that is required for the
production of secretory vesicles from the
Golgi (Bankaitis et al., 1990). This
requirement can be relieved by inactivation
of the cytosine 5'-diphosphate (CDP)-
choline pathway for phosphatidylcholine
biosynthesis (Cleves et al., 1991) or by
increasing the supply of DAG to the Golgi
(Kearns et al., 1997). Recently, a sec14
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mutant that was inactivated for
phosphatidylinositol (PI), but not
phosphatidylcholine (PC) transfer activity,
was shown to be able to rescue the lethality
and the Golgi secretory defects associated
with sec14-ts or sec14 mutations. These
findings indicate that PI binding/transfer
seems to be dispensable for Sec14p
function in vivo (Phillips et al., 1999).
GPI-anchored proteins are attached to the
membrane via a glycosylphosphatidyl-
inositol-(GPI) anchor whose carbohydrate
core is conserved in all eukaryotes. Apart
from membrane attachment, the precise
role of the GPI-anchor is not known, but it
has been proposed to play a role in protein
sorting. In vitro and in vivo data suggest
that ceramides are required for trafficking
of GPI-anchored proteins from the
endoplasmic reticulum (ER) to the Golgi
apparatus in yeast (Horvath et al., 1994;
Skrzypek et al., 1997; Sutterlin et al.,
1997).
Members of the synaptobrevin/VAMP
family of v-SNAREs are involved in
vesicle docking and have been shown to be
essential for exocytosis in yeast. Recessive
mutations in either ELO2 or ELO3, two
genes that mediate the elongation of very
long chain fatty acids, allow yeast to grow
normally and secrete in the absence of
v-SNAREs. Thus, the v-SNARE require-
ment in constitutive exocytosis can be
abrogated by mutations in genes involved
in lipid synthesis (David et al., 1998).
5.2. Lipid requirement in endocytosis
The VMA2 gene encodes the 60 kD
vacuolar H+-ATPase (V-ATPase) regula-
tory subunit (subunit B). In cells bearing a
disruption of VMA2 (vma2), the
V-ATPase does not assemble on the
vacuolar membrane and consequently the
lumen of the vacuole fails to become
acidified. Yeast vma2 mutants are able to
grow if the external medium is around
pH 5.5 but not at pH 7 or higher pH
(Yamashiro et al., 1990), because the cells
are able to take up protons from the
medium by fluid-phase endocytosis. Based
on this result a screen for isolation of
endocytosis-deficient (end) mutants was
developed, taking advantage of the
synthetic lethality of endocytic mutants
with vma2.
Figure 4. The vma2 synthetic lethality mutant
screen
The VMA2 chromosomal gene is disrupted by LEU2
in a yeast strain carrying the wild type VMA2 gene
on a URA3 low copy plasmid (pCY36). After
mutagenesis some of the cells will become
endocytosis-deficient (end) mutants. These end
mutants cannot grow without a wild type copy of
VMA2 thus cannot lose the pCY36 plasmid.
5’-fluoro-orotic acid (5’-FOA) is used to screen for
end mutants, because only the Ura- cells, which are
END+ can grow on this selective medium.
Introduction 25
The principle of this screen is presented in
Figure 4 and resulted in isolation of the
end8-1 and end11-1 mutants among others
(Munn and Riezman, 1994). The cloning
and sequencing of these two genes
revealed that END8 is allelic to LCB1, an
enzyme required in sphingolipid synthesis
and that END11 encodes ERG2 an enzyme
involved in ergosterol synthesis (Munn et
al., 1999). These findings showed that
mutants affected in lipid biosynthesis are
defective in endocytosis.
5.2.1. Sphingosine bases requirement for
endocytosis
The LCB1 gene is essential and encodes a
subunit of the serine palmitoyl-transferase
enzyme (SPT; Buede et al., 1991). SPT
catalyses the first step in de novo
sphingolipid synthesis, the condensation of
serine and palmitoyl-CoA to yield the
3-ketosphinganine (KDS; see Figure 5 and
Nagiec et al., 1994). In yeast, sphingosine
bases (KDS, PHS and DHS) are generated
by de novo synthesis in the ER.
The end8-1 = lcb1-100 mutant cells have a
temperature-sensitive growth defect. At
24°C this mutant exhibits -factor uptake
kinetics that are almost like wild-type cells,
but at 37°C the mutant is clearly defective.
Moreover, the lcb1-100 cells are defective
for accumulation of LY in the vacuole at
24°C and 37°C and showed a few small
vacuoles when viewed by Nomarski optics.
In summary, the lcb1-100 mutant is
defective in the internalization step of both
receptor-mediated and fluid-phase
endocytosis at non-permissive temperature
(Munn and Riezman, 1994).
These findings suggest that sphingosine
bases might play an important role in the
internalization step of endocytosis. To test
this hypothesis, sphingosine bases (PHS
and DHS) were added externally to the
lcb1-100 strain and the rate of receptor-
mediated endocytosis was determined.
Both phytosphingosine (PHS) and
dihydrosphingosine (DHS) were able to
suppress the endocytic defect observed in
lcb1-100 cells (Zanolari et al., 2000). The
use of genetic approaches should help to
identify the sphingosine base compound
(KDS, DHS or PHS) that is required for
endocytosis in yeast. The Sur2p activity is
required to interconvert DHS and PHS in
yeast (see Figure 5; Haak et al., 1997). To
check whether one of these two
compounds is specifically required for the
suppression, the double mutant lcb1 sur2
cells can be tested for -factor uptake in
presence of DHS or PHS. The recent
identification of two Saccharomyces
cerevisiae genes encoding sphingosine
kinases, LCB4 and LCB5 (Nagiec et al.,
1998), should indicate whether
phosphorylated sphingosine bases are
required to trigger endocytosis in yeast.
Figure 5. Sphingolipid biosynthetic pathway in
yeast
Known pathway intermediates, substrates, and
genes implicated in sphingolipid biosynthesis are
indicated. Sphingolipids are characterized by the
presence of a long chain fatty acid that is amide-
linked to a sphingosine long chain base moiety.
Sphingosine long chain bases are indicated.
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Sphingosine bases and their
phosphorylated derivatives (DHS-1P and
PHS-1P) are thought to be signaling
molecules for regulating a variety of
mammalian cellular processes including
cell growth, motility and apoptosis
(Hannun, 1996; Perry and Hannun, 1998).
Sphingolipids and phosphorylated sphingo-
sine bases have also been implicated in the
yeast stress response (Jenkins et al., 1997;
Mandala et al., 1998; Skrzypek et al.,
1999). Sphingosine bases or ceramides
have been proposed to activate protein
phosphatases. The best candidate for a
ceramide-activated protein phosphatase
(CAPP) in yeast is the protein phosphatase
2A (PP2A), which has two regulatory
subunits, Cdc55p and Tpd3p (Healy et al.,
1991; van Zyl et al., 1992), and a catalytic
subunit. The catalytic subunit of CAPP has
been postulated to be Sit4p (Nickels and
Broach, 1996), but three other genes that
are functionally overlapping, PPH21,
PPH22 and PPH3, encode the major yeast
PP2A catalytic activity (Ronne et al., 1991;
Sneddon et al., 1990). In a lcb1 cdc55
double mutant and in a lcb1 pph21
pph22 pph3 pph21-ts strain, endocytosis
is restored in the absence of sphingosine
synthesis (Friant et al., 2000). Therefore,
the sphingosine requirement for
endocytosis can be suppressed by PP2A
mutations. Furthermore, overexpression of
two kinases can suppress the sphingosine
requirement for both receptor-mediated
and fluid-phase endocytosis (Friant et al.,
2000).
In summary, the sphingosine requirement
for endocytosis can be suppressed by loss
of PP2A activity or by overexpression of
two kinases, suggesting a signaling
function of sphingosine in activation of a
protein kinase and a protein phosphatase
acting sequentially in endocytosis.
5.2.2. Specific sterol requirement for
endocytosis
The end11-1 mutant is defective for the
internalization step of endocytosis and has
been shown to be allelic to ERG2 (Munn et
al., 1999). The ERG2 gene encodes the
sterol C-8 isomerase, an enzyme required
for one of the late steps in ergosterol
synthesis (see Figure 6; Arthington et al.,
1991). Ergosterol is the principal sterol in
yeast and is an essential lipid component
for proper function of the membranes
(Daum et al., 1998). The end11(erg2)-1
mutant is defective for LY accumulation in
the vacuole and for -factor uptake at both
24°C and 37°C (Munn and Riezman,
1994). These results suggest an important
role of ergosterol in the internalization step
of endocytosis.
Figure 6. Ergosterol biosynthesis in yeast
The ergosterol biosynthesis pathway is described
from zymosterol to ergosterol. The first steps of this
pathway to the mevalonate pathway and the
farnesyl pyrophosphate to zymosterol pathway are
not described. The last steps of ergosterol synthesis
represented here are non-essential.
Introduction 27
To test this hypothesis some other erg
mutants were analyzed for endocytosis
(Munn et al., 1999). Yeast cells require
sterols for viability. Only the last steps of
ergosterol biosynthesis (formation of
zymosterol to ergosterol ) are not essential
and therefore enzymes that are involved in
these steps can be mutated (see Figure 6).
The erg6 and the double mutant erg2
erg6 strains were analyzed for -factor
uptake and LY accumulation at both 24°C
and 37°C. The erg6 cells exhibited
reduced internalization of -factor at 24°C
and 37°C and a wild-type LY accumulation
in the vacuole, whereas in the erg2 erg6
mutant cells both LY and -factor uptake
were completely defective (Munn et al.,
1999). The ERG6 gene encodes the sterol
C-24 methyl transferase and catalyses the
formation of fecosterol that serves as
substrate for the Erg2p enzyme (see
Figure 6; McCammon et al., 1984). One
characteristic of the ergosterol biosynthesis
pathway is that mutations in the Erg2p
and/or Erg6p do not prevent subsequent
enzymes from altering the improperly
modified substrates (Lees et al., 1995;
Parks and Casey, 1995). Thus these
mutations lead to accumulation of sterol
structures that are not normal intermediates
of the pathway. To correlate the endocytic
defects that are observed in erg2, erg6 and
erg2 erg6 mutants with the sterol
composition, the sterols accumulating in
these different erg mutants were analyzed.
The results suggested that the state of
desaturation of the B-ring may be critical
for the internalization step of endocytosis
in yeast (Munn et al., 1999).
Recently, plasma membrane cholesterol
was shown to play a critical role in
clathrin-coated pit internalization in
mammalian cells (Rodal et al., 1999; Subtil
et al., 1999). Cholesterol depletion from
the plasma membrane inhibited transferrin
and EGF endocytosis, demonstrating an
essential role of cholesterol for the
formation of clathrin-coated endocytic
vesicles. In summary, sterols were
identified as a novel requirement for
endocytosis in yeast and in animal cells,
but the exact role(s) of sterols are unknown
up to now. The use of genetic approaches
should help to clarify the ergosterol
requirement for endocytosis in yeast.
6. Outlook
The studies in yeast have revealed several
crucial aspects of the internalization step of
receptor-mediated endocytosis. The actin
cytoskeleton plays a major role and several
actin-associated protein complexes are
involved in the process. A great number of
proteins have been isolated based on their
role in the internalization step of
endocytosis and surely more proteins will
be discovered in the future. However, very
little is known about the function of these
proteins in endocytosis. The Arp2/3
complex has been implicated in actin-
nucleation and pointed-end capping but
whether these functions are required for
endocytosis or if there is an additional
endocytic function of the complex is
unknown. The type I myosin, Myo5p, is a
motor protein and thus may be involved in
force generation in endocytosis. However,
nothing is known about which step(s) in
the endocytic pathway require force and
how this force is generated. The major
goals for the future are to understand the
precise role of the different protein
complexes involved in the internalization
step, how their functions are regulated and
how they co-operate to drive the
internalization step of endocytosis.
The lipid requirement for endocytosis in
yeast is still conceptually at an early stage.
The link between a sphingosine signaling
pathway and the internalization step of
endocytosis remains to be defined. The
near future should provide significant
advances in the identification and
characterization of downstream effectors
and upstream regulators of the sphingosine
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activated signaling pathway. Likewise,
there is a gap in our understanding of the
ergosterol requirement for the
internalization step. Analysis of other
viable erg single and double mutants
should permit the development of theories
to explain how sterols function in
endocytosis.
The combination of genetic and
biochemical approaches should help to
answer the remaining questions about the
protein and lipid requirements in yeast
endocytosis.
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Recent findings
The internalization step of endocytosis is
differentially affected by different actin
mutant alleles. The findings that two actin
mutant alleles (act1-1, end7-1) affect the
internalization step of endocytosis (Kübler
and Riezman, 1993; Munn et al., 1995) and
that most other internalization mutants
(e.g. sla2/end4, rvs167) affect the actin
cytoskeleton, clearly support a central role
of actin in endocytosis in yeast. However,
the actin requirement seems to be rather
specific since other mutants disrupting
proper actin localization (e.g. pfy1, tpm1)
do not affect endocytosis (Munn et al.,
1995). A recent study has further
investigated the role of actin in endocytosis
by using an isogenic collection of actin
mutants (Whitacre et al., 2001). The actin
mutants exhibited a wide range in their
abilities to internalize -factor at 25°C and
37°C. Some alleles internalize like a wt
strain or are defective at both temperatures,
while other alleles have a ts phenotype
with defects in internalization only at 37°C.
Interestingly, there may be a correlation
between defects in internalization and
growth on salt of the different actin alleles
with the exception of act1-4. The act1-4
allele is severly impaired for internalization
at 25°C and 37°C but is not especially salt-
sensitive suggesting that this allele has a
somewhat more specific effect on
endocytosis (Whitacre et al., 2001).
Furthermore, the same study demonstrated
that internalization in yeast is affected by
high external osmolarity (600 mM NaCl or
1 M sorbitol) as is the case in mammalian
cells.
1. New proteins involved in
endocytosis
A recent study has used a mutant library
generated by the European Functional
Analysis Network (EUROFAN) to screen
for strains defective in fluid-phase
endocytosis. A total of 700 strains
disrupted for a single non-essential ORF
were tested and 14 mutants were identified
(Wiederkehr et al., 2001). As about 2% of
the tested strains were defective in the
accumulation of LY in the vacuole, the
authors extrapolated that approximately
110 non-essential genes present in the
yeast genome might be required for
efficient fluid phase endocytosis.
Interestingly, only 2 of the 14 mutants
show a partial defect in the internalization
step (Gagny et al., 2000; Wiederkehr et al.,
2001) while the rest was affected in post-
internalization steps. This is in marked
contrast to previous screens for
endocytosis-deficient mutants which
yielded mostly internalization mutants (see
D'Hondt et al., 2000, and references
therein). Both new internalization mutants,
YNL177c and EDE1, show a mild defect
affecting mostly the initial internalization
rate. Interestingly, Ede1p contains several
EH-domains like two other proteins
(End3p and Pan1p) already implicated in
the internalization step (Benedetti et al.,
1994; Raths et al., 1993; Tang et al., 1997;
Wendland et al., 1996). Combination of
ede1 with either rsp5-1, pan1-10 or
end3-1 leads to a synthetic growth defect
(Gagny et al., 2000) suggesting that Ede1p
might be linked to the Pan1p-complex
previously described (see section 3.2.4).
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2. Actin-associated protein complexes
Recent studies have found an increasing
cross-talk between the previously
described protein complexes involved in
endocytosis (see section 3.2). Interestingly,
several of these findings deal with the
Arp2/3 complex further emphasizing its
central role in actin dynamics.
As mentioned previously, Cmd1p has at
least two roles in endocytosis. One is to
regulate the type I myosins Myo3p and
Myo5p, and this function is affected by the
cmd1-247 and cmd1-226 mutations. The
second function is affected by the
cmd1-228 and cmd1-226 mutations and the
target is unknown (Geli et al., 1998). A
recent study identified Arc35p, the 35 kDa
subunit of the Arp2/3 complex, as the
second target of Cmd1p in endocytosis
(Schaerer-Brodbeck and Riezman, 2000a).
Overexpression of wild type or mutant
Cmd1p (except cmd1-228p and
cmd1-226p) suppressed both the endocytic
and actin cytoskeleton defect of arc35-1.
Furthermore, Arc35p was shown to interact
with Cmd1p and to be required for the
cortical localization of Cmd1p (Schaerer-
Brodbeck and Riezman, 2000a). Taken
together these data suggest an important
functional interaction between the 35 kDa
subunit of the Arp2/3 complex Arc35p and
calmodulin. Interestingly, the other target
of Cmd1p function in endocytosis, the type
I myosins (Geli et al., 1998), has been
implicated in Arp2/3 complex mediated
actin assembly (Evangelista et al., 2000;
Lechler et al., 2000; see section 4 of the
Results). The acidic domain of type I
myosins interacts with the Arp2/3 complex
via Arc40p and Arc19p. Furthermore,
Las17p also interacts with Myo3/5p. More
importantly, the acidic domains of
Myo3/5p were shown to be genetically
redundant with the acidic domain of
Las17p (Evangelista et al., 2000; Lechler
et al., 2000). These findings explain the
mild phenotype of deleting the acidic
domain of Las17p compared to a complete
knockout las17 (Winter et al., 1999),
since Myo3/5p are still present. Using an
in vitro assay, Myo3/5p were shown to be
essential for cortical actin assembly. This
function required motor activity as well as
phosphorylation of the motor domain by
PAK’s (Lechler et al., 2000). Interestingly,
the function of Myo5p in actin
polymerization requires interaction with
Vrp1p (see section 4 of the Results). Taken
together these findings support a very close
connection between the Myo5p complex
and the Arp2/3 complex (see section 3.2.).
Abp1p has been identified as another
activator of Arp2/3 complex (Goode et al.,
2001). Abp1p interacts biochemically with
the Arp2/3 complex and purified Abp1p
activates the actin polymerization activity
of the Arp2/3 complex in vitro (Goode et
al., 2001). Abp1p has been shown to
interact with Rvs167p (Lila and Drubin,
1997) and might therefore connect the
Rvs167p complex and the Arp2/3 complex
(see section 3.2.).
A recent two-hybrid screen using Rvs167p
and Rvs161p as baits identified a large
number of interacting proteins (Bon et al.,
2000). However, since no confirmation of
the interactions using other techniques
were made, these proteins cannot be
considered bona fide interactors. Instead, a
possible interesting link between the
Rvs167p complex and the Pan1p complex
via Sla1p might take place (Ayscough et
al., 1999; Tang et al., 2000). Sla1p was
shown to associate with both Pan1p and
End3p (Tang et al., 2000) suggesting that
Sla1p participates in the Pan1p complex.
Another study showed that Sla1p is
required for correct localization of Sla2p
(Ayscough et al., 1999), a component of
the Rvs167p complex, suggesting that
Sla1p might regulate Sla2p function.
In summary, these recent findings point to
a complex protein-protein interactions
network involved in regulating actin
dynamics and/or endocytosis in yeast.
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3. Sphingoid base requirement
The lcb1-100 (end8-1) mutant was isolated
in a screen for endocytosis-deficient
mutants and shown to affect the
internalization step (Munn and Riezman,
1994). Since Lcb1p is involved in the first
step of sphingolipid biosynthesis, these
findings suggested that ongoing sphingoid
base synthesis is required for endocytosis.
Indeed, exogenous sphingoid bases can
suppress the endocytic defect of lcb1-100
(Zanolari et al., 2000). In order to identify
the intermediate in the sphingolipid
synthesis pathway required for the
internalization, the lcb1-100 mutant was
combined with mutations that affect the
utilization of exogenously added sphingoid
bases. Using conditions, where no
DHS-1-P (lcb1/4/5) or no ceramides
(lcb1/3/ysr3 respectively addition of
australifungin) are made, addition of DHS
still suppressed the internalization defect of
lcb1-100 (Zanolari et al., 2000). These data
strongly suggest that sphingoid bases DHS
or PHS are required for the internalization
step of endocytosis in yeast. Interestingly,
the lcb1-100 strain shows a non-polarized
actin cytoskeleton at 37°C. Addition of
DHS can partially restore proper actin
localization (Zanolari et al., 2000)
suggesting that at least one function of
sphingoid bases in endocytosis might be
mediated via the actin cytoskeleton.
Since sphingoid bases are rapidly turned
over, they are ideal candidates to act as
signaling molecules. Indeed, inactivation
of the CDC55 regulatory or PPH catalytic
subunits of protein phosphatase 2A (PP2A)
suppress the endocytic defect of lcb1-100
(Friant et al., 2000). Similarly,
overexpression of the protein kinases
Yck2p (completely) or Pkc1p (partially)
suppressed the endocytic defect of
lcb1-100 (Friant et al., 2000). These data
suggest a function of sphingoid bases in
activating a protein phosphorylation
pathway required for the internalization
step. Interestingly, Yck2p and Pkc1p have
an overlapping function in endocytosis
because only cells with impaired activity of
both kinases are defective for endocytosis
(Friant et al., 2000). In addition, PP2A
mutations or kinase overexpression
partially suppressed the actin cytoskeleton
defect of lcb1-100 further supporting the
hypothesis that the actin cytoskeleton is
likely to be one target of sphingoid base
synthesis requirement (Friant et al., 2000).
4. Sterols function early in Ste2p
internalization
The erg2-1 (end11-1) mutant was isolated
in a screen for endocytosis-deficient
mutants and shown to affect the
internalization step (Munn and Riezman,
1994). Erg2p is involved in one of the late
steps of ergosterol biosynthesis suggesting
a function for sterols in endocytosis. A
study using different erg mutants indicated
that the state of desaturation of the B-ring
may be important for the internalization
step (Munn et al., 1999). However, a recent
study analyzing more erg mutants has
suggested that B-ring desaturation is not
the sole structural requirement but that also
side-chain methylation is important for the
internalization step (Heese-Peck et al.,
submitted). In contrast to most other
endocytosis mutants, at least two
erg mutants (erg2erg6, erg3erg6)
affecting internalization do not have
pronounced actin cytoskeleton defects.
However, they affect Ste2p
phosphorylation (Heese-Peck et al.,
submitted) suggesting that sterols function
early in receptor-mediated endocytosis in
yeast. Interestingly, an erg3 strain
internalizes -factor like a wt strain while
it is defective in fluid-phase endocytosis
(LY-uptake) suggesting that sterols also
function further downstream of the
endocytic pathway on the way to the
vacuole (Heese-Peck et al., submitted).
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One possible role of sterols in endocytosis
may be to provide the proper environment
(“rafts”) to recruit the endocytic machinery
and/or cargo (e.g. Ste2p). Interestingly, two
recent studies have demonstrated that
homo-oligomeric complexes of Ste2p are
functional units of endocytosis (Overton
and Blumer, 2000; Yesilaltay and Jenness,
2000). A tempting hypothesis would be
that Ste2p oligomerization requires a
proper membrane environment (and thus
appropriate sterols) and that oligo-
merization is required for efficient
phosphorylation of the receptor. However,
no effect of oligomerization of Ste2p on its
own phosphorylation has been reported up
to now.
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Results
The results are presented in the form of four manuscripts. Two of them have been published
and the other two are being submitted for publication.
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Rvs161p and Rvs167p, the two yeast amphiphysin
homologs, function together in vivo
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Abstract:
Mutations in RVS161 and RVS167, the two yeast amphiphysin homologs, cause very similar
growth phenotypes, a depolarized actin cytoskeleton and a defect in the internalization step of
endocytosis. Rvs161p and Rvs167p have been shown to interact in the two-hybrid system but
their localization in the cell may be different raising the question whether the interaction is
physiologically relevant. Here we demonstrate that the two proteins function together in vivo.
We find that the steady state level of Rvs167p is strongly reduced in a rvs161 strain.
Similarly, the level of Rvs161p is strongly reduced in a rvs167 strain. We demonstrate that
these reduced protein levels at steady state are due to a decreased stability of either
Rvs protein in the absence of the other. Furthermore, we find that the amount and ratio of
Rvs161p and Rvs167p are critical parameters for receptor-mediated endocytosis. In addition,
using the two-hybrid system we show that the interaction of Rvs167p with actin is not
abolished in an abp1 strain suggesting that Abp1p is not essential for this interaction.
I wrote the manuscript and performed all the experiments.
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Introduction
The yeast Rvs161p and Rvs167p, together
with mammalian amphiphysin I and II,
nematode and fission yeast isoforms,
constitute a family of conserved proteins
(Wigge and McMahon, 1998). The
N-termini of the different proteins share
the highest homology and this common
domain was called the BAR-domain (BIN/
Amphiphysin/RVS-domain; Sakamuro et
al., 1996). Rvs161p consists only of the
BAR-domain (Figure 1) while the other
members of the family have an SH3-
domain at their C-termini and a central
domain varying among the different
proteins. In the case of Rvs167p, the
central domain is rich in glycine, proline
and alanine and therefore is called the
GPA-domain (Figure 1).
Figure 1. Schematic overview of the domains of
Rvs161p and Rvs167p
BAR, BIN/Amphiphysin/RVS domain; GPA,
glycine-proline-alanine-rich region; SH3, Src
homology 3 domain.
The mammalian homolog, amphiphysin I,
was first identified as a brain protein
enriched at presynaptic regions (Lichte et
al., 1992). The identification of dynamin,
synaptojanin, the c-subunit of AP2-
adaptin and clathrin as amphiphysin I-
interacting proteins further implicated
amphiphysin I in endocytosis (Wigge and
McMahon, 1998). A more broadly
expressed isoform, amphiphysin II, has
been identified by several groups and was
found to interact with the same proteins
that interact with amphiphysin I (Wigge
and McMahon, 1998). Interestingly, the
two isoforms can be coimmunoprecipitated
from brain extracts suggesting that they act
in concert (Wigge et al., 1997). Indeed,
two studies (Ramjaun et al., 1997; Wigge
et al., 1997) found that the two
amphiphysin isoforms colocalize in brain.
However, a third study identified a
different subcellular localization of the two
isoforms (Butler et al., 1997).
Amphiphysin I was shown to be
concentrated in the cortical cytoplasm of
nerve terminals, whereas amphiphysin II
was concentrated in axon initial segments
and nodes of Ranvier (Butler et al., 1997).
The two yeast members of the
amphiphysin family, encoded by RVS161
and RVS167, were first identified in a
screen for mutations causing reduced
viability upon nutrient starvation (Bauer et
al., 1993; Crouzet et al., 1991). RVS161
was also identified in a screen for
endocytosis mutants (Munn et al., 1995).
Mutations in rvs161 or rvs167 exhibit the
same phenotypes except for a defect in cell
fusion only found in the rvs161 mutant
(Brizzio et al., 1998). The mutant
phenotypes include defects in endocytosis,
cell polarization, bud site selection in
diploid cells, and a depolarized actin
cytoskeleton (Bauer et al., 1993; Munn et
al., 1995; Sivadon et al., 1995). Rvs161p
and Rvs167p have been shown to interact
through the BAR-domain in the two-hybrid
system (Navarro et al., 1997). However,
their localization in the cell seems to be
different, raising the question whether the
Rvs161p-Rvs167p interaction is relevant
in vivo. Rvs161p was shown to be mainly
cytosolic in unbudded cells and upon bud
emergence it localizes mainly to the
mother-bud neck region (Brizzio et al.,
1998). In contrast, in unbudded cells
Rvs167p is localized mainly in small
cortical patches throughout the cell which
polarize at the bud emergence site and in
small buds (Balguerie et al., 1999). Using
the two-hybrid system the BAR-domain of
Rvs167 has also been shown to mediate
homodimerization in one study (Colwill et
al., 1999) while another study failed to
detect any Rvs167p-Rvs167p interaction
(Navarro et al., 1997).
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Mutations in rvs161 and rvs167 affect the
actin cytoskeleton (Bauer et al., 1993;
Sivadon et al., 1995). Interestingly, the
SH3-domain of Rvs167p has been shown
to interact with actin in the two-hybrid
system (Amberg et al., 1995). The finding
that Rvs167p interacts with the actin
binding protein Abp1p through its
GPA/SH3-domains (Lila and Drubin,
1997) led to the hypothesis that Abp1p
could mediate the interaction between
Rvs167p and actin.
In this study we investigated whether
Rvs161p and Rvs167p indeed function
together in vivo. We find that the steady
state level of Rvs161p is strongly reduced
in a rvs167 strain. Similarly, the level of
Rvs167p is strongly reduced in a rvs161
strain. We demonstrate that these reduced
protein levels at steady state are caused by
a decreased stability of either Rvs protein
in a strain mutated in the other rvs gene.
Furthermore, we provide evidence that the
amount and ratio of Rvs161p and Rvs167p
are critical parameters for receptor-
mediated endocytosis. In addition, using
the two-hybrid system we find that Abp1p
is not required to mediate the interaction of
Rvs167p with actin.
Material and Methods
Yeast strains, media and general
techniques
Yeast strains used in this study were
EGY48 (Mat a his3 trp1 ura3
leu2::lexAop6-LEU2), RH448 (Mat a his4
leu2 lys2 ura3 bar1), RH3376 (Mat a his3
leu2 trp1 ura3 bar1), RH2600 (Mat a his4
ura3 rvs161 bar1), RH2950 (Mat a his4
leu2 trp1::URA3 ura3 rvs167::TRP1
bar1), RH5238 (Mat a his3 trp1 ura3
leu2::lexAop6-LEU2 abp1::KanMX6) and
RH5239 (Mat a his3 trp1 ura3
leu2::lexAop6-LEU2 rvs161::KanMX6).
Strains that did not bear plasmids were
grown in complete media YPUAD (2%
glucose, 2% peptone, 1% yeast extract,
40 g/ml uracil, 40 g/ml adenine and
40 g/ml tryptophan, 2% agar for solid
media). Unless mentioned otherwise,
strains bearing plasmids were selected on
SD minimal media (Dulic et al., 1991).
Standard recombinant DNA techniques
were used (Sambrook et al., 1989).
Restriction endonucleases were obtained
from MBI Fermentas, Klenow from
Boehringer Mannheim and Pfu polymerase
was obtained from Stratagene.
Plasmid constructions
pEG202 and pJG4-5 were described
elsewhere (Gyuris et al., 1993), both
plasmids contain a 2 origin of replication.
The reporter gene plasmid pSH18-34 was
described elsewhere (Estojak et al., 1995),
it contains eight LexA-operators upstream
of the reporter gene GAL1-LacZ. To
construct pEGRVS161 the RVS161-ORF
was amplified by the polymerase chain
reaction with Pfu polymerase using the
5’-primer GATACGGAATTCATGAGTT
GGGAAGGTTTTAAG and 3’-primer
GAGTATTCCGCTCGAGTTATTTTATC
CCGAGCGCACAAAT introducing an
EcoR I-site upstream and a Xho I-site
downstream of the RVS161-ORF. The
fragment was then inserted as an EcoR I-
Xho I-fragment into pEG202. To construct
pJGACT1 the ACT1-ORF was amplified by
the polymerase chain reaction using the
5’-primer GATACGGAATTCATGGATT
CTGGTATGTTCTAG and 3’-primer
TACGCGGATCCTTAGAAACACTTGT
GGTGAACG introducing an EcoR I-site
upstream and a BamH I-site downstream of
the ACT1-ORF. The fragment was then cut
with BamH I, the 5’ overhang filled in with
Klenow, and cut with EcoR I. This
fragment was then inserted in a pJG4-5
which was cut with Xho I, the 5’ overhang
filled in with Klenow, and cut with EcoR I.
To construct pEGRVS167 the RVS167-
ORF was amplified by the polymerase
chain reaction using the 5’-primer
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RVS167,1 (GATACGGAATTCATGAGT
TTTAAAGGGTTTACCAAG) and
3’-primer RVS167,2 (GAGTATTCCGCT
CGAGCTAGTTCTTGTTGAGTTGCAC
G) introducing an EcoR I-site upstream
and a Xho I-site downstream of the
RVS167-ORF. The fragment was then
inserted as an EcoR I-Xho I-fragment into
pEG202. pJGRVS167 was described
elsewhere (Geli et al., 2000). To construct
pJGBAR the BAR-domain of RVS167 was
amplified by the polymerase chain reaction
using the 5’-primer RVS167,1 and
3’-primer GAGTATTCCGCTCGAGCTA
CTTAGAGTAACCGAGTTTAAAG
introducing an EcoR I-site upstream and a
Xho I-site downstream of the BAR-
domain. The fragment was then inserted as
an EcoR I-Xho I-fragment into pJG4-5. To
construct pJGBAR/GPA the BAR- and
GPA-domains of RVS167 were amplified
by the polymerase chain reaction using the
5’-primer RVS167,1 and 3’-primer
RVS167,6 (GAGTATTCCGCTCGAGCT
AGCCAGGAGCTGCCGCTACG) intro-
ducing an EcoR I-site upstream and a
Xho I-site downstream of the BAR/GPA-
domains. The fragment was then inserted
as an EcoR I-Xho I-fragment into pJG4-5.
To construct pJGGPA the GPA-domain of
RVS167 was amplified by the polymerase
chain reaction using the 5’-primer
RVS167,8 (GATACGGAATTCCTTTAA
ACTCGGTTACTCTAAG) and 3’-primer
RVS167,6 introducing an EcoR I-site
upstream and a Xho I-site downstream of
the GPA-domain. The fragment was then
inserted as an EcoR I-Xho I-fragment into
pJG4-5. To construct pJGGPA/SH3 the
GPA-and SH3-domains of RVS167 were
amplified by the polymerase chain reaction
using the 5’-primer RVS167,8 and
3’-primer RVS167,2 introducing an
EcoR I-site upstream and a Xho I-site
downstream of the GPA/SH3-domains.
The fragment was then inserted as an
EcoR I-Xho I-fragment into pJG4-5. To
construct pJGSH3 the SH3-domain of
RVS167 was amplified by the polymerase
chain reaction using the 5’-primer
GATACGGAATTCCCTGGCGTTGAAA
CTGTTACCG and 3’-primer RVS167,2
introducing an EcoR I-site upstream and a
Xho I-site downstream of the SH3-domain.
The fragment was then inserted as an
EcoR I-Xho I-fragment into pJG4-5. To
construct p181RVS161 and p195RVS161
the 2.2-kb EcoR I fragment from pUB1-3
(Munn et al., 1995) was excised and cloned
into Yeplac181 (p181; Gietz and Sugino,
1988) and Yeplac195 (p195; Gietz and
Sugino, 1988). To construct p181RVS167
and p195RVS167 the 1.8-kb Kpn I-Sph I
fragment from pFBKS (Bauer et al., 1993)
was excised and cloned into Yeplac181
(p181) and Yeplac195 (p195).
Two-hybrid analysis
Two-hybrid analysis was performed as
described (Geli et al., 1998). Briefly, the
strains contain the reporter plasmid
pSH18-34 with the reporter gene
GAL1-LacZ under the control of eight
LexA-operators. To assay the interaction
between bait and prey the strains are
streaked out on plates containing X-Gal.
The positive colonies turn dark while the
negative ones remain white.
Protein extracts and immunoblotting
Yeast strains were grown to exponential
phase, harvested and lysed with glass beads
in 500 l lysis buffer (50 mM Tris-HCl
pH 7.5, 5 mM EDTA, 0.5% SDS and
1 g/ml of the protease inhibitors
aprotinin, leupeptin, pepstatin A,
chymostatin and antipain). The protein
concentration of the lysates was measured
using the Bio-Rad protein assay.
Equivalent amounts of each sample were
analyzed by SDS-PAGE (Laemmli, 1970)
and immunoblotting with antibodies
against Rvs161p and Rvs167p. As a
control, antibodies against Sla2p were used
(Wesp et al., 1997).
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Pulse-chase experiments
Metabolic labeling of cells was carried out
as described previously (Munn et al., 1995)
with the modification that the cells were
not converted to spheroplasts, but were
lysed with glass beads in 200 l of lysis
buffer and then heated for 3 minutes at
95°C. Rvs161p or Rvs167p were immuno-
precipitated from the lysates and analyzed
by SDS-PAGE and autoradiography.
Coimmunoprecipitation
WT (RH448) and rvs167 (RH2950)
strains were grown to exponential phase,
harvested and converted to spheroplasts
using lyticase (Raths et al., 1993). The
spheroplasts were lysed by osmotic shock
in 2 ml of buffer (20 mM MES pH 6.5,
100 mM NaCl, 5 mM MgCl2, 1% NP-40,
0.5 mM PMSF and 1 g/ml of the protease
inhibitors pepstatin, leupeptin, antipain).
The protein concentration of the lysates
was measured using the Bio-Rad protein
assay. Equal amounts of total protein for
both strains were taken and proteins were
immunoprecipitated with antibodies
against Rvs167p. The immunoprecipitates
were analyzed by SDS-PAGE and
immunoblotting with antibodies against
Rvs161p.
-factor uptakes
-factor uptakes (continuous presence)
were done as described previously (Dulic
et al., 1991). The strains were tested at
24°C. The internalization rates were
calculated as the percentage of counts
internalized per time unit in the linear
range and normalized to the internalization
rate of the strain with the empty vector set
to 100%. The results represent the average
of at least three independent experiments
and the standard deviation was calculated.
Growth curves
The strains transformed with the indicated
plasmids were grown overnight and the
cell density was determined. The cultures
were diluted to about 106 cells/ml, a
sample was taken (time point 0) and the
cultures were incubated at 24°C. Every
3 hours a sample was taken and the cell
density determined.
Actin staining
Yeast cell pre-cultures were grown at 24°C
in SD selective media in order to maintain
the plasmids. Cells taken from the
pre-culture were then grown at 24°C in
YPUAD to early log phase. Cells at
1.5 x 107 were then fixed in fomaldehyde
and stained with TRITC-phalloidin (Sigma,
St. Louis, MO) to visualize F-actin
essentially as described previously
(Benedetti et al., 1994).
Results
Interactions of the BAR-domain of
Rvs167p
Rvs167p can be divided into three regions:
the N-terminal BAR-domain, the GPA-
domain and the C-terminal SH3-domain
(Figure 1). Two previous studies have
shown that the BAR-domain of Rvs167p
interacts with Rvs161p. However, in one of
these reports the BAR-domain of Rvs167p
also interacted with full-length Rvs167p
(Colwill et al., 1999) while in the other
report no such interaction was detected
(Navarro et al., 1997). In order to clarify
this point we tested these interactions in a
different two-hybrid system. Both previous
studies used a two-hybrid system with the
yeast Gal4p as DNA-binding domain while
in our system the E.coli protein LexA is
used as DNA-binding domain. As expected
we detected a strong interaction of
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Rvs161p with the BAR-domain of
Rvs167p (Figure 2A). As shown in Figure
2B we also detected a strong interaction
between full-length Rvs167p and the BAR-
domain of Rvs167p. Since the BAR-
domain of Rvs167p mediates both the
interactions with Rvs161p and Rvs167p
there is the possibility that the interaction
of Rvs167p with itself is indirect and
mediated via Rvs161p. To test this we
performed a two-hybrid analysis in a
rvs161 strain and still detected a strong
Rvs167p-Rvs167p interaction (Figure 2C),
suggesting that the interaction is direct or
mediated by another protein than Rvs161p.
To confirm the report that Rvs161p and
Rvs167p form a complex in vivo (Navarro
et al., 1997), we showed that the two
proteins could be coimmunoprecipitated
under native conditions with antibodies
against Rvs167p (Figure 2D).
Reduced stability of Rvs proteins in the
absence of its partner
Interestingly, the localization of Rvs161p
(mostly cytoplasmic, at mother-bud neck
region in small budded cells) and Rvs167p
(small cortical patches that polarize upon
bud emergence) seems to be different
(Balguerie et al., 1999; Brizzio et al.,
1998). These findings raise the question
whether the interaction of Rvs161p with
Rvs167p is required in vivo. We found that
when compared to a WT strain at steady
state, the level of Rvs167p is strongly
reduced in a rvs161 strain (Figure 3A).
Similarly the level of Rvs161p is strongly
reduced in a rvs167 strain (Figure 3A).
As control we detected Sla2p, a protein
that is also required for endocytosis and
actin organization (Wesp et al., 1997). Its
levels were constant in the three strains
(Figure 3A). A decreased synthesis or an
increased instability of the proteins in the
mutant strains could cause these reduced
protein levels at steady state. In order to
address this question, we performed pulse-
chase experiments in the different strains.
As shown in Figure 3B, both Rvs161p in a
rvs167 strain and Rvs167p in a rvs161
strain are unstable when compared to a WT
strain. Taken together these data suggest an
in vivo function for the Rvs161p-Rvs167p
interaction in stabilizing both proteins.
Figure 2. Two-hybrid interactions of the BAR
domain of Rvs167p
Strains containing the reporter gene plasmid
pSH18-34 with the LacZ-gene under the control of
eight LexA-operators, a bait and a prey were
streaked out on plates containing X-Gal. Positive
interactors turn dark while negative colonies remain
white. (A) Full-length Rvs161p as bait
(pEGRVS161) was tested against full-length
Rvs167p (pJGRVS167) and indicated Rvs167p-
domains as preys. (B) Full-length Rvs167p as bait
(pEGRVS167) was tested against full-length
Rvs167p (pJGRVS167) and indicated Rvs167p-
domains as preys. (C) The interaction of Rvs167p
with itself was tested in a WT (EGY48) and in a
rvs161 (RH5239) strain. (D) Coimmunopreci-
pitation of Rvs161p and Rvs167p. Lysates from
WT (RH448) and rvs167 (RH2950) were
incubated with antibodies against Rvs167p or with a
preimmuneserum and the immunoprecipitates were
analyzed by SDS-PAGE and immunoblotting with
antibodies against Rvs161p.
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Figure 3. Interaction of Rvs161p and Rvs167p is
required for the stability of both proteins
(A) Protein extracts from WT (RH3376), rvs161
(RH2600) and rvs167 (RH2950) at steady state
were analyzed by SDS-PAGE and immunoblotting
with antibodies against Rvs161p and Rvs167p. As a
control the same extracts were blotted with
antibodies against Sla2p. (B) Pulse-chase
experiments. WT (RH3376), rvs161 (RH2600)
and rvs167 (RH2950) cells were metabolically
labeled and lysates were prepared as described in
Materials and Methods. Proteins were immuno-
precipitated from the lysates with antibodies against
Rvs161p or Rvs167p and the immunoprecipitates
were analyzed by SDS-PAGE and autoradiography.
Amount and ratio of Rvs161p and
Rvs167p are critical parameters for
endocytosis
Mutations in rvs161 or rvs167 have both
been shown to affect the internalization
step of receptor-mediated endocytosis
(Munn et al., 1995). In order to learn more
about the involvement of the proteins in
endocytosis we decided to overexpress
them and measure how they affect -factor
internalization. Introduction of a
2-plasmid with RVS161 or RVS167 in a
WT strain does not affect -factor
internalization (Figure 4A). Interestingly,
overexpression of Rvs167p in a rvs161
strain exacerbated the endocytic defect of
this strain (Figure 4B). Similarly, over-
expression of Rvs161p in a rvs167 strain
exacerbated the endocytic defect of this
strain (Figure 4C). The protein levels of
Rvs161p and Rvs167p upon over-
expression in a WT or a mutated strain are
similar (data not shown). Interestingly,
co-overexpression of both Rvs161p and
Rvs167p in a WT strain reduces -factor
internalization to about two thirds of WT
rate (Figure 4D). Taken together these data
suggest that not only the amounts of
Rvs161p and Rvs167p, but also their ratio
are critical parameters for endocytosis.
We have tested the same strains
overexpressing the Rvs proteins for an
actin and a growth phenotype. As shown in
Figures 5A-H, overexpression of the Rvs
proteins either individually or together in a
WT strain does not affect the actin
cytoskeleton profoundly. The cells have a
normal polarized actin cytoskeleton with
cables running along the mother-bud axis.
Also the growth rates of the different
strains are not greatly affected (Figure 5I).
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Figure 4. -factor uptakes
(A) WT strain (RH3376) transformed with either p181, p181RVS161 or p181RVS167 were tested for -factor
internalization at 24°C. The internalization rates were calculated as the percentage of counts internalized per
time unit in the linear range and normalized to the strain with p181 set to 100%. Note that the internalization rate
of the WT strain transformed with p181 is ~ 4.6 %/min. (B) rvs161 strain (RH2600) transformed with either
p195 or p195RVS167 were tested for -factor internalization at 24°C. The internalization rates were calculated
as the percentage of counts internalized per time unit in the linear range and normalized to the strain with p195
set to 100%. Note that the internalization rate of the rvs161 strain transformed with p195 is ~1.7 %/min.
(C) rvs167 strain (RH2950) transformed with either p181 or p181RVS161 were tested for -factor
internalization at 24°C. The internalization rates were calculated as the percentage of counts internalized per
time unit in the linear range and normalized to the strain with p181 set to 100%. Note that the internalization rate
of the rvs167 strain transformed with p181 is ~ 2.0 %/min. (D) WT strain (RH3376) transformed with
combinations of either p181, p195, p181RVS167 and p195RVS161 were tested for -factor internalization at
24°C. The internalization rates were calculated as the percentage of counts internalized per time unit in the linear
range and normalized to the strain with p181/p195 set to 100%.
As shown in Figures 6A to 6H, over-
expression of Rvs167p in a rvs161 strain
or overexpression of Rvs161p in a rvs167
strain does not further deteriorate or
ameliorate the actin defect exhibited by the
mutants. We detect a mild growth
phenotype upon overexpression of
Rvs167p in the rvs161 strain when
compared to the strain with the empty
vector (Figure 6I). Overexpression of
Rvs161p in a rvs167 strain has no
obvious effect on the growth rate
(Figure 6I).
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Figure 5. Actin staining and growth curve
(A - H) WT strain (RH3376) transformed with p181 and p195 (A, B), p181 and p195RVS161 (C, D),
p181RVS167 and p195 (E, F), p181RVS167 and p195RVS161 (G, H) were fixed and filamentous actin was
visualized using TRITC-phalloidin (panels A, C, E, G) or Nomarski optics (panels B, D, F, H). (I) The same
strains were grown overnight. The cultures were diluted to about 106 cells/ml, incubated at 24°C and the cell
densities were determined every three hours.
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Figure 6. Actin staining and growth curve
(A - D) rvs161 strain (RH2600) transformed with either p195 (A, B) or p195RVS167 (C, D) were fixed and
filamentous actin was visualized using TRITC-phalloidin (panels A, C) or Nomarski optics (panels B, D).
(E - H) rvs167 strain (RH2950) transformed with either p181 (E, F) or p181RVS161 (G, H) were fixed and
filamentous actin was visualized using TRITC-phalloidin (panels E, G) or Nomarski optics (panels F, H).
(I) The same strains were grown overnight. The cultures were diluted to about 106 cells/ml, incubated at 24°C
and the cell densities were determined every three hours.
Interaction of Rvs167p with actin does
not require Abp1p
Mutations in rvs167 affect the actin
cytoskeleton (Bauer et al., 1993) and
Rvs167p has been shown to interact with
actin via its SH3-domain (Amberg et al.,
1995). The actin binding protein Abp1p
has been proposed to mediate this
interaction of Rvs167p and actin since it
interacts with the GPA/SH3-domains of
Rvs167p (Lila and Drubin, 1997). As
Results 45
shown in Figure 7, the interaction of
Rvs167p with actin in the two-hybrid
system is not abolished in an abp1 strain
showing that Abp1p is not required to
mediate the interaction of Rvs167p with
actin. Interestingly, we also detect an
interaction of Rvs161p with actin in the
two-hybrid system. However, this
interaction is abolished in a rvs167 strain
suggesting that the interaction of Rvs161p
with actin is mediated via Rvs167p (data
not shown).
Figure 7. Two-hybrid analysis
The interaction of Rvs167p (pEGRVS167) with
actin (pJGACT1) was tested in a WT (EGY48) and
in an abp1 (RH5238) strain. The strains contain
the reporter gene plasmid pSH18-34 with the LacZ-
gene under the control of eight LexA-operators, a
bait and a prey. They were streaked out on plates
containing X-Gal. Positive interactors turn dark
while negative colonies remain white.
Discussion
In this study we provide direct evidence
that Rvs161p and Rvs167p function
together in vivo. We find that the steady
state levels of the two proteins are
inderdependent. This effect is caused by a
dramatically decreased stability of either
Rvs protein in the absence of its partner.
These data provide evidence that the
interaction of Rvs161p and Rvs167p is
physiologically relevant and required for
the stability of both proteins. Furthermore
these findings might explain the almost
identical phenotypes that are seen upon
mutation of the two genes individually.
The mutant phenotypes detected in either
mutant strain might be a combination of
loss of both Rvs proteins. Nevertheless,
one function, the Rvs161p function in cell
fusion (Brizzio et al., 1998), does not seem
to require Rvs protein-protein interaction.
Apparently, the highly reduced levels of
Rvs161p in the rvs167 mutant are
sufficient for this function. As seen in
Figure 3B, Rvs161p is more sensitive to
Rvs167p levels than vice versa. Since
Rvs167p has two additional domains when
compared to Rvs161p this difference might
reflect a partial stabilization of Rvs167p in
the absence of Rvs161p via interactions
mediated by these domains with other
proteins (e.g. interaction with actin).
As mentioned in the introduction, two
previous studies have investigated the
cellular localization of Rvs161p (mostly
cytoplasmic, at mother-bud neck region in
small budded cells; Brizzio et al., 1998)
and Rvs167p (small cortical patches that
polarize upon bud emergence; Balguerie et
al., 1999). The two proteins apparently do
not co-localize in the cell, however in this
study we have provided evidence that these
two proteins do function together in vivo.
This discrepancy might be explained if one
considers that Rvs161p localization is
mainly cytosolic. Therefore it might also
be localized to the Rvs167p-containing
patches but is not concentrated there. In the
case of Rvs167p, the bright fluorescence
caused by its high concentration in cortical
patches might make it difficult to detect an
additional weak diffuse cytosolic staining.
Therefore it is possible, that a certain
amount of Rvs167p is localized to the
cytosol and interacts with Rvs161p.
Interestingly, overexpression of either
Rvs161p or Rvs167p alone in a WT strain
has no major effect on the internalization
step of endocytosis. However, co-
overexpression of both proteins reduced
the -factor internalization rate to two
thirds of WT levels. Also, overexpression
of Rvs161p in a rvs167 strain, as well as
overexpression of Rvs167p in a rvs161
strain, exacerbated the endocytic defect
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found in the mutated strains. Since the
amount of protein upon overexpression is
similar in all the strains (WT, rvs161 and
rvs167, data not shown) we conclude that
both the amount and the ratio of Rvs161p
and Rvs167p are critical parameters for the
internalization step of endocytosis. We
have tested the strains used for the
endocytosis assays for an actin and a
growth phenotype. None of the strains
overexpressing the Rvs proteins exhibited
an obvious change in their actin
cytoskeleton when compared to the strains
with the empty vectors. Also the growth
rates were almost identical with the
exception of a mild defect detected upon
overexpression of Rvs167p in the rvs161
strain. The endocytic defect we detect in
some of the strains overexpressing the
Rvs proteins might be explained in two
ways. One possibility would be that
overexpression of the Rvs proteins causes a
very subtle actin defect not detectable by
immunofluorescence but affecting
endocytosis. Another possibility would be
that by overexpressing the Rvs proteins
another protein required for endocytosis is
titrated out and therefore endocytosis is
affected.
By using the two-hybrid system we
detected an interaction of Rvs167p with
itself mediated via the BAR-domain as
previously described (Colwill et al., 1999).
Since the same domain also mediates the
interaction with Rvs161p, we wanted to
determine if the Rvs167p-Rvs167p
interaction is direct or mediated via
Rvs161p. Two-hybrid analysis in an
rvs161 strain demonstrated that Rvs161p
is not required for this interaction and
therefore Rvs167p either interacts directly
with itself or the interaction is mediated via
another protein than Rvs161p.
Interestingly, amphiphysin I has also been
shown to interact with itself in mammalian
cells (Slepnev et al., 1998).
Mutations in rvs161 and rvs167 have been
shown to affect the actin cytoskeleton
(Bauer et al., 1993; Sivadon et al., 1995).
A previous study has shown that Rvs167p
interacts with actin via its SH3-domain
(Amberg et al., 1995) and it was suggested
that the actin binding protein Abp1p could
mediate this Rvs167p-actin interaction
(Lila and Drubin, 1997). Here we show
that in the two-hybrid system Rvs167p
interacts with actin in an abp1 strain
showing that Abp1p is not required for this
interaction. There are several possible
explanations for this finding. First, it could
be that in the absence of Abp1p another
protein takes over its function. Second,
there could be more than one protein
involved in mediating this interaction.
Third, Rvs167p could interact directly with
actin. Another potential candidate to
mediate the Rvs167p-actin interaction
could be Las17p, since it was shown to
interact with the GPA/SH3 domains of
Rvs167p in the two-hybrid system
(Madania et al., 1999).
rvs mutant cells show pleiotropic
phenotypes including sensitivity to non-
optimal growth conditions, defects in the
organization of the actin cytoskeleton,
defects in bud-site selection and
endocytosis (Bauer et al., 1993; Munn et
al., 1995; Sivadon et al., 1995).
Interestingly, Rvs167p was identified as a
target of the Pho85 cyclin-dependent
kinase and thus might be involved in the
regulation of the actin cytoskeleton early in
cell cycle (Lee et al., 1998). Also its
mammalian homolog, amphiphysin, has
been shown to be regulated by
phosphorylation (Bauerfeind et al., 1997;
Slepnev et al., 1998). In addition,
amphiphysin I has been implicated in the
autoimmune Stiff-Man syndrome disorder
associated with breast cancer and
amphiphysin II has been shown to interact
with the MYC oncoprotein implicating it in
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cell cycle control (David et al., 1994;
Sakamuro et al., 1996). Taken together
these data suggest that some general
functions and regulation of these proteins
have been conserved through evolution. In
addition, these findings implicate the
members of this protein family not only as
important players in intracellular
membrane trafficking but also in mediating
signals during the cell cycle.
In summary, we demonstrate for the first
time that the yeast amphiphysin homologs
Rvs161p and Rvs167p function together
in vivo. The interaction between the
proteins seems to be crucial for their
stability. Furthermore, we show that the
amount and ratio of Rvs161p and Rvs167p
are critical parameters for the
internalization step of endocytosis.
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Abstract:
In yeast, sphingoid base synthesis is required for the internalization step of endocytosis and
organization of the actin cytoskeleton. We show that overexpression of one of two kinases
Pkh1p or Pkh2p, that are homologous to mammalian 3-phosphoinositide-dependent kinase-1
(PDK1), can specifically suppress the sphingoid base synthesis requirement for endocytosis.
Pkh1p and Pkh2p have an overlapping function because only a mutant with impaired function
of both kinases is defective for endocytosis. We show that Pkh1/2p kinases are activated
in vitro by nanomolar concentrations of sphingoid base (PHS). These results suggest that
Pkh1/2p kinases are part of a sphingoid base-mediated signaling pathway that is required for
the internalization step of endocytosis. Two downstream effectors of this signaling cascade
were identified, the Pkc1p kinase and the amphiphysin homolog, Rvs167p. Both proteins are
phosphorylated by Pkh1/2p kinases and play a role in endocytosis.
My contribution to this work is shown in Figure 3A.
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Introduction
Endocytosis is the process whereby
eukaryotic cells internalize extracellular
material as well as part of their own plasma
membrane. This pathway is commonly
used for uptake of nutrients, down-
regulation of receptors and removal of
other proteins from the cell surface. The
development of several reporter systems to
study endocytosis, as well as the use of
genetic studies in the yeast Saccharomyces
cerevisiae has allowed the identification of
many components required for this
pathway. The internalization step of
endocytosis requires actin, proteins that are
required for proper actin cytoskeleton
organization, such as fimbrin, calmodulin,
type I myosin, the amphiphysin homologs
Rvs161p and Rvs167p, clathrin, and a
large set of proteins associated to these
major components (D’Hondt et al., 2000;
Geli and Riezman, 1998; Lombardi et al.,
2001; Riezman et al., 1996).
Recently, not only proteins but also lipids
have been implicated in several stages of
membrane trafficking, but the role of lipids
in vesicle budding and fusion in living cells
is poorly understood. It is known that the
sphingolipid synthesis pathway is neces-
sary for trafficking of glycosylphosphati-
dylinositol (GPI)-anchored proteins from
the endoplasmic reticulum to the Golgi
apparatus (Horvath et al., 1994; Sütterlin et
al., 1997). Phospholipids, in particular
phosphorylated derivatives of phospha-
tidylinositol (PtdIns), also appear to play a
critical role in regulating transport events
(De Camilli et al., 1996). Sterols have been
implicated in control of the internalization
step of endocytosis in both yeast and
mammalian cells (Munn et al., 1999; Rodal
et al., 1999; Subtil et al., 1999). Sphingoid
bases have also been shown to play a role
in regulation of cell surface expression of
amino acid permeases (Skrzypek et al.,
1998).
Using the S. cerevisiae lcb1-100 mutant, a
requirement for sphingoid base synthesis
for the internalization step of endocytosis
and for proper actin cytoskeleton
organization was revealed (Zanolari et al.,
2000). The LCB1 gene encodes a subunit
of the serine palmitoyltransferase that
catalyses the first step in sphingolipid
synthesis, the condensation of serine and
palmitoyl-CoA to yield 3-ketosphinganine
(Nagiec et al., 1994). The sphingoid base
requirement for endocytosis can be
suppressed by loss of protein phosphatase
2A activity or by overexpression of two
kinases (Pkc1p or Yck2p), suggesting a
signaling function of sphingoid bases in
activation of a protein kinase and a protein
phosphatase acting sequentially in
endocytosis (Friant et al., 2000).
These results imply that the function of
sphingoid bases in endocytosis is to control
protein phosphorylation. In mammalian
cells, studies revealed that sphingosine
induces in vitro phosphorylation of
endogenous proteins through the activation
of protein kinases (Pushkareva et al., 1992)
and two unidentified sphingosine-activated
protein kinases were characterized by their
substrate specificity and their sphingosine
requirement (Pushkareva et al., 1993).
Sphingosine acts also by inhibiting some
kinases like protein kinase C (Hannun et
al., 1986) or by activating some others, like
the casein kinase II (McDonald et al.,
1991), the atypical protein kinase C
isoform  (Muller et al., 1995), the p21
activated kinase-1 (PAK1; Bokoch et al.,
1998) and the 3-phosphoinositide-
dependent kinase-1 (PDK1; King et al.,
2000). Thus sphingoid bases play a dual
role in the regulation of protein
phosphorylation.
It was recently shown that sphingosine
stimulates PDK1 kinase autophospho-
rylation and increases the phosphorylation
of known PDK1 substrates like PAK1, Akt
and PKC  kinases in vitro suggesting that
sphingosine is a novel activator of PDK1
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(King et al., 2000). PDK1 phosphorylates
several protein kinases in vitro and is
responsible for activating these enzymes
in vivo (Alessi et al., 1998; Le Good et al.,
1998; Pullen et al., 1998). S. cerevisiae has
two PDK1 homologs encoded by the
PKH1 and PKH2 genes. Similarly,
Pkh1/2p kinases were shown to
phosphorylate and activate several protein
kinases including Ypk1/2p and Pkc1p both
in vitro and in vivo (Casamayor et al.,
1999; Inagaki et al., 1999). Pkh1p and
Pkh2p kinases share an essential role for
cell growth since the double knockout
pkh1 pkh2 yeast strain is not viable.
Synthetic lethality of pkh1 pkh2 double
mutant is complemented by full length
human PDK1, or human PDK1 lacking the
C-terminal pleckstrin homology (PH)
domain that was shown to bind
phosphoinositides (Casamayor et al.,
1999). Furthermore both Pkh1p and Pkh2p
kinases contain no obvious PH domain, in
contrast to Human and Drosophila PDK1,
suggesting that in yeast the activation of
Pkh1/2p kinases may not be dependent on
phosphoinositides.
A recent study revealed that yeast cells
overproducing PKH1 display an increased
resistance to myriocin treatment, a serine
palmitoyl transferase (Lcb1p) inhibitor
(Sun et al., 2000). Pkh2p was shown to
phosphorylate Pkc1p kinase in vitro and
the temperature-sensitivity of a pkh-ts
(pkh1-ts pkh2) mutant is partially
suppressed by a PKC1-R398P dominant
mutation (Inagaki et al., 1999). In a
previous study, we showed that PKC1
overexpression or PKC1-R398P expression
can suppress the sphingoid base
requirement for endocytosis, suggesting a
link between sphingoid base synthesis and
Pkc1p activation (Friant et al., 2000).
These results suggest that the Pkh1/2p
kinases may be activated by sphingoid
bases and play a role in endocytosis via
Pkc1p activation. To test this hypothesis,
we investigated the implication of Pkh1/2p
kinases in endocytosis.
Here, we show that overexpression of one
of two protein kinases, Pkh1p or Pkh2p,
can abrogate the sphingoid base synthesis
requirement for endocytosis and restore a
proper organization of the actin
cytoskeleton in lcb1-100 mutant cells. The
two kinases have an overlapping function
in endocytosis because only a mutant with
impaired function of both kinases is
defective in the internalization step of
endocytosis. Furthermore, phosphorylation
of Pkc1p by Pkh1p or Pkh2p kinase
in vitro is increased in the presence of
nanomolar concentration of sphingoid
base. These results imply that the function
of sphingoid base in endocytosis is to
activate a signaling pathway via Pkh1/2p
kinases. The ultimate target of the
sphingoid base-mediated signaling
pathway may be the endocytic machinery
via a novel effector, the amphiphysin-
homolog Rvs167p (R. Lombardi et al.,
accompanying study) and/or the actin
cytoskeleton via the Pkc1p kinase.
Results
Overexpression of Pkh1/2p kinases
restores endocytosis in the lcb1-100
mutant
To test if yeast PDK1 homologs, Pkh1/2p
kinases, could be part of the sphingoid base
requirement for endocytosis, we analyzed
if PKH1 or PKH2 overexpression could
suppress the endocytic defect of the
lcb1-100 mutant. The lcb1-100 strain was
transformed with high copy (2 plasmids
bearing PKH1 or PKH2 genes (Table I).
Neither of the two protein kinases tested
was able to suppress the temperature-
sensitive growth phenotype displayed by
the lcb1-100 mutant (data not shown). The
same strains overexpressing Pkh1p or
Pkh2p kinases were tested for
internalization of [35S]-factor at 37°C.
High copy expression of PKH2 and to a
less extent PKH1 restored the defect in
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-factor internalization of the lcb1-100
mutant cells at 37°C (Figure 1A). To
compare the suppressor effect of the
Pkh1/2p kinases, we tested in parallel the
two other kinases, Yck2p and Pkc1p, that
were already shown to restore the lcb1-100
defect in endocytosis (Figure 1A; Friant et
al., 2000). The -factor uptake rate
displayed by the lcb1-100 cells
overexpressing PKH2 overlaps more or
less with the one overexpressing YCK2,
whereas PKH1 suppressor effect is more
similar to the one of PKC1 (Figure 1A).
Figure 1. Overexpression of PKH1 and PKH2
specifically suppresses the lcb1-100 -factor
internalization defect
(A) Strain RH3802 (lcb1) was transformed with
high copy plasmids carrying PKH1, PKH2, PKC1
or YCK2 kinase genes (Table I) and the
corresponding transformants were assayed for
-factor internalization at 37oC and compared with
lcb1-100 cells. (B) The sla2-41 (end4-1) and end6-1
(rvs161) temperature sensitive mutants (RH3802,
RH1597 and RH2082) were transformed with a
high copy number plasmid bearing PKH1 or PKH2
and assayed for -factor uptake at 37°C.
To determine if other endocytosis mutants
could also be suppressed by PKH1 or
PKH2 overexpression, the sla2-41 (end4-1)
and end6-1 (rvs161) strains were
transformed with the 2 plasmids bearing
the PKH1/2 genes and assayed for -factor
uptake at 37°C (Figure 1B). These two
mutants are defective for -factor
internalization at 37°C (Munn et al., 1995;
Raths et al., 1993). The high copy
expression of PKH1 or PKH2 did not
restore endocytosis in these strains
(Figure 1B), showing that Pkh1/2p over-
expression specifically suppresses the
lcb1-100 endocytic defect.
The ability of lcb1-100 cells
overexpressing PKH1 or PKH2 to carry
out fluid-phase endocytosis at 37°C was
also tested and compared to wild type and
lcb1-100 cells (Figure 2). The lcb1-100
mutant showed a few small vacuoles when
viewed by Nomarski optics and was
defective for uptake and accumulation of
the fluorescent dye lucifer yellow (LY) in
the vacuole at 37°C (Zanolari et al., 2000).
Consistent with the -factor uptake results,
overexpression of PKH1 or PKH2 allowed
the lcb1-100 mutant to accumulate LY in
the vacuole even tough the vacuole
morphology defect was not restored
(Figure 2).
Taken together, these results show that
overexpression of Pkh1/2p kinases
specifically suppress both receptor-
mediated and fluid-phase endocytosis
defects of the lcb1-100 mutant.
Furthermore, they support the notion that
sphingoid bases may activate a protein
phosphorylation pathway required for the
internalization step of endocytosis and
mediated via Pkh1/2p kinases.
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Figure 2. PKH1/2 overexpression suppresses the fluid-phase endocytic defect of the lcb1-100 mutant
Wild-type cells (WT, RH448) and lcb1-100 (lcb1, RH3802) cells carrying either a PKH1 or a PKH2 high copy
number plasmid (lcb1+PKH1 or lcb1+PKH2) were assayed for LY accumulation in the vacuole at 37°C. The
same field of cells viewed by fluorescence (left panel) and by Nomarski optics (right panel) is shown. Note that
lcb1-100 cells have fragmented vacuoles when compared to wild-type cells (right panel).
Pkh1/2p kinases are required for
endocytosis
To determine whether Pkh1/2p kinase
activity is required for the internalization
step of endocytosis, -factor uptake and
LY accumulation of pkh1, pkh2 and
pkh-ts strains were assayed (Figure 3
and 4). PKH1 and PKH2 have overlapping
function for cell growth (Casamayor et al.,
1999; Inagaki et al., 1999). The pkh-ts
strain harbors a chromosomal deletion of
the PKH2 gene (pkh2::LEU2) and a
temperature-sensitive pkh1-ts mutant allele
(pkh1D398G ; Inagaki et al., 1999). The
single disruptants and temperature-
sensitive mutant strains were assayed for
-factor uptake and compared to wild-type
cells (Figure 3A and 3B). The single
mutant cells pkh1 and pkh2 internalized
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-factor with the same rate as wild-type
cells at 37°C (Figure 3A). At 24°C, the
pkh-ts strain showed a partial -factor
internalization defect when compared to
wild-type cells, and at 37°C the mutant
strain was unable to internalize -factor
(Figure 3B). Therefore, we conclude that
Pkh1p and Pkh2p kinases have an
overlapping function for endocytosis and
that the loss of Pkh1/2p kinase activity
affects the internalization step of receptor-
mediated endocytosis.
Figure 3. Pkh1/2p are required for receptor-
mediated endocytosis
(A) Pkh1p and Pkh2p have redundant function in
endocytosis. The single mutant pkh1 (RH3802)
and pkh2 (RH4336) cells were assayed for
-factor uptake at 37°C and compared to the wild-
type cells (WT, RH448). (B) Pkh1/2p kinases are
required for endocytosis. Radiolabeled -factor
uptake assays were performed at 24°C (open
symbols) or 37°C (closed symbols) on wild-type
(RH448) and pkh-ts (RH4329) strains.
As the pkh-ts mutant is defective for
receptor-mediated internalization at 37°C it
was important to examine whether this
mutant is also defective for fluid-phase
endocytosis. Therefore, we tested for a
defect using the LY uptake assay. The
pkh-ts cells were completely defective in
LY accumulation at 37°C (Figure 4). These
results show that Pkh1p and Pkh2p have an
overlapping function in endocytosis,
because only the cells with impaired
activity for both kinases were defective for
the internalization step of endocytosis.
Figure 4. Pkh1/2p kinases are required for fluid-
phase endocytosis
Wild-type (WT, RH448) and pkh-ts (RH4598) cells
were incubated with LY for 1 hr at 37°C. To
visualize LY uptake, cells were viewed by FITC-
fluorescence optics (left panel). The same fields of
cells were viewed by Nomarski optics (right panel)
to visualize the vacuoles.
Overexpression of Pkh1/2p specifically
corrects the actin defect of the lcb1-100
mutant
The lcb1-100 mutant is defective in the
organization of the actin cytoskeleton at
37°C. This defect, like the endocytic
defect, can be suppressed by addition of
phytosphingosine (PHS) or overexpression
of Yck2p or Pkc1p kinases in the lcb1-100
cells (Friant et al., 2000; Zanolari et al.,
2000). Therefore, it is conceivable that
overexpression of the Pkh1/2p kinases,
which restored endocytosis in the lcb1-100
mutant, may also correct the actin
organization defect of this mutant. To test
this, we examined whether Pkh1p or Pkh2p
overexpression in the lcb1-100 mutant
could restore the polarized distribution of
actin at 37°C. Wild-type, lcb1-100 and
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lcb1-100 overexpressing PKH1 or PKH2
cells were grown at 24°C, shifted to 37°C
for 2 hours and the cells were fixed and
stained with TRITC-phalloidin to visualize
F-actin (Figure 5). A shift from 24°C to
37°C causes a heat-induced reorganization
of the actin cytoskeleton in wild-type yeast
cells to a non-polarized distribution.
Normal polarized actin localization is
restored after 1.5-2 h at 37°C in wild type
cells (Figure 5). In contrast, this
perturbation was irreversible in the
lcb1-100 mutant cells, as seen by the
accumulation of actin patches in the
mother cell of the budded cells (Figure 5;
Zanolari et al., 2000). However, lcb1-100
mutant cells that were suppressed for
endocytosis either by Pkh1p or Pkh2p
kinase overexpression, displayed polarized
distribution of actin that was more similar
to wild-type cells with cortical actin
patches concentrated in the bud (Figure 5).
Figure 5. Pkh1/2p kinases overexpression suppresses specifically the lcb1-100 actin organization defect
Logarithmic cultures of wild-type cells (WT, RH448), lcb1-100, end4-1 (sla2-41) and end6-1 (rvs161) mutant
cells (RH3802, RH1597 and RH2082) without or with the PKH1 and PKH2 plasmids, were grown at 24°C,
shifted to 37°C for 2 hr, fixed, stained with TRITC-phalloidin and observed by fluorescence (actin) and
Nomarski (DIC) microscopy.
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Pkh1/2p kinases have been shown to be
required for proper actin cytoskeleton
organization in yeast (Inagaki et al., 1999).
To determine if the suppression by PKH1/2
was specific for the sphingoid base
synthesis requirement of lcb1-100 cells,
two other endocytic mutant that display
actin cytoskeleton defects the sla2-41
(end4-1) and end6-1 (rvs161), were tested
(Munn et al., 1995; Raths et al., 1993). The
sla2-41 and end6-1 mutants were trans-
formed with the high copy number
plasmids bearing PKH1 or PKH2 genes
and assayed for actin localization at 37°C
(Figure 5). Proper actin localization was
not restored by either PKH1 or PKH2
overexpression in these mutants, showing
that suppression is specific for the lcb1-100
mutant. The above results suggest that one
target of the sphingoid base synthesis
requirement is likely to be the actin
cytoskeleton because overexpression of the
Pkh1/2p kinases specifically corrected the
actin defect in the lcb1-100 mutant.
Sphingoid base activates Pkh1p and
Pkh2p kinase activity in vitro
We could show that Pkh1p and Pkh2p
kinases are required for endocytosis and
that their overexpression can suppress the
requirement for sphingoid base synthesis.
The above results suggest that like their
mammalian homologue PDK1, Pkh1p and
Pkh2p could be directly activated by
sphingoid base as part of a signaling
cascade required for the internalization step
of endocytosis. To test this hypothesis, we
developed an in vitro phosphorylation
assay by using immunoprecipitated Pkh1p
or Pkh2p incubated in presence of
increasing concentration of phyto-
sphingosine (PHS). Wild-type cells were
transformed with a plasmid bearing PKH1
or PKH2 genes tagged at their C-terminus
with a triple HA epitope (Table I). These
two Pkh1-HA3 and Pkh2-HA3 constructs
are functional because they can suppress
the temperature sensitive growth
phenotype displayed by the pkh-ts strain
(data not shown). It was recently shown
that Pkh1/2p kinases directly phospho-
rylate and thus activate Pkc1p (Inagaki et
al., 1999). Therefore, we used immuno-
precipitated Pkc1p as the natural substrate
for Pkh1p and Pkh2p kinase in our in vitro
assay. A wild-type strain was transformed
with a multicopy plasmid encoding Pkc1p
triple HA tagged at its C-terminus (pTS94).
This construct is functional since a
pkc1-2 strain transformed with this plasmid
shows no growth defect at 37°C anymore.
Pkh1-HA3, Pkh2-HA3 or Pkc1-HA3 were
immunoprecipitated with an anti-HA
antibody. Immunoprecipitated Pkc1-HA3
shows a proper folding and activity
because in an in vitro phosphorylation
assay the immunoprecipitated Pkc1-HA3
phosphorylated correctly its substrate, the
myelin basic protein (Antonsson et al.,
1994; data not shown). Immuno-
precipitated Pkh1-HA3 or Pkh2-HA3 was
incubated in presence of its substrate
Pkc1-HA3, and aliquots of this kinase-
substrate mix were incubated with
[-32P]ATP in the presence of increasing
concentration of phytosphingosine (PHS)
(Figure 6). A control without Pkh1/2p
kinase to determine the amount of
Pkc1-HA3 autophosphorylation was done
in parallel. Phosphorylated [32P]Pkc1-HA3
was revealed by using a Cyclone Storage
Phosphor Imager (Packard) after
electrophoresis on a 7.5% SDS-PAGE
(Figure 6A and 6C) and the amount of
radiolabeled Pkc1-HA3 was quantified
(Figure 6B and 6D). All phosphorylation
assays were performed at least twice, the
results shown are from one of the
independent experiments that gave nearly
identical results. PHS was found to be a
potent activator of both Pkh1p and Pkh2p
kinases, since at concentration as low as
0.5 nM there is an increase in Pkc1-HA3
phosphorylation (Figure 6A and 6C)
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therefore an activation of Pkh1/2p kinase
activity. A 3-fold activation of both Pkh1p
and Pkh2p kinase activity is observed in
the presence of 2.5 nM to 25 nM PHS
respectively (Figure 6B and 6D). However,
PHS becomes less effective at higher
concentrations and at 500 nM PHS
inhibited both Pkh1p and Pkh2p
phosphorylation of Pkc1p (Figure 6).
These findings suggest that PHS has a
bifunctional effect on Pkh1/2p activity in
vitro, stimulating the activity at low
concentrations and inhibiting it at high
concentrations. These results show that
Pkh1/2p kinases are directly activated by
PHS in vitro and are one of the yeast
sphingoid base-activated kinases.
Figure 6. Phytosphingosine activates the Pkh1/2p kinases
(A) Immunoprecipitated Pkh1-HA3 was incubated with its substrate Pkc1-HA3 in the presence of [-32P]ATP and
increasing amounts of PHS. Phosphorylated Pkc1-HA3 was revealed by a Cyclone Storage Phosphor Imager
(Packard) after separation on a 7.5% SDS-PAGE. (B) The amount of radiolabeled [32P]Pkc1-HA3 was quantified
in each lane and basal phosphorylation of Pkc1p by Pkh1p without PHS was set as 1. (C) and (D) The same
assay was done using Pkh2-HA3 as the kinase.
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Discussion
The major finding of this study is that
Pkh1/2p kinases are part of a sphingoid
base-mediated signaling pathway required
for the internalization step of endocytosis
and for proper actin cytoskeleton
organization in yeast. As shown
previously, the actin cytoskeleton plays an
essential role in the internalization step of
endocytosis in yeast, because yeast mutants
in actin and actin-binding proteins are
defective in endocytosis (Kübler and
Riezman, 1993; Munn et al., 1995). Here
we showed that overexpression of PKH1/2
restored the endocytic and the actin
cytoskeleton organization defect of the
lcb1-100 mutant. It is interesting to note,
that neither PKH1 nor PKH2 over-
expression restored the endocytic or actin
defect of other mutants that are defective in
the internalization step of endocytosis and
in actin cytoskeleton organization, meaning
that this suppressor effect was specific for
the lcb1-100 mutation. We show that
Pkh1p and Pkh2p kinases have redundant
functions for both fluid-phase and receptor-
mediated endo-cytosis. A previous study
has shown that these two kinases are also
required for actin cytoskeleton organi-
zation, since the pkh-ts strain displays a
defect in actin polarization upon shift to
37°C (Inagaki et al., 1999). These results
suggest that Pkh1/2 kinases play adirect
role in endocytosis perhaps by regulating
the endocytic machinery and/or the actin
cytoskeleton. Here, we showed that
sphingoid base activates both Pkh1p and
Pkh2p protein kinases in vitro. All these
results together suggest that there is a
sphingoid base-mediated signaling path-
way required for endocytosis and that the
sphingoid base activated kinase that
mediates this cascade are the Pkh1/2p
kinases.
Pkh1p and Pkh2p are the yeast homologs
of mammalian PDK1 kinase. Human,
Drosophila and C. elegans PDK1 kinases
contain a pleckstrin homology (PH)
domain and this PH domain binds
PI(3,4,5)P3 and PI(3,4)P2 (Currie et al.,
1999; Fruman et al., 1999; Stephens et al.,
1998). In contrast, the two yeast members
of this kinase family, Pkh1p and Pkh2p,
lack the PH domain (Casamayor et al.,
1999). It was previously shown that
mammalian PDK1 lacking the PH domain
was sufficient to rescue pkh1 pkh2
mutant cells from lethality (Casamayor et
al., 1999). Furthermore, yeast cells are not
able to generate PI(3,4,5)P3 and PI(3,4)P2
(Hawkins et al., 1993) and Pkh1p does not
bind PI(3,4,5)P3 under conditions where
this phospholipid binds tightly to PDK1
(R. Currie and C.P. Downes, unpublished
data). These findings suggest that Pkh1/2
kinases are not regulated by phospho-
inositides like their mammalian
counterpart. The best candidates for
regulating Pkh1/2p kinases activity are
sphingoid bases, because a previous study
showed that mammalian PDK1 kinase is
activated in vitro in presence of
sphingosine and that elevated intracellular
sphingosine level increases PDK1 activity
in vivo (King et al., 2000). Here, we
showed that overexpression of PKH1 or
PKH2 suppresses the endocytic defect of
the lcb1-100 mutant strain that is impaired
in sphingoid base synthesis. Moreover, by
using an in vitro kinase assay we could
show that both Pkh1p and Pkh2p are
activated by nanomolar concentration of
phytosphingosine (PHS). There is a three
fold increase in Pkh1/2p kinases activity in
presence of very low concentrations of
PHS (0.5 to 2.5 nM). Using the same
in vitro kinase assay, we also tested the
ability of dihydrosphingosine (DHS),
another sphingoid base that was shown to
suppress the lcb1-100 endocytic defect
(Zanolari et al., 2000), to activate Pkh1p
kinase. We obtained the same results as for
PHS (data not shown). All these results
together suggest that both PDK1 and its
yeast counterparts Pkh1/2p kinases are
sphingoid base-activated kinases. Further-
more, the results obtained here together
with previous results showing that neither
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phosphorylated sphingoid bases nor
ceramides or sphingolipids are required for
endocytosis (Zanolari et al., 2000), suggest
that sphingoid bases (DHS and/or PHS) are
required for Pkh1/2 kinases activation.
However, we cannot rule out the possibility
that another yet unidentified derivative of
PHS/DHS could be the true Pkh1/2 kinase
activator, but this derivative cannot be
phosphorylated sphingoid base because
yeast incapable of generating phospho-
rylated sphingoid bases are capable of
endocytosis (Zanolari et al., 2000).
Pkc1p and Ypk1/2p kinases were identified
as downstream effectors of the Pkh1/2p
protein kinase cascade. These two kinases
are directly phosphorylated by Pkh kinase
in vitro (Casamayor et al., 1999; Inagaki et
al., 1999). Reduced Pkc1p activity was
observed in a pkh-ts mutant strain
indicating that Pkh1/2p kinases are
required for Pkc1p function in vivo
(Inagaki et al., 1999). In a previous study,
we could show that an increased gene
dosage of PKC1 or expression of a
dominant, activated allele of PKC1
suppresses the endocytic defect of the
lcb1-100 mutant (Friant et al., 2000). The
above results showed that Pkc1p phospho-
rylation by Pkh1/2p kinases is activated by
sphingoid base in vitro. These data suggest
that Pkc1p may be activated by Pkh1/2p
kinases in response to sphingoid base and
that this signaling cascade is required for
the internalization step of endocytosis. The
essential role for Pkh1/2 kinases in
endocytosis is further confirmed by the
strong endocytic defect observed in a
pkh-ts mutant strain. The lcb1-100 mutant
strain blocked in sphingoid base synthesis
shows a similar endocytosis defect
(Zanolari et al., 2000), whereas the pkc1-ts
mutant cells showed wild-type endocytosis
(Friant et al., 2000). Therefore, the Pkc1p
kinase is one of the downstream effectors
of the Pkh1/2p signaling cascade, but it is
not the only one required for the
internalization step of endocytosis. Yck2p
kinase could be another downstream
effector, because overexpression also
suppresses the lcb1-100 endocytosis defect
and only the double mutant pkc1-ts yck-ts
strain is completely defective for
endocytosis (Friant et al., 2000). We did
not find a consensus PDK1/2-Pkh1/2
phosphorylation site in the Yck2p kinase,
whereas both Pkc1p and Ypk1/2p kinases
have these site (Casamayor et al., 1999),
meaning that Yck2p is probably not
directly activated by Pkh1/2p. There could
be another kinase upstream of Yck2p in the
signaling cascade. The Ypk1/2p kinases
would be good candidates.
The Ypk1p kinase was recently identified
as a multicopy suppressor gene that
restores growth in presence of a serine
palmitoyl transferase (Lcb1p) inhibitor.
Furthermore, phosphorylation of the
Ypk1p kinase is increased in presence of
PHS (Sun et al., 2000). This
phosphorylation could be due to activation
of Pkh1/2p kinases by PHS, because
Ypk1p is directly phosphorylated by Pkh2p
in vitro (Casamayor et al., 1999). In
agreement with this hypothesis, it was
shown that Pkh kinase activity was
required for maximal Ypk1p phospho-
rylation in vivo (Casamayor et al., 1999).
These data suggest that Pkh1/2p kinases
might be tightly regulated by sphingoid
bases, not only for their function in
endocytosis, but for their overall function
in regulating several yeast processes, like
cell growth, control of the mitogen-
activated protein kinases and organization
of the actin cytoskeleton. In a previous
study, we could show that YPK1 or YPK2
overexpression did not suppress the
lcb1-100 endocytosis defect (Friant et al.,
2000), suggesting that these kinases are not
part of the signaling cascade required for
the internalization step of endocytosis.
However, we cannot exclude that YPK1/2
overexpression would not be sufficient to
mimic the Pkh1/2p activation effect on
these kinases, because they may not be
active in their dephosphorylated state, even
if overexpressed.
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In summary, our results are the first
example of a sphingoid base activated
signaling pathway being used to regulate a
step of membrane traffic. Many details
remain to be discovered, including the
identification of the downstream effectors
of the Pkh1/2p sphingoid base activated
protein kinase and the mechanism whereby
sphingoid base controls the relative
activities of protein kinases. The ultimate
target of the sphingoid base mediated
signaling pathway may be the endocytic
machinery via a novel effector, the
amphiphysin homolog Rvs167p
(R. Lombardi et al., accompanying study;
Lombardi and Riezman, 2001) and/or the
actin cytoskeleton via the Pkc1p kinase.
The ease of genetic and molecular studies
in yeast should help to understand these
questions.
Materials and Methods
Plasmids, strains, media and genetic
manipulations
Plasmids and yeast strains used in this
study are listed in Tables I and II,
respectively. Disruption mutants were
created by integrative transformation using
standard techniques. Yeast cell cultures
and genetic manipulations were carried out
essentially as described (Sherman et al.,
1983). Yeast cells were transformed by the
LiAc method using single-stranded carrier
DNA and DMSO (Hill et al., 1991;
Schiestl and Gietz, 1989). Rich YPUAD
medium and synthetic minimal media (SD)
complemented with the appropriate
nutrients for plasmid maintenance were
prepared as described (Munn et al., 1995).
Endocytosis assays
Lucifer yellow-carbohydrazide (LY)
(Fluka, Buchs, Switzerland) assays were
performed as described (Dulic et al., 1991;
Munn and Riezman, 1994). Yeast
precultures were grown at 24°C in SD
selective media in order to maintain the
plasmids. Cells taken from the pre-culture
were then grown at 24°C in YPUAD to
mid log phase, shifted to 37°C for 15 min
and incubated for 1 h at 37°C with LY.
[35S]-factor uptake assays were
performed on mid-log phase cells using the
continuous presence protocol as described
(Dulic et al., 1991). Pre-cultures were done
at 24°C in SD selective media in order to
maintain the plasmids. Cells taken from the
pre-culture were then grown at 24°C in
YPUAD medium, the -factor uptake
assays were carried out at 24°C or 37°C
after 15 min preincubation at the respective
temperature. All uptake assays were
performed at least twice, the results shown
are from one of the independent
experiments, which gave nearly identical
results.
Rhodamine-Phalloidin staining of actin
Yeast cells pre-cultures were grown at
24°C in SD selective media in order to
maintain the plasmids. Cells taken from the
pre-culture were then grown at 24°C in
YPUAD medium to early log phase. Cells
at 1 x 107 cells/ml were then incubated for
2 hr at 37°C, fixed in formaldehyde and
stained with TRITC-phalloidin (Sigma,
St. Louis, MO) to visualize F-actin
essentially as described previously
(Benedetti et al., 1994).
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Table I. Plasmids
Plasmid Yeast Ori Insert Source
YEp195-PKH1 2 PKH1 Schmelzle and Hall
YEp195-PKH2 2 PKH2 Schmelzle and Hall
pTS80 2 PKH1-HA3 Schmelzle and Hall
pTS81 2 PKH2-HA3 Schmelzle and Hall
pSH24 2 PKC1 Helliwell et al., 1998
pTS101 2 PKC1-HA3 Schmelzle and Hall
pL2.3 2 YCK2 Robinson et al., 1992
Table II. Yeast strains
Strains Genotype Source
RH448 leu2 ura3 his4 lys2 bar1 Lab. Strain
RH1597 leu2 ura3 his4 bar1 end4-1 Raths et al., 1993
RH2082 leu2 ura3 his4 bar1 end6-1 Munn et al., 1995
RH3802 leu2 ura3 his4 his3 ade2 lys2 bar1 lcb1-100 Friant et al., 2000
RH3809 leu2 ura3 his4 bar1 lcb1-100 Friant et al., 2000
RH5388 leu2 ura3 ade2 trp1 bar1::URA3 pkh2::LEU2 This study
RH5411 leu2 ura3 his2 ade1 trp1 bar1::URA3 This study
RH5412 leu2 ura3 his2 ade1 trp1 bar1::URA3 pkh1-ts pkh2::LEU2 This study
RH5413 leu2 ura3 his3 ade2 trp1 lys2 bar1 pkh1::TRP1 This study
All strains listed in this table are MAT a.
In vitro phosphorylation assay
Wild-type yeast cells (RH448) transformed
with plasmids bearing PKC1-HA3,
PKH1-HA3 or PKH2-HA3 were grown at
24°C in SD selective media in order to
maintain the plasmids. Cells around
1.5 x 107 cells/ml were then harvested and
total yeast proteins were extracted by glass
beads lysis in a buffer containing, 50 mM
HEPES pH 7.5, 150 mM KCl, 1 mM
EDTA, 1 mM EGTA, 10% glycerol and
1 g/ml of the protease inhibitors
aprotinin, leupeptin, pepstatin A,
chymostatin and antipain. The protein
concentration of the lysates was measured
using the Bio-Rad protein assay. Equal
amounts of total protein for the different
kinases were taken and triple HA-tagged
kinases were immunoprecipitated over-
night at 4°C from these extracts using 5 l
of anti-HA rat monoclonal antibody (Clone
3F10, Boehringer Manheim), 50 l of 30%
protein G-sepharose beads in a final
volume of 750 l immunoprecipitation
buffer (50 mM Tris-HCl pH 7.5, 150 mM
NaCl, 1 mM EDTA, 1 mM EGTA, 1%
Nonidet P-40 and 1 g/ml of the protease
inhibitors aprotinin, leupeptin, pepstatin A,
chymostatin and antipain). Beads were
then washed three times in immuno-
precipitation buffer and two times in
40 mM MOPS pH 7.5 buffer and
resuspended in phosphorylation buffer
(40 mM MOPS pH 7.5, 1 mM DTT and
10 mM MgCl2). Equal amounts of kinase-
beads (Pkh1p or Pkh2p beads) were mixed
with Pkc1p-beads (substrate). In order to
determine the amount of autophospho-
rylation, a control containing the same
amount of Pkc1p beads mixed with
phosphorylation buffer was treated in
parallel. The kinase-substrat mix was
aliquoted and 1 l of D-erythro-phyto-
sphingosine (PHS) at the proper dilution in
ethanol was added to the mix in order to
get a final concentration of 0.5, 2.5, 25,
100, 200 or 500 nM of PHS in each
reaction assay. The control reaction
without PHS was done by adding 1 l of
ethanol to the reaction. After 10 min of
pre-incubation at room temperature, 2 l of
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[32P]ATP mix (1 mM ATP and 4 Ci
[-32P]ATP) was added and the phospho-
rylation reaction was run for 30 min at
room temperature. The reaction was
stopped by addition of cold ATP at a final
concentration of 50 mM and Laemmli
protein sample buffer. Samples were boiled
for 5 min and the total reaction was loaded
on a 7.5 % SDS-PAGE. After
electrophoresis, the gel was washed once in
12.5% TCA and two times in Coomassie
blue destaining solution. Phosphorylated
Pkc1-HA3 was revealed and quantified by
using a Cyclone Storage Phosphor Imager
(Packard). All phosphorylation assays were
performed at least twice. The results shown
are from one of the independent
experiments, which gave nearly identical
results.
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Abstract:
The internalization step of endocytosis in yeast requires the actin cytoskeleton and a large
number of actin-associated proteins. To understand the functions of the different proteins
involved in this step we have looked for protein-protein interactions among them. We find
that three proteins involved in this process, Rvs167p, Myo5p and Sla2p/End4p, interact with
each other and form a 600 kDa protein complex most likely involved in regulating the actin
cytoskeleton. We also identified Rvs167p as an important target for regulation of endocytosis
by Pkh2p protein kinase. Pkh1/2p kinases are homologous to mammalian 3-phosphoinositide-
dependent kinase-1 (PDK1). By sequence comparison we identified a putative phospho-
rylation site at the extreme N-terminus of Rvs167p and we could show that Pkh2p is able to
phosphorylate Rvs167p in vitro. We mutated the phosphorylated Thr7 to an alanine and
demonstrate that this point mutation affects the internalization step of endocytosis in vivo.
Interestingly, the point mutation did not affect the actin cytoskeleton suggesting a possible
direct function of Rvs167p in endocytosis besides its role in actin cytoskeleton function.
I wrote the manuscript and performed all shown experiments.
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Introduction
Endocytosis is a general mechanism
whereby eukaryotic cells internalize
portions of their own plasma membrane
together with molecules from the external
environment. Several studies in the yeast
Saccharomyces cerevisiae have identified a
large number of mutants defective in the
internalization step of endocytosis and
initial analysis of these mutants revealed
the central role of the actin cytoskeleton
and actin associated proteins in the
internalization step (Lombardi et al.,
2001). However, little is known about the
exact function of the different proteins
involved in endocytosis.
Studies in mammalian cells have identified
a complex protein-protein interactions
network acting in clathrin-mediated
endocytosis (Slepnev and De Camilli,
2000). One of the key player is dynamin, a
GTPase shown to be essential for the final
pinching off of endocytic vesicles
(Hinshaw, 2000). Amphiphysin interacts
via its SH3-domain with the PRD-domain
of dynamin and is thought to localize
dynamin to the clathrin-coated pits (Wigge
and McMahon, 1998). Besides these two
proteins a large number of other proteins
have been implicated in this process and
most of them interact with either dynamin,
amphiphysin, clathrin or the AP-2 adaptor
complex (Slepnev and De Camilli, 2000)
but little is known about their exact
function. One exception is endophilin,
which was recently shown to exhibit
lysophosphatidic acid acyl transferase
activity and thus might affect the
membrane curvature directly (Schmidt et
al., 1999). Furthermore, phosphorylation
was shown to be an important regulatory
mechanism for clathrin-mediated endocy-
tosis. The association of an important
subset of proteins (e.g. dynamin and
amphiphysin) with other components of the
endocytic machinery is controlled by
coordinated phosphorylation-dephospho-
rylation cycles (Slepnev et al., 1998).
Interestingly, several yeast proteins
involved in the internalization step of
endocytosis show homology to mammalian
proteins implicated in clathrin-mediated
endocytosis. For example, Rvs161p and
Rvs167p are homologous to amphiphysin
and yeast contains also clathrin and AP-2
adaptors. However, clathrin is only
partially required for endocytosis in yeast
(Payne et al., 1988; Tan et al., 1993) and
AP-2 adaptors are not required at all
(Huang et al., 1999). Instead, actin is
absolutely required in yeast (Kübler and
Riezman, 1993) while its involvement in
mammalian cells is less clear (Geli and
Riezman, 1998). In addition, none of the
three yeast proteins with significant
homology to dynamin seems to be
involved in the internalization step of
endocytosis (Geli and Riezman, 1998).
To understand the role of some of the
proteins involved in the internalization step
of endocytosis in yeast, we looked for
protein-protein interactions among them.
We found that the yeast amphiphysin
homolog Rvs167p interacts with both
Sla2p/End4p and Myo5p. Sla2p is an actin-
binding protein whose actin-binding
domain resides in its C-terminal talin-
homology domain (McCann and Craig,
1997). Sla2p was shown to be required for
the internalization step of endocytosis and
for proper actin cytoskeleton function
(Holtzman et al., 1993; Raths et al., 1993;
Wesp et al., 1997). Its mammalian
homolog Hip1R (Huntingtin interacting
protein 1 related) was shown to localize to
clathrin coated pits implicating this protein
in endocytosis (Engqvist-Goldstein et al.,
1999). Myo5p is a type I myosin shown to
be required for the internalization step of
endocytosis and polarization of the actin
cytoskeleton (Geli and Riezman, 1996;
Goodson et al., 1996). Recently, Myo5p
together with its homolog Myo3p have
been implicated as key players in
regulating actin polymerization
(Evangelista et al., 2000; Geli et al., 2000;
Lechler et al., 2000).
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Here, we demonstrate that Rvs167p,
Myo5p and Sla2p cofractionate in gel
filtration experiments. Furthermore, we
could coprecipitate the three proteins from
these gel filtration fractions suggesting that
they form a protein complex with an
approximate size of 600 kDa. We further
show that the interaction of the complex
with actin is probably mediated via Sla2p
and Rvs167p.
Rvs167p has been shown to interact with
an increasing number of proteins
(Lombardi et al., 2001) and therefore these
different interactions must be tightly
regulated. One obvious regulatory
mechanism would be protein phospho-
rylation. In an accompanying article, Friant
and coworkers have identified a pair of
homologous protein kinases in yeast,
Pkh1p and Pkh2p, that are required for the
internalization step of endocytosis. These
kinases are the yeast homologs of the
mammalian kinase PDK1 (3-phospho-
inositide-dependent kinase 1) and were
shown to share an essential function
(Casamayor et al., 1999; Inagaki et al.,
1999). PDK1 was shown to phosphorylate
and thus activate a large set of protein
kinases and thereby elicits important
physiological responses (Belham et al.,
1999; Vanhaesebroeck and Alessi, 2000).
In a search of the yeast protein database for
proteins containing the PDK/Pkh-
consensus phosphorylation site we
retrieved Rvs167p. Rvs167p has been
shown to be phosphorylated by the Pho85
cyclin dependent protein kinase involved in
cell cycle regulation (Lee et al., 1998). The
same study demonstrated that Rvs167p is
still phosphorylated in vivo in the absence
of Pho85 suggesting that other kinases also
phosphorylate the protein (Lee et al.,
1998). The putative PDK/Pkh-
phosphorylation site of Rvs167p is
localised at the extreme N-terminus of the
protein. The N-terminal BAR-domain of
Rvs167p was shown to be sufficient to
rescue most of the phenotypes of a rvs167
strain (Colwill et al., 1999). We
demonstrate that Rvs167p is an in vitro
substrate for Pkh2p but not for Pkc1p or
Ypk1p, two kinases implicated in the Pkh-
signaling cascade (Casamayor et al., 1999;
Inagaki et al., 1999). Furthermore, we
show that mutation of the phosphorylated
Thr7 to Ala affects the internalization step
of endocytosis in vivo. The same point
mutation does not affect the actin
cytoskeleton suggesting that the phospho-
rylation of Rvs167p by Pkh2p is important
for the endocytic function of Rvs167p but
perhaps not for its actin cytoskeleton
function.
Figure 1. Schematic overview of the domains of
Rvs167p, Sla2p/End4p and Myo5p
BAR: BIN/Amphiphysin/RVS domain; GPA:
glycine-proline-alanine-rich region; SH3: Src
homology 3 domain; Pro-rich: proline-rich region;
cc: coiled coil region; Talin-like: Talin homology
domain (I/LWEQ module); Head: motor domain of
myosins; basic: region rich in basic amino acids;
TH2n: N-terminal part of tail homology 2 domain;
TH2c: C-terminal part of tail homology 2 domain.
SLA2-M, SLA2-C and MYO5 show some of the
constructs used for the two-hybrid analysis.
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Rvs167p interacts with Sla2p/End4p and
Myo5p
In order to dissect the internalization step
of endocytosis on a molecular level we
looked for protein-protein interactions
among proteins corresponding to some of
the known proteins defective in endocytic
mutants. As shown in Figure 2A and 2B
we detected a strong interaction of
Rvs167p with both Sla2p/End4p and
Myo5p in the two-hybrid system. Since the
three proteins are built up of different
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domains (see Figure 1) we investigated
which of these domains are involved in the
interactions. We found that the N-terminal
BAR-domain of Rvs167p interacted with
both the medial and C-terminal parts of
Sla2p (Figure 2A). The interaction of
Rvs167p with the tail of Myo5p was
mediated by either the BAR- or the SH3-
domain of Rvs167p (Figure 2B). The
TH2n- as well as the SH3-domain of
Myo5p were sufficient to mediate the
interaction with Rvs167p (Figure 2C).
Figure 2. Two-hybrid interactions of Rvs167p
with Sla2p and Myo5p
Yeast strain EGY48 containing the reporter gene
plasmid pSH18-34 with the lacZ gene under the
control of eight LexA operators, a bait, and a prey
were streaked out on plates containing X-Gal.
Positive interactors turn dark and negative colonies
remain white. (A) Rvs167p interacts with Sla2p via
its BAR-domain. The central (pJGSLA2-M) and
C-terminal (pJGSLA2-C) parts of Sla2p as a prey
were tested against full-length Rvs167p
(pEGRVS167) and indicated Rvs167p domains as
baits. (B) Rvs167p interacts with Myo5p via its
BAR- and SH3-domains. The tail of Myo5p
(pEGMYO5) as a bait was tested against full length
Rvs167p (pJGRVS167) and indicated Rvs167p
domains as preys. (C) Myo5p interacts with
Rvs167p via its TH2n- and SH3-domains. Full
length Rvs167p (pJGRVS167) as a prey was tested
against the indicated Myo5p domains as baits.
To confirm biochemically these two-hybrid
interactions we constructed a tagged
version of Rvs167p on a CEN-plasmid
(pRVS167-MYC5-HIS6). The construct is
functional because it rescued the growth
defect of a rvs167 strain on YPUAD +
1M NaCl plates to the same extent as a
WT-copy of RVS167 on a CEN-plasmid
(pRVS167, Figure 3A). We precipitated
Rvs167-Myc5-His6p from total cell extracts
with Ni-NTA-agarose beads (Qiagen Inc.)
and analyzed the pellets by immuno-
blotting using antibodies for the Myc-
epitope, Sla2p and Myo5p. We found that
both Myo5p and Sla2p coprecipitated with
Rvs167-Myc5-His6p (Figure 3B). These
coprecipitations were specific because they
occurred only in cells expressing the
tagged Rvs167-Myc5-His6p and not in cells
expressing WT-Rvs167p. Taken together
the two-hybrid and biochemical data
demonstrate that Rvs167p interacts with
Myo5p and Sla2p.
Rvs167p, Myo5p and Sla2p are part of a
600 kDa protein complex
We next wanted to further characterize the
Rvs167p, Myo5p, Sla2p protein complex
by performing gel filtration experiments.
We loaded total cell extracts on a
Superose 6 column, collected 1 ml
fractions, TCA precipitated the proteins
and analyzed them by SDS-PAGE and
immunoblotting. When we used the same
strain as for the coprecipitation experi-
ments (RH5237 + pRVS167-MYC5-HIS6)
we had a very weak signal with the
antibodies against Myo5p due to the low
amount of protein loaded on the column.
Therefore, we decided to use a strain with a
Myc-tagged Myo5p (RH5264). As shown
in Figure 3C, mycMyo5p was found in
fractions 9 to 11, 14 and 15, with the
highest amounts in fractions 14 and 15,
which was where Sla2p was also found.
Rvs167p was found in fractions 8 to 20
with a peak in fractions 14 and 15. These
data show that all three proteins
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cofractionate in fractions 14 and 15. We
detected exactly the same distribution of
Sla2p and Rvs167p when we used lysates
from the RH5237 + pRVS167-MYC5-HIS6
strain (data not shown) and therefore used
this strain to determine if the three proteins
indeed interact with each other in fractions
14 and 15, where they cofractionate. We
pooled the fractions 14 and 15, precipitated
Rvs167-Myc5-His6p with Ni-NTA-agarose
beads and analyzed the pellet by
immunoblotting. A strong signal for
Myo5p and Sla2p could be detected
coprecipitating with Rvs167-Myc5-His6p
(Figure 3D) indicating that Rvs167p,
Myo5p and Sla2p form a protein complex
with an approximate size of 550-600 kDa.
Figure 3. Rvs167p, Sla2p and Myo5p form a 600 kDa protein complex
(A) Rvs167-Myc5-His6p is functional. RH5237 transformed with either Ycplac33 (empty plasmid), pRVS167 or
pRVS167-MYC5-HIS6 was streaked out on YPUAD + 1 M NaCl plates and grown for three days at 30°C.
(B) Coprecipitation of Sla2p and Myo5p with Rvs167p from cell lysates. Total cell lysates from strain RH5237
transformed with either pRVS167 or pRVS167-MYC5-HIS6 were incubated with Ni-NTA-agarose beads and the
precipitates were analyzed by SDS-PAGE and immunoblotting with antibodies against Myo5p, Sla2p and
Myc-epitope (for Rvs167-Myc5-His6p). (C) Gel filtration experiment. Total cell lysates from strain RH5264 were
fractionated on a Superose 6 column and the proteins of the different fractions TCA-precipitated and analyzed by
SDS-PAGE and immunoblotting with antibodies against Rvs167p, Sla2p and Myc-epitope (for mycMyo5p).
(D) Coprecipitation of Myo5p and Sla2p with Rvs167p from gel filtration fractions 14 and 15. Total cell lysates
from strain RH5237 + pRVS167-MYC5-HIS6 were fractionated on a Superose 6 column. Fractions 14 and 15
were pooled, incubated with Ni-NTA-agarose beads and the precipitates were analyzed by SDS-PAGE and
immunoblotting with antibodies against Myo5p, Sla2p and Myc-epitope (for Rvs167-Myc5-His6p).   
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Interaction of the complex with actin is
mediated by Rvs167p and Sla2p
Rvs167p, Myo5p and Sla2p were all shown
to interact with actin (Amberg et al., 1995;
Geli et al., 2000; McCann and Craig,
1997). However, in the case of Myo5p it
has been shown that the interaction with
actin is indirect and mediated via Vrp1p
(Geli et al., 2000).
Figure 4. Interaction of the 600 kDa protein
complex with actin is mediated by Sla2p and
Rvs167p
Yeast strains containing the reporter gene plasmid
pSH18-34 with the lacZ gene under the control of
eight LexA operators, a bait, and a prey were
streaked out on plates containing X-Gal. Positive
interactors turn dark and negative colonies remain
white. (A) Interaction of Sla2p with actin depends
on Rvs167p. The C-terminal part of Sla2p
(pEGSLA2-C) as bait was tested against full length
Act1p (pJGACT1) as a prey in a WT (EGY48),
myo5 (RH5510) and rvs167 (RH5237) strain.
(B) Interaction of Rvs167p with actin depends on
Sla2p. Full length Rvs167p (pEGRVS167) as bait
was tested against full length Act1p (pJGACT1) as a
prey in a WT (EGY48), myo5 (RH5510) and
sla2 (RH5511) strain. (C) Interaction of Myo5p
with actin depends on both Rvs167p and Sla2p. Full
length tail of Myo5p (pEGMYO5) as bait was tested
against full length Act1p (pJGACT1) as a prey in a
WT (EGY48), rvs167 (RH5237) and sla2
(RH5511) strain.
Since we have demonstrated that the three
proteins form a protein complex we wanted
to determine if the interaction of any of
these proteins with actin is affected in the
absence of one of the other subunits of the
complex. As shown in Figure 4A, the
interaction of Sla2p with actin in the two-
hybrid system was affected in an rvs167
but not in a myo5 strain. Similarly, the
interaction of Rvs167p with actin was
affected in a sla2 but not in a myo5
strain (Figure 4B). Interestingly, the
interaction of the tail of Myo5p with actin
was affected in both an rvs167 and a
sla2 strain (Figure 4C). Taken together
these data suggest that the interaction of
the 600 kDa protein complex with actin
requires both Rvs167p and Sla2p.
Rvs167p is phosphorylated at Thr7 by
Pkh2p in vitro
Rvs167p has been shown to interact with a
large number of proteins (Lombardi et al.,
2001) and we have identified two new ones
in this study. It is clear, that these
interactions must be regulated and one
obvious mechanism could be by protein
phosphorylation. Indeed, Rvs167p has
been shown to be phosphorylated by the
Pho85 cyclin-dependent kinase (Lee et al.,
1998). In the same study, the authors
demonstrated that Rvs167p is still
phosphorylated in the absence of Pho85,
albeit to a lesser degree, suggesting that
other kinases also phosphorylate it. In an
accompanying article Friant and
co-workers demonstrate that two protein
kinases, Pkh1p and Pkh2p, are required for
the internalization step of endocytosis.
These two kinases are the yeast homologs
of mammalian PDK1 (Casamayor et al.,
1999; Inagaki et al., 1999) and a consensus
phosphorylation site for these kinases has
been determined (see Figure 5; Casamayor
et al., 1999). By searching the yeast
proteins database we found that Rvs167p
contains a putative Pkh-phosphorylation
site at its extreme N-terminus (Figure 5).
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Figure 5. Rvs167p contains a putative
PDK/PKH-consensus phosphorylation site
Comparison of the PDK- and PKH-phosphorylation
sites in human respectively yeast proteins. Entrez
protein database accession numbers: PKB,
XP_015191; SGK, XP_004255; p70 S6K,
AAA36411; PKC, AAA60101; Ypk1p, P12688;
Ypk2p, P18961; Pkc1p, AAA34878; Rvs167p,
S40887.
Using an in vitro phosphorylation assay we
could show, that Pkh2p was able to
phosphorylate Rvs167p (Figure 6A). The
phosphorylation was specific for Pkh2p
since Pkc1p and Ypk1p, two protein
kinases implicated in the Pkh-signaling
cascade (Casamayor et al., 1999; Inagaki et
al., 1999), were not able to phosphorylate
Rvs167p in vitro (Figure 6A). Since we
localized the putative Pkh-phosphorylation
site in Rvs167p to amino acids 3 to 7 we
wanted to investigate if Thr7 is the residue
that is phosphorylated by Pkh2p. We
constructed a point mutant, where the Thr7
was changed to an alanine (RVS167-TA-
MYC5-HIS6) and used this Rvs167-TA-
Myc5-His6p as a substrate for Pkh2p in the
in vitro phosphorylation assay. As shown
in Figure 6B, mutant Rvs167-TA-
Myc5-His6p was not phosphorylated by
Pkh2p. As a further control we used a
kinase negative form of Pkh2p (PKH2-KR;
Inagaki et al., 1999) and as shown in
Figure 6B, Pkh2-KRp did not phospho-
rylate Rvs167p. These results show that
Pkh2p kinase phosphorylates specifically
and directly the yeast amphiphysin
homolog Rvs167p.
Figure 6. In vitro phosphorylation of Rvs167p at
Thr 7 by Pkh2p
(A) In vitro phosphorylation of Rvs167p by Pkh2p.
Yeast strain RH5237 transformed with either
pPKH2, pPKC1, pYPK1, pRVS167-MYC5-HIS6
were grown to log phase. Pkh2-HA3p, Pkc1-HA3p
and Ypk1-HA3p were immunoprecipitated from cell
extracts. In vitro protein kinase assay were
conducted with immunoprecipitated Rvs167-Myc5-
His6p as a substrate. (B) Thr7 is the phosphorylation
site on Rvs167p. Yeast strain RH5237 transformed
with either pPKH2, pPKH2-KR, pRVS167-MYC5-
HIS6 or pRVS167-TA-MYC5-HIS6 were grown to log
phase. Pkh2-HA3p and HA2-Pkh2-KRp were
immunoprecipitated from cell extracts. In vitro
protein kinase assay were conducted with immuno-
precipitated Rvs167-Myc5-His6p or Rvs167-TA-
Myc5-His6p as a substrate (top). A parallel set of
immune complexes was subjected to immuno-
blotting of Pkh2-HA3p, HA2-Pkh2-KRp,
Rvs167-Myc5-His6p or Rvs167-TA-Myc5-His6p
(bottom).
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Figure 7. Phosphorylation of Rvs167p at Thr7 is required in vivo
(A) Phosphorylation of Rvs167p at Thr 7 is required for the internalization step of endocytosis in vivo. Yeast
strains RH5262 transformed with either Ycplac33 (empty plasmid), pRVS167-MYC5-HIS6 or pRVS167-TA-
MYC5-HIS6 were tested for -factor internalization at 24°C. The values correspond to the average of three
independent experiments with standard deviations smaller than 10%. (B) Phosphorylation of Rvs167p at Thr7 is
not required for its actin cytoskeleton function. Yeast strains RH5262 transformed with either Ycplac33 (empty
plasmid), pRVS167-MYC5-HIS6 or pRVS167-TA-MYC5-HIS6 were fixed, and filamentous actin was visualized
using TRITC-phalloidin (left panels) and Nomarski optics (right panels).   
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Phosphorylation of Rvs167p facilitates
the internalization step of endocytosis
In a next step, we investigated if the
phosphorylation of Rvs167p by Pkh2p is
physiologically relevant. To do this, we
replaced the wild type RVS167 with the
mutated RVS167-TA-MYC5-HIS6 allele and
assayed its effect on the internalization step
of endocytosis. As shown in Figure 7A, we
found that the mutated protein was not able
to restore the internalization defect of a
rvs167 strain to WT-levels. Instead, we
found that the ability of the strain
expressing Rvs167-TA-Myc5-His6p to
internalize radiolabeled -factor was
significantly less than the strain expressing
Rvs167-Myc5-His6p suggesting that
phosphorylation at Thr7 is important for
endocytosis in vivo. Since an rvs167
strain exhibits a depolarized actin
cytoskeleton (Bauer et al., 1993) and actin
is one of the key requirements for
endocytosis in yeast (Kübler and Riezman,
1993) we determined if the mutant
Rvs167-TA-Myc5-His6p was also unable to
completely restore the actin defect of the
deletion strain. As shown in Figure 7B,
expression of Rvs167-TA-Myc5-His6p in
the rvs167 strain completely restored the
actin defect suggesting that the endocytic
defect detected may not be due to a defect
in the actin cytoskeleton.
Discussion
In this study we demonstrated that
Rvs167p, Sla2p and Myo5p, three proteins
required for the internalization step of
endocytosis and for actin function, form an
approximately 600 kDa protein complex
probably involved in regulating the actin
cytoskeleton. We showed that the three
proteins can be coprecipitated from total
cell lysates, that they partially cofractionate
in gel filtration experiments and can be
coprecipitated from these gel filtration
fractions. Using the two-hybrid system we
have investigated which domains of the
proteins are involved in these interactions.
We found that both the central (containing
two coiled-coil domains) and the
C-terminal (containing the talin-like
domain) parts of Sla2p interact with
Rvs167p. We have also tested the
N-terminal part of Sla2p but we did not
detect any interaction with Rvs167p (data
not shown). Interestingly, we found that
the BAR-domain of Rvs167p interacts with
both Myo5p and Sla2p. A previous study
demonstrated that the BAR-domain of
Rvs167p is sufficient to rescue most of the
phenotypes of a rvs167 strain (Colwill et
al., 1999) suggesting that the BAR-domain
might be the most important domain of
Rvs167p. Additionally, we found that the
SH3-domain of Rvs167p also interacts
with Myo5p. In the case of Myo5p, we
showed that either the TH2n- or the SH3-
domain were sufficient to interact with
Rvs167p. The SH3-domain of Myo5p has
been shown to interact with Vrp1p, another
protein involved in the internalization step
of endocytosis (Anderson et al., 1998; Geli
et al., 2000; Munn et al., 1995). Taken
together these data suggest a rather
complicated interaction pattern among
Rvs167p, Myo5p and Sla2p.
Interestingly, a previous study
demonstrated that the tail of Myo5p
interacts with actin in a physiologically
relevant manner and that this interaction is
mediated by Vrp1p (Geli et al., 2000).
Here we find, that in the absence of either
Rvs167p or Sla2p the interaction of Myo5p
with actin in the two-hybrid system is
abolished. One possible explanation could
be that the interaction of Myo5p with
Vrp1p is stabilized when Myo5p is part of
the protein complex with Rvs167p and
Sla2p. The interaction of Rvs167p with
actin and of Sla2p with actin is affected in
absence of Sla2p respectively Rvs167p
suggesting that the two interactions
stabilize each other. Taken together these
data suggest that Myo5p, Rvs167p and
Sla2p form an approximately 600 kDa
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protein complex stabilized by multiple
interactions among the proteins and
probably involved in regulating the actin
cytoskeleton.
In our gel filtration experiments
(Figure 3C) we found, that both Myo5p
and Rvs167p were not confined to
fractions 14 and 15, while Sla2p was
almost exclusively found in these fractions.
We could also detect Myo5p in fractions
9 to 11 suggesting that Myo5p is also
found in another high molecular weight
complex (approximately 2000 kDa). It will
be interesting to determine with which
proteins Myo5p interacts in this complex
since no Sla2p can be detected in these
fractions and Rvs167p does not seem to be
enriched in these fractions. In contrast to
the very distinct distribution of Myo5p and
Sla2p in our gel filtration experiments,
Rvs167p is more broadly distributed. As
already mentioned, Rvs167p has been
shown to interact with a large number of
proteins (Lombardi et al., 2001).
Therefore, this broad distribution might
reflect the involvement of Rvs167p in
several different protein complexes. We
have previously shown that Rvs167p needs
to interact with its homolog Rvs161p for
proper in vivo function (Lombardi and
Riezman, 2001). Interestingly, we find that
the distribution of Rvs161p in the gel
filtration experiments closely resembles
that of Rvs167p (our unpublished data)
supporting the view that the broad
distribution of Rvs167p might reflect
participation in several complexes rather
than just smearing of the protein.
In mammalian cells, amphiphysin has been
proposed to function as a scaffold protein
that might recruit part of the endocytic
machinery including dynamin to sites of
endocytosis (Wigge and McMahon, 1998).
The yeast amphiphysin homolog Rvs167p
might perform a similar function in
Saccharomyces cerevisiae. As already
mentioned, none of the yeast dynamin-
homologs is involved in the internalization
step of endocytosis (Geli and Riezman,
1998). Instead, the actin cytoskeleton and
the motor protein Myo5p are absolutely
required (Geli and Riezman, 1996; Kübler
and Riezman, 1993) and in this study we
have demonstrated that Rvs167p interacts
with Myo5p. If we assume that dynamin
works as a mechanochemical enzyme in
mammalian cells (and therefore provides
the driving force to pinch off the endocytic
vesicles) and if we take into account that
recent studies have demonstrated the
involvement of Myo5p in regulating actin
polymerization (Evangelista et al., 2000;
Geli et al., 2000; Lechler et al., 2000) it is
very tempting to put up the following
hypothesis. The combined functions of
Myo5p as a motor protein and in inducing
actin polymerization might be the driving
force to pinch off endocytic vesicles in
yeast and thus might be the functional
equivalent to dynamin in mammalian cells.
In agreement with this hypothesis the
molecular environments of dynamin and
Myo5p are very similar in terms of
interacting with amphiphysin/Rvs167p and
being part of a complex protein-protein
interactions network. Furthermore, recent
studies in mammalian cells have shown
that endocytic vesicles are associated with
actin comet tails (Merrifield et al., 1999;
Rozelle et al., 2000) suggesting that actin
polymerization might be involved in
pinching off vesicles from the plasma
membrane.
In this study we also identified Rvs167p as
a target of Pkh2p protein kinase. Pkh2p
together with Pkh1p are part of a sphingoid
base-mediated signaling pathway that is
required for the internalization step of
endocytosis (see accompanying article by
Friant et al.; previous section). Rvs167p is
directly and specifically phosphorylated by
Pkh2p in vitro and could therefore be part
of the sphingoid base-activated signaling
cascade like Pkc1p, another substrate of
Pkh2p. It is worthwhile to point out, that to
our knowledge, Rvs167p is the first non-
kinase target of the PDK1/2/Pkh1/2p
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kinases identified so far. We have
demonstrated that Rvs167p is phospho-
rylated at a specific site (Thr 7) in vitro by
Pkh2p, but not by two other kinases (Pkc1p
and Ypk1p) involved in the Pkh-signaling
pathway or in the internalization step of
endocytosis like Pkc1p (Friant et al.,
2000). Mutation of Thr7 to an alanine
showed that this mutant Rvs167-TA-Myc5-
His6p was not phosphorylated anymore by
Pkh2p in vitro.
The phosphorylation of Rvs167p by Pkh2p
is physiologically relevant. Expression of
the mutated Rvs167-TA-Myc5-His6p in an
rvs167 strain uncovered an endocytic
phenotype of the point mutation in vivo.
Interestingly, we found that the same point
mutation was apparently able to completely
restore the actin cytoskeleton defect of an
rvs167 strain. However, the immuno-
fluorescence assay for actin function is not
a quantitative assay and we could have
missed a small defect in Rvs167p function
using this assay. Taken together these data
demonstrate that the phosphorylation of
Rvs167p at Thr7 by Pkh2p is required
in vivo for the full function of Rvs167p in
the internalization step of endocytosis but
perhaps not for the actin cytoskeleton
function, suggesting that Rvs167p may
have a direct role in the internalization step
of endocytosis that is independent of its
actin function. However, since the
endocytic defect seen upon complete loss
of Rvs167p is more pronounced than the
one seen in the mutant Rvs167-TAp, we
must also conclude that the actin
cytoskeleton function of Rvs167p is
important for endocytosis.
What might be the endocytic function of
Rvs167p that is regulated by Pkh2p-
dependent phosphorylation? Since we
found that the BAR-domain of Rvs167p
contains the phosphorylation site and this
domain is also sufficient to mediate
interaction with both Sla2p and Myo5p,
one obvious option would be that the
assembly of the protein complex is
regulated by this phosphorylation. Using
the two-hybrid system we investigated if
the Thr7 to Ala mutation affects one these
interactions. However, we still detected a
strong interaction between Rvs167-TAp
and either Myo5p or Sla2p (data not
shown) suggesting that the association of
Sla2p and Myo5p with Rvs167p may not
be regulated by this phosphorylation.
However, we cannot rule out the
possibility, that association of other
proteins to this complex is regulated by
phosphorylation of Rvs167p at Thr7.
Interestingly, human amphiphysin I also
contains a PDK2-phosphorylation site at
amino acids 401-405: FNGFT (Entrez
protein database accession number
XP_004749). The localization of this
putative site is different from the one we
identified in Rvs167p. However, two
recent studies have shown that
amphiphysin is a substrate for Cdk5 kinase
(Floyd et al., 2001; Rosales et al., 2000)
and Cdk5 is the mammalian homolog of
the yeast kinase Pho85 that was shown to
phosphorylate Rvs167p (Lee et al., 1998).
Therefore, both proteins, Rvs167p and
amphiphysin, are regulated by homologous
kinases, Pho85 and Cdk5, and thus it might
well be that amphiphysin I is also regulated
by PDK2 as we have shown here for Pkh2p
regulation of Rvs167p .
In summary, we demonstrated that
Rvs167p is an important player of the
endocytic machinery in yeast. We have
identified an approximately 600 kDa
protein complex containing Myo5p,
Rvs167p, Sla2p and probably other
unidentified proteins most likely involved
in regulating the actin cytoskeleton.
Furthermore, we identified Rvs167p as the
first non-kinase target for PDK/Pkh-protein
kinases and demonstrated that this
phosphorylation by Pkh2p is important
in vivo. We have provided evidence that
suggests separation of the function of
Rvs167p in the internalization step of
endocytosis from its function in regulating
the actin cytoskeleton.
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Materials and Methods
Yeast strains and media
Yeast strains used in this study are listed in
Table I. Strains that did not bear plasmids
were grown in complete media YPUAD
(2% glucose, 2% peptone, 1% yeast
extract, 40 g/ml uracile, 40 g/ml adenine
and 40 g/ml tryptophan, 2% agar for solid
media). Unless mentioned otherwise,
strains bearing plasmids were selected on
SD minimal media (Dulic et al., 1991).
DNA techniques and plasmid
construction
Standard recombinant DNA techniques
were used (Sambrook et al., 1989).
Restriction endonucleases were obtained
from MBI Fermentas and Pfu polymerase
was obtained from Stratagene. Plasmids
used in this study and their relevant
features are listed in Table II. Further
details are available upon request.
Table I. Yeast strains
Strain Genotype Source
EGY48 Mat a his3 trp1 ura3 leu2::lexAop6-LEU2 (Gyuris et al., 1993)
RH5237 Mat  his3 leu2 trp1 ura3 rvs167::trp1::LEU2 bar1 this study
RH5262 Mat a his3 leu2 trp1 ura3 rvs167::trp1::LEU2 VRP1-HA3-TRP1 bar1 this study
RH5264 Mat a ade2 his3 leu2 trp1 ura3 mycMYO5::URA3::myo5::TRP1 bar1 this study
RH5510 Mat a his3 trp1 ura3 leu2::lexAop6-LEU2 myo5::KanMX6 this study
RH5511 Mat  his3 leu2 lys2 trp1 ura3 sla2::his3::LEU2 bar1 this study
Table II. Plasmids
Plasmid Yeast Ori Insert Source
pEG202 2 LexA (Gyuris et al., 1993)
pJG4-5 2 B42 (Gyuris et al., 1993)
pSH18-34 2 8 LexA Op. LacZ (Gyuris et al., 1993)
pEGRVS167 2 RVS167 (Lombardi and Riezman, 2001)
pEGBAR 2 LexA-BAR-domain of RVS167 (aa 1-281) this study
pEGBAR/GPA 2 LexA-BAR- and GPA-domains of RVS167 (aa 1-423) this study
pEGGPA 2 LexA-GPA-domain of RVS167 (aa 292-423) this study
pEGSH3 2 LexA-SH3-domain of RVS167 (aa 421-482) this study
pJGRVS167 2 B42-RVS167 (Geli et al., 2000)
pJGBAR 2 B42-BAR-domain of RVS167 (aa 1-281) (Lombardi and Riezman, 2001)
pJGBAR/GPA 2 B42-BAR- and GPA-domains of RVS167 (aa 1-423) (Lombardi and Riezman, 2001)
pJGGPA 2 B42-GPA-domain of RVS167 (aa 292-423) (Lombardi and Riezman, 2001)
pJGGPA/SH3 2 B42-GPA- and SH3-domains of RVS167 (aa 292-482) (Lombardi and Riezman, 2001)
pJGSH3 2 B42-SH3-domain of RVS167 (aa 421-482) (Lombardi and Riezman, 2001)
pEGSLA2-C 2 LexA-C-terminal part of SLA2 (aa 665-968) this study
pJGSLA2-M 2 B42-central part of SLA2 (aa 334-664) this study
pJGSLA2-C 2 B42-C-terminal part of SLA2 (aa 665-968) this study
pJGACT1 2 B42-ACT1 (Lombardi and Riezman, 2001)
pEGMYO5 2 LexA-MYO5 tail (aa 757-1219) (Geli et al., 2000)
pEGMYO5-TH2c 2 LexA-myo5-TH2c tail (aa 757-1181) (Geli et al., 2000)
pEGMYO5-SH3,TH2c 2 LexA-myo5-SH3,TH2c tail (aa 757-1091) (Geli et al., 2000)
pEGMYO5-TH2,SH3 2 LexA-myo5-TH2,SH3 tail (aa 757-996) (Geli et al., 2000)
pEGMYO5-TH2n 2 LexA-myo5-TH2n tail (aa 757-996 + aa 1095-1219) (Geli et al., 2000)
pEGMYO5-TH2n 2 LexA-TH2n-domain of MYO5 (aa 984-1091) (Geli et al., 2000)
pEGMYO5-TH2c 2 LexA-TH2c-domain of MYO5 (aa 1142-1219) (Geli et al., 2000)
pEGMYO5-SH3 2 LexA-SH3-domain of MYO5 (aa 1085-1181) (Geli et al., 2000)
pRVS167 CEN pFBKS, RVS167 (Bauer et al., 1993)
pRVS167-MYC5-HIS6 CEN RVS167-MYC5-HIS6 this study
pRVS167-TA- MYC5-HIS6 CEN RVS167-MYC5-HIS6 with Thr3 mutated to Ala this study
pPKH2 2 pTS81, PKH2-HA3 Schmelzle and Hall
pPKH2-KR 2 pKT10, GAL-HA2-PKH2-(K208R) (Inagaki et al., 1999)
pPKC1 2 pTS94, PKC1-HA3 Schmelzle and Hall
pYPK1 2 pTS82, YPK1-HA3 Schmelzle and Hall
Ycplac33 CEN no insert (Gietz and Sugino, 1988)
Results 75
Two-hybrid analysis
Two-hybrid analysis was performed as
described (Geli et al., 1998). Briefly, to
assay the interaction between a bait and a
prey, the strains containing the reporter
gene plasmid (pSH18-34), bait and prey
were streaked out on plates containing
X-Gal. The positive colonies turn dark
while the negative ones remain white.
Protein extracts
Strains were grown to exponential phase,
harvested and converted to spheroplasts
using lyticase (Raths et al., 1993). The
spheroplasts were lysed by osmotic shock
in 1 ml lysis buffer (137 mM NaCl, 3 mM
KCl, 6 mM Na2HPO4, 1 mM NaH2PO4,
1.5 mM KH2PO4, 10 mM EGTA, and
1 g/ml of the protease inhibitors
aprotinin, leupeptin, pepstatin A,
chymostatin and antipain). The protein
concentration of the lysates was measured
using the Bio-Rad protein assay.
Coprecipitation experiments
Equal amounts of total protein for RH5237
+ pRVS167 and RH5237 + pRVS167-
MYC5-HIS6 were taken, lysis buffer was
added to a final volume of 0.9 ml and
100 l of Ni-NTA-agarose beads (Qiagen
Inc.) were added. After two hours of
incubation the beads were washed three
times with 1 ml lysis buffer + 0.5% NP-40.
The precipitates were analyzed by
SDS-PAGE and immunoblotting with
antibodies against Myo5p, Sla2p and
Myc-epitope.
Gel filtration experiments
Protein extracts were loaded onto a
Superose 6 gel filtration column (1.0 x
30 cm, Amersham Pharmacia Biotech).
The column was developed with running
buffer (137 mM NaCl, 3 mM KCl, 6 mM
Na2HPO4, 1 mM NaH2PO4, 1.5 mM
KH2PO4) at a flow rate of 0.2 ml/min. 1 ml
fractions were collected, the proteins TCA-
precipitated and analyzed by SDS-PAGE
and immunoblotting with antibodies
against Myo5p, Sla2p and Myc-epitope.
The molecular mass standards were ferritin
(440 kDa), thyroglobulin (669 kDa) and
blue dextran (2000 kDa).
For the coprecipitation experiment the
fractions 14 and 15 were pooled and the
proteins were precipitated as described
above.
In vitro phosphorylation experiments
Strains were grown to exponential phase,
harvested and lysed with glass beads in
buffer (50 mM HEPES pH 7.5, 20%
glycerol, 1 mM EDTA, 1 mM EGTA,
150 mM KCl, and 1 g/ml of the protease
inhibitors aprotinin, leupeptin, pepstatin A,
chymostatin and antipain). The protein
concentration of the lysates was measured
using the Bio-Rad protein assay. Equal
amounts of total protein for the different
kinases and substrates were taken and
immunoprecipitation buffer (50 mM
Tris-HCl pH 7.5, 150 mM NaCl, 1 mM
EDTA, 1mM EGTA, 1% NP-40, and
1 g/ml of the protease inhibitors
aprotinin, leupeptin, pepstatin A,
chymostatin and antipain) was added to a
final volume of 0.8 ml. Then 8 l of
antibodies against the HA-epitope (for
Pkh2-HA3p, HA2-Pkh2-KRp, Pkc1-HA3p
and Ypk1-HA3p) respectively antibodies
against Myc-epitope (for Rvs167-Myc5-
His6p and Rvs167-TA-Myc5-His6p) and
60 l of a 30% protein G-sepharose
solution were added. After an overnight
incubation the beads were washed three
times with 1 ml immunoprecipitation
buffer, two times with 1 ml buffer (40 mM
MOPS pH 7.5) and resuspended in 60 l
phosphorylation buffer (40 mM MOPS
pH 7.5, 1 mM DTT, 1 mM MgCl2). For the
phosphorylation experiments 10 l of
sepharose beads-substrate immuno-
complex (or 10 l phosphorylation buffer
for the control) were incubated with 10 l
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of sepharose beads-protein kinase immuno-
complex (or 10 l phosphorylation buffer
for the control) and 3 Ci 32P--ATP for
30’ at room temperature. Sample buffer +
50 mM ATP was added and the samples
were analyzed by SDS-PAGE and
autoradiography.
-Factor uptakes
-Factor uptakes (continuous presence)
were done as described previously (Dulic
et al., 1991). The results represent the
average of at least three independent
experiments.
Actin staining
Yeast cell pre-cultures were grown at 24°C
in SD selective media to maintain the
plasmids. Cells taken from the pre-culture
were then grown at 24°C in YPUAD to
early log phase, fixed in formaldehyde and
stained with TRITC-phalloidin (Sigma) to
visualize F-actin essentially as described
previously (Benedetti et al., 1994).
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Abstract
The yeast type I myosins (MYO3 and MYO5) are involved in endocytosis and in the
polarization of the actin cytoskeleton. The tail of these proteins contains a TH2 (Tail
Homology 2) domain that constitutes a putative actin-binding site. Because of the important
mechanistic implications of a second ATP-independent actin-binding site, we analyzed its
functional relevance in vivo. Even though the myosin tail interacts with actin and this
interaction seems functionally important, deletion of a major portion of the TH2 domain did
not abolish interaction. In contrast, we found that the SH3 domain of Myo5p significantly
contributes to this interaction implicating other proteins. We found that Vrp1p, the yeast
homolog of WIP (WASP Interacting Protein), seems necessary to sustain the Myo5p tail/
F-actin interaction. Consistent with recent results implicating the yeast type I myosins in
regulating actin polymerization in vivo, we demonstrate that the C-terminal domain of Myo5p
is able to induce cytosol-dependent actin polymerization in vitro and that this activity requires
both an intact Myo5p SH3 domain and possibly Vrp1p.
My contribution to this work is shown in Figures 1C and 3A.
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Introduction
The type I myosins are actin activated
ATPases that bear a short positively-
charged tail that binds acidic phospholipids
and cellular membranes. This feature
suggests their role in membrane dynamics
(Mooseker and Cheney, 1995; Pollard et
al., 1991). However, demonstration of their
involvement in specific tasks has been
difficult. Only recently, genetic approaches
have brought some light to this point (Geli
and Riezman, 1996; Goodson et al., 1996;
Jung et al., 1996; Novak et al., 1995).
MYO3 and MYO5 encode the type I
myosins of the yeast Saccharomyces
cerevisiae. Deletion of either gene does not
result in any obvious phenotype for
growth, whereas a double knockout is
synthetically lethal or nearly so suggesting
functional redundancy (Geli and Riezman,
1996; Goodson et al., 1996). The yeast
type I myosins are required for the uptake
step of endocytosis and the polarization of
the actin cytoskeleton (Geli and Riezman,
1996; Goodson et al., 1996). However, the
mechanistic basis for their function in these
processes is unknown.
Besides the putative membrane binding
domain (TH1), the tails of Myo3p and
Myo5p contain two C-terminal domains
that are homologous to other members of
this protein family: an Ala and Pro rich
domain (TH2) and a Src Homology
Domain 3 (SH3 or TH3) (Mooseker and
Cheney, 1995; Pollard et al., 1991). SH3
domains are present in variety of proteins
associated with the organization of the
actin cytoskeleton and with signal
transduction. This domain mediates
protein-protein interactions through
binding to proline (Pro) rich stretches
(Kuriyan and Cowburn, 1997). The TH2
domain of the protozoal type I myosins
binds actin in vitro (Brzeska et al., 1988;
Doberstein and Pollard, 1992; Jung and
Hammer, 1994; Rosenfeld and Rener,
1994). However, in contrast to the motor
head-actin interaction, ATP does not
influence the affinity of the TH2-actin
interaction in vitro.
A second ATP-independent actin binding
site on the type I myosins could have
important mechanistic implications. It has
been suggested that the TH2 domain could
serve to recruit type I myosin molecules
onto the actin filaments, securing a high
local concentration of myosin heads when
the actin/myosin ratio is low and thus it
might help to achieve processivity
(Albanesi et al., 1985). Alternatively, a
second actin binding site could allow the
type I myosins to crosslink and contract
actin filaments (Fujisaki et al., 1985;
Lynch et al., 1986).
Despite the extensive biochemical
characterization of the ATP-independent
actomyosin interaction of the protozoal
type I myosins, its physiological relevance
remains obscure. We decided to use site
directed mutagenesis on MYO5 and the
Wertman collection of actin alleles
(Amberg et al., 1995; Wertman et al.,
1992) to investigate whether the ATP-
independent actomyosin interaction is
functionally relevant. We find that the
Myo5p tail binds F-actin in an ATP-
independent manner and this interaction
appears to be functionally important.
However, in contrast to what was found for
the protozoal type I myosins, the SH3
domain of Myo5p significantly contributes
to this ATP-independent actomyosin
interaction in vivo suggesting that the actin
binding might not be direct. Consistently,
we find that the yeast homolog of the
human WIP (WASP Interacting Protein),
Vrp1p (Vaduva et al., 1999), is required to
sustain the SH3-dependent Myo5p tail-
actin interaction. Consistent with a recently
proposed role of the yeast type I myosins
in regulating actin polymerization in vivo
(Evangelista et al., 2000; Lechler et al.,
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2000) we find that gluthatione sepharose
beads coated with a fusion protein
consisting of GST and the C-terminal
fragment of Myo5p trigger cytosol-
dependent actin polymerization in vitro and
strikingly, such activity seems to require
both an intact SH3 domain and Vrp1p.
Results
Functionally relevant interaction
between Myo5p tail and actin
The presence of a TH2 domain in Myo5p
(Goodson et al., 1996) suggests that the
Myo5p tail bears an ATP-independent
actin-binding site. To investigate this
possibility we tested the ability of myc-
tagged Myo5p (Geli et al., 1998) to pellet
with exogenously added F-actin in the
presence or absence of ATP. As expected,
a significant amount of Myo5p interacted
with F-actin in the presence of ATP
(Figure 1A). In contrast, a degradation
product lacking a C-terminal fragment of
about 25 KDa (Figure 1A,*) failed to pellet
with F-actin under these conditions.
According to the shift in apparent
molecular weight, the missing C-terminal
fragment should include the TH2 and the
SH3 domains. In agreement, a mutant
Myo5p lacking these domains (Myo5-
(TH2, SH3)p) had an apparent molecular
weight similar to that of the Myo5p
degradation product (*) and failed to pellet
with F-actin in the presence of ATP
(Figure 1A). A LexA-fusion protein
containing only the TH2 and the SH3
domains of Myo5p interacted with F-actin
regardless of the presence or absence of
ATP in the buffer (Figure 1A, LexA-
(TH2,SH3)). These results were confirmed
using the two-hybrid assay. The MYO5 tail
(MYO5) strongly induced transcription of a
-galactosidase reporter gene when tested
against actin (ACT1; Figure 1C).
Truncation of the Myo5p tail immediately
upstream of the TH2 domain abolished the
interaction (MYO5-(TH2,SH3)) whereas a
fragment containing the TH2 and the SH3
domains (TH2,SH3) was sufficient to
trigger transcription of the reporter	
(Figure 1C).
In order to investigate whether the Myo5p
tail-actin interaction was functionally
relevant, we used a subset of the actin
alleles from the Wertman collection
(Wertman et al., 1992). These actin
mutations have been shown to
differentially affect interaction with several
actin-binding proteins (Amberg et al.,
1995). Since Act1p and Myo5p are
required for the internalization step of
endocytosis (Geli and Riezman, 1996;
Kübler and Riezman, 1993), the -factor
uptake assay (Dulic et al., 1991) can be
used to monitor subtle differences in the
function of different ACT1 and MYO5
alleles in vivo. Thus, if the Myo5p tail-
actin interaction was functionally
important for endocytosis, all actin
mutations affecting binding to Myo5p
should also exhibit defective uptake
kinetics. The opposite assertion is not
necessarily true since additional actin
binding proteins are necessary for the
endocytic uptake. We actually found that
all mutations that strongly diminished the
interaction with the Myo5p tail severely
impaired endocytosis (Figure 2A, MYO5).
Consistent with this result, the mutant
Myo5-(TH2,SH3)p, which was unable to
pellet with actin in the presence of ATP,
was also unable to sustain endocytosis
(Figure 2B).
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Figure 1. The Myo5p tail interacts with actin
(A) Cytosolic fractions were prepared from strains bearing integrated versions of wt or mutant myo5
(SCMIG277, SCMIG278, SCMIG279, SCMIG280) or a strain expressing the TH2 and SH3 domains fused to
LexA (EGY48 pEG202-TH2,SH3) in a buffer containing 1 mM ATP. Purified actin (+ actin) or buffer (- actin)
were added to cell extracts. After allowing actin polymerization, one sample containing exogenously added actin
was incubated with apyrase to hydrolyze ATP (+ apyrase). F-actin was recovered by centrifugation and the pellet
analyzed by immunoblotting. 9E10 was used for detection of Myo5p, and EW/IK for detection of the LexA
fusion protein. One quarter of the protein extract utilized per incubation was loaded as total. (B) Recombinant
GST fusion proteins (GST-TH2,SH3 or GST-SH3,TH2c) were incubated with cytosolic fractions of a wt strain
(RH3975) and increasing concentrations of G-actin. After allowing actin polymerization, F-actin was recovered
by centrifugation and the pellets were analyzed for the presence of the recombinant proteins by immunoblotting
using the EW/IK antibody. The increasing amounts of actin in the pellet were monitored by Ponceau Red
staining. The same amount of GST fusion proteins used per assay were loaded as total. (C) Different MYO5 tail
fragments (pEG202MYO5; pEG202myo5-TH2,SH3; pEG202myo5-TH2n; pEG202myo5-SH3,TH2c;
pEG202-TH2,SH3; pEG202-SH2,TH2c; pEG202-TH2n; pEG202-SH3; pEG202-TH2c) were tested versus
ACT1 (pJG4-5ACT1), or versus the B42 transcriptional activator (pJG4-5) as a control, in the two-hybrid assay
on X-Gal-containing plates.
The SH3 of Myo5p contributes to the
functionally relevant Myo5p tail-actin
interaction
The C-terminal fragment of the Myo5p tail
that seems necessary and sufficient to
mediate the ATP-independent actomyosin
interaction bears both the TH2 and the SH3
domains. The SH3 domain of most
protozoal type I myosins is placed at the
C-terminus immediately downstream of the
TH2 domain (Mooseker and Cheney,
1995). In contrast, the SH3 domain of
Myo5p and Myo3p is inserted within the
TH2 domain and it splits it into an
N-terminal region of about 110 amino
acids (TH2n) with more than 40% of Pro
and Ala content, and a C-terminal region of
about 70 amino acids with only half the
percentage of Pro and Ala (TH2c).
Deletion of the region encoding the TH2n
results in a MYO5 allele that can
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complement the growth defect of a myo3
myo5 mutant and does not display any
defect in actin polarization suggesting that
this domain is not required for Myo5p
function (Anderson et al., 1998). In
agreement, we found that the analogous
mutant could sustain endocytosis with
nearly wt kinetics in a myo3 background
(Figure 2B, myo5-(TH2n)). Since our data
suggested that the Myo5p tail-actin
interaction is required to sustain
endocytosis we investigated this further.
We found that actually, deletion of the
N-terminal portion of the TH2 domain
neither abolished the ATP-independent
actin binding of Myo5p in the pelleting
assay (Figure 1A, Myo5-(TH2n)p) nor
the Myo5p tail-actin interaction in the two-
hybrid system (Figure 1C, Myo5-
(TH2n)p). However, we found that a
Myo5p truncated immediately upstream of
the SH3 domain no longer pelleted with
F-actin in the presence of ATP (Figure 1A,
Myo5-(SH3,TH2c)p) and its tail only
weakly interacted with actin in the two-
hybrid system (Figure 1C, MYO5-
(SH3,TH2c)). Additionally, the C-termi-
nal fragment containing only the SH3 and
TH2c domains was able to interact with
actin both in the pelleting (Figure 1B) and
the two-hybrid assays (Figure 1C). The
two-hybrid analysis indicated that both, the
SH3 and the TH2c domains, were
necessary to sustain the interaction
(Figure 1C). Consistent with the functional
significance of the (SH3,TH2c)-mediated
Myo5p-actin interaction, truncation of
Myo5p immediately upstream of the SH3
domain blocked its ability to sustain
endocytosis (Figure 2B, myo5-
(SH3,TH2c)). Additionally, the most
C-terminal Myo5p fragment containing the
SH3 domain (SH3, TH2c) was sufficient to
reproduce the Myo5p tail footprint on actin
(Figure 2A).
Vrp1p is required to sustain a
physiologically relevant interaction
between the Myo5p tail and F-actin
Our data indicates that the SH3 domain of
Myo5p might be required to sustain a
functionally relevant Myo5p tail-actin
interaction. To further test this possibility
we analyzed the effect of a point mutation
in a conserved residue of the SH3 domain
(W1123S). Consistent with the requirement
of the SH3 domain in the functionally
relevant Myo5p tail-actin interaction, the
W1123S mutation prevented binding of the
(SH3,TH2c) fragment with actin in the
two-hybrid and abolished the interaction
between a GST fusion protein containing
the TH2 and SH3 domains in the pelleting
assays (Figure 3B). This result strongly
suggested that the SH3 domain is required
for the physiologically relevant Myo5p
tail-actin interaction.
The contribution of the SH3 domain to the
Myo5p tail-actin interaction implicated that
some intermediate proteins might be
involved. In an effort to identify the
cytosolic components required for the
Myo5p tail-actin interaction we tested the
need for Vrp1p. Several findings point to
the potential role of Vrp1p in this binding
event. It was shown that the Myo5p SH3
domain interacts with the proline-rich
protein Vrp1p (Anderson et al., 1998). On
the other hand, Vrp1p, likewise Myo5p, is
required for the uptake step of endocytosis
and the polarization of the actin
cytoskeleton (Munn et al., 1995; Vaduva et
al., 1997) and it interacts with actin in the
two-hybrid system (Vaduva et al., 1997).
Additionally, we observed that the
W1123S mutation, that prevented binding
of the of the Myo5p C-terminal fragment to
actin, also abolished interaction of this
domain with Vrp1p in the two-hybrid assay
(Figure 3A).
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Figure 2. The Myo5p tail-actin interaction is functionally relevant
(A) The indicated MYO5 tail fragments or END3 as control (pEG202MYO5; pEG202-TH2,SH3;
pEG202-SH3,TH2c; pEGEND3) were tested versus the indicated ACT1 alleles (pJG4-5act1-x) in the two-hybrid
X-Gal-containing plate assay. The same actin mutants were tested for their ability to sustain endocytosis in vivo.
The percentage of cell-bound -factor internalized/min is indicated. (B) myo3 strains bearing integrated myc-
tagged wt or mutant MYO5 (SCMIG277, SCMIG278, SCMIG279, SCMIG280) were tested for -factor
internalization. The percentage of cell-bound -factor internalized/min is indicated. The expression level of the
integrated proteins (lower panel) was monitored by immunoblotting. 9E10 was used for detection of wt and
mutant Myo5p (lanes 1 - 4). C4 was used for detection of actin as internal reference.
In agreement with a possible requirement
of Vrp1p for the Myo5p tail-actin
interaction, we observed a strong inhibition
of the MYO5/ACT1-induced -galacto-
sidase transcription in the vrp1 strain,
when compared to wt cells (Figure 3A).
Three criteria indicated that this effect was
specific. First, deletion of another protein
required for the uptake step of endocytosis
and the organization of the actin
cytoskeleton, did not significantly affect
the Myo5p tail-actin interaction
(Figure 3A, end3). Second, the inter-
action of the Myo5p tail with another
protein appeared unaffected in the vrp1
strain (Figure 3A, MYO5-RVS167). Third,
an N- and a C-terminal truncations of
VRP1, which were equally unable to
complement the growth defect of a vrp1
strain at 37
C (Vaduva et al., 1997),
differentially restored the two-hybrid
Myo5p tail actin interaction in the vrp1
cells. The requirement of Vrp1p for the
Myo5p tail-actin interaction was confirmed
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using the actin pelleting assay. The GST-
(SH3,TH2) fusion protein failed to pellet
with F-actin when cytosol from a vrp1
strain was used in the assay (Figure 3C).
Also consistent with a proposed role of
Vrp1p in mediating the Myo5p tail-actin
interaction, HA tagged Vrp1p was also
found in the actin pellet together with
Myo5p regardless of the presence or
absence of ATP in the buffer (Figure 3B).
To further test this hypothesis we compare
the footprint of Myo5p and Vrp1p on the
actin molecule. If Vrp1p was really
required to mediate the Myo5p tail-actin
interaction, all mutations that diminish
Vrp1p-Act1p binding should also impair
the interaction of Act1p with the Myo5p
tail. As expected, the Myo5p and Vrp1p
footprints on actin were strikingly similar
(Figure 3C).
An intact SH3 domain and Vrp1p seem
to be required for Myo5p-induced
localized actin polymerization
Recent results strongly suggest that the
yeast type I myosins might be implicated in
the regulation of localized actin
polymerization in vivo (Evangelista et al.,
2000; Lechler et al., 2000). Myo3p and
Myo5p physically interact with the
Arp2p/Arp3p actin-nucleating complex
(Evangelista et al., 2000; Lechler et al.,
2000) and they are required for polarized
assembly of cortical actin patches in a semi
in vitro assay (Lechler et al., 2000). On the
other hand, Vrp1p has also been implicated
in the regulation of actin polymerization
in vivo. Overexpression of Las17p, the
yeast homolog of WASP (Wiscott Aldrich
Syndrome Protein), suppresses the actin
polarization and endocytic defect of a ts
allele of VRP1 but not of a null mutation
(Naqvi et al., 1998). Las17p interacts with
the Arp2p/Arp3p complex and activates its
actin nucleation activity in vitro (Madania
et al., 1999; Winter et al., 1999).
Additionally, a vrp1 strain is hyper-
sensitive to the inhibitor of actin
polymerization Latrunculin A and a vrp1
temperature sensitive (ts) mutant can be
suppressed by increasing the intracellular
concentration of actin by providing an
extra copy of ACT1 (Vaduva et al., 1997).
We collected further evidence in vivo
indicating that Vrp1p and the yeast type I
myosins are together involved in positive
regulation of actin polymerization and that
this function is required for the uptake step
of endocytosis in yeast. We previously
showed that the myo5 mutant (but not
myo3 cells) exhibits a partial endocytosis
defect at 37
C (Geli and Riezman, 1996)
(Figure 4A). Thus, the wt MYO3 seems to
be less efficient than MYO5 to sustain
endocytosis at high temperatures.
Interestingly, increasing the intracellular
actin concentration by providing an extra
copy of ACT1 could partially rescue the ts
endocytic defect of the myo5 strain
(Figure 4A). Also, overexpression of
Vrp1p efficiently rescued the endocytosis
defect of a myo5 strain. However, over-
expression of Vrp1p or Act1p was not able
to restore endocytosis in a myo3 myo5-
(TH2,SH3) strain suggesting that
suppression required the presence of at
least one myosin I-SH3 domain (data not
shown). Interestingly, overexpression of
Las17p failed to restore endocytosis in the
myo5 strain, suggesting that type I
myosins and Las17p only share partially
overlapping functions (Evangelista et al.,
2000; Lechler et al., 2000). Additionally,
deletion of MYO5, but interestingly not
deletion of MYO3, exhibits synthetic
lethality with mutations in genes
specifically involved in the regulation of
actin polymerization (ARP3, VRP1) but not
with other genes required for polarization
of the actin cytoskeleton and endocytosis
(i.e. SLA2, RVS161, RVS167, ABP1, SAC6,
END3; Figure 4B).
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Figure 3. Vrp1p is required for the Myo5p tail-actin interaction
(A) Upper left panel: the most C-terminal MYO5 fragment containing the SH3 domain (pEG202-SH3,TH2c) wt
or the same fragment bearing a point mutation in the SH3 domain (W1223S) was tested versus ACT1
(pJG4-5ACT1) or VRP1 (pJG4-5VRP1) using the two-hybrid assay on X-Gal-containing plates. Lower left panel:
the MYO5 tail (pEG202MYO5) was tested versus ACT1 (pJG4-5ACT1) or RVS167 (pJG4-5RVS167) in wt
(RH2884) or isogenic end3 (SCMIG45) or vrp1 (SCMIG48) strains bearing the -galactosidase reporter gene
(pSH18-34). Enzyme activity was monitored on X-Gal-containing plates. Right panel: the MYO5 tail
(pEG202MYO5) was tested versus ACT1 (pJG4-5ACT1) in a vrp1 (SCMIG48) strain bearing the -galacto-
sidase reporter gene (pSH18-34), and either an empty plasmid (Ycplac111) or the same plasmid bearing wt or
the indicated mutant vrp1 genes. Enzyme activity was monitored on X-Gal-containing plates. (B) Upper panel:
recombinant purified GST fusion proteins containing the wt TH2 and SH3 domains (GST-TH2,SH3) wt, or the
same construct bearing the W1223S mutatin in the SH3 domain were incubated with cytosolic fractions from wt
(RH3975) or vrp1 (SCMIG48) strains and increasing concentrations of G-actin. After allowing polymerization,
F-actin was recovered by centrifugation and the pellets analyzed for the presence of the recombinant fusion
proteins by immunoblotting using the EW/IK antibody. The increasing amounts of actin in the pellet were
monitored by Ponceau Red staining. The same amounts of GST fusion proteins used per assay were loaded as
total (T). Lower panel: a cytosolic fraction from a strain bearing a plasmid with an HA-tagged VRP1
(SCMIG277 p181VRP1HA) was prepared in a buffer containing 1 mM ATP. Either purified G-actin (+ actin) or
G-buffer (- actin) was added to the cell extracts. After allowing actin polymerization, one of the samples
containing actin was incubated with apyrase to hydrolyze ATP (+ apyrase). F-actin was recovered by
centrifugation and the pellet analyzed by immunoblotting using the anti-HA antibody. One quarter of the protein
extract utilized per incubation was loaded as total (T). (C) The MYO5 tail (pEG202MYO5) or VRP1
(pEG202VRP1) was tested versus the indicated ACT1 alleles (pJG4-5act1-x) in the EGY48 strain using the two-
hybrid assay on X-Gal-containing plates.
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It has recently been pointed out that the
C-terminal region of Myo5p shares
homology with Las17p including an acidic
peptide required for the interaction and
activation of the Arp2p/Arp3p complex
(Winter et al., 1999). Given this
information and all previous data regarding
the role of Vrp1p and the yeast type I
myosins in the regulation of actin
polymerization, we hypothesize that
Myo3p and Myo5p might be able to induce
localized actin polymerization and this
activity might then require the interaction
with Vrp1p. In order to directly test this
hypothesis we established a visual actin
polymerization assay in vitro based on Ma
et al. 1998a and 1998b (Ma et al., 1998a;
Ma et al., 1998b). In this assay gluthatione
sepharose beads coated with GST fusion
proteins are incubated with cell extracts in
the presence of trace amounts of
rhodamine-labeled actin. The de novo
polymerization of actin triggered by a
given GST-fusion protein can be monitored
under the microscope by visualizing the
accumulation of fluorescent signal on the
sepharose beads. We chose this assay
because, in contrast to the pyrene actin
polymerization assay (Cooper et al., 1983),
it allows to monitor not only actin
polymerization but also its localization.
Strikingly, we found that beads coated with
the GST-(SH3,TH2) fusion protein, but not
those coated with naked GST, accumulate
a bright fluorescent signal when incubated
in cell extracts from a wt strain in the
presence of rhodamine labeled actin
(Figure 4C). The signal was abolished
when the assay was performed in the
presence of the Latrunculin A or DNAse I
(Figure 4C, table). This result clearly
points to a direct role of the yeast type I
myosins in the regulation of actin
polymerization. Myosin-induced actin
polymerization was clearly dependent on
the presence of other cellular components
since no signal was detected on the GST-
(SH3,TH2) coated beads when buffer was
used in the assay instead of a cellular
extract. Consistent with a proposed
function of the yeast type I myosins in the
activation of the Arp2/3 complex actin
nucleation activity, myosin induced actin
polymerization seemed dependent on the
presence of the complex since extracts
from an arp2-2 mutant were unable to
sustain actin polymerization onto the
beads. To investigate a possible
requirement of the Vrp1p-Myo5p
interaction in this process, we assayed the
GST fusion protein bearing the point
mutation that abolished interaction of the
Myo5p SH3 domain with Vrp1p
(W1123S). Interestingly, this construct was
unable to trigger accumulation of
fluorescently labeled actin onto the coated
beads indicating that an intact SH3 domain
is required for Myo5p-induced localized
actin polymerization. This result also
hinted the involvement of Vrp1p in the
process. Consistently, we found that
cellular extracts from a vrp1 strain were
unable to sustain accumulation of
rhodamine-labeled actin onto GST-
(TH2,SH3) coated beads (Figure 4C).
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Figure 4. Myo5p might regulate localized actin polymerization
(A) A myo5 strain (RH3976) bearing plasmids carrying ACT1 (p413ACT1) and VRP1 (p181VRP1) or the
corresponding control plasmids (pRS413 and Ycplac181, respectively) was tested for internalization of -factor.
The percentage of cell-bound -factor internalized/min is shown. A wt (RH3975) was assayed as control.
(B) arp3-62 (SCMIG286) and vrp1 (RH2892) strains were crossed to myo5 strains (SCMIG276 and RH3976,
respectively) bearing a centromeric plasmid with the MYO5 and URA3 genes (p33MYO5), to construct the
corresponding single or double mutations carrying p33MYO5, which were streaked on 5’-FOA plates. A
representative of each genotype is shown. Lack of synthetic lethality (SL, see table -) between myo3 or myo5
mutations and the indicated mutants (vrp1, arp3-62, sac6, rvs161, rvs167, end3 and sla2) was assessed
by standard tetrad analysis. * Even though the myo5sla2 spores failed to germinate, the double mutant
covered with the p33MYO5 plasmid was able to grow on 5’-FOA plates. (C) The C-terminal fragment of the
Myo5p tail is able to induce actin polymerization in vitro. Glutathione-Sepharose beads coated with either GST
or GST fused to the MYO5 TH2 and SH3 domains (GST-TH2,SH3), or the same fusion portein bearing the
W1123S mutation, were incubated with extracts from either a wt (RH3975), vrp1 (SCMIG48) or arp2-2
(SCMIG4165) strain, or buffer (none), in the presence of rhodamine-actin. Samples were incubated at 30°C and
the fluorescent signal visualized using a fluorescence microscope. Latrunculin A (LatA) or Dnase I was added to
the samples (wt + LatA and wt + Dnase I, respectively) during the incubation. For the wt + Pha + LatA sample,
actin filaments polymerized in the absence of beads were stabilized with phalloidin (Pha) prior to the addition of
GST-TH2,SH3-coated beads and latrunculin A. Representative (+) and (-) signals are recorded in the left panel
(GST-TH2,SH3 and GST, respectively). The appearance of the beads in a given sample was homogeneous and
the assays were repeated at least three times independently.
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Discussion
An intact Myo5p SH3 domain is
required to sustain a physiologically
relevant interaction between the Myo5p
tail and F-actin
As previously demonstrated for the
protozoal type I myosins that contain a
TH2 domain (Brzeska et al., 1988;
Doberstein and Pollard, 1992; Jung and
Hammer, 1994; Rosenfeld and Rener,
1994), we found that the Myo5p tail
interacts with F-actin. Despite the
extensive biochemical characterization of
the second actin-binding site of the
protozoal type I myosins, no experiments
have addressed its role in vivo. We provide
here the first genetic evidence suggesting
that the Myo5p tail-actin interaction is
physiologically relevant. We found that a
number of mutations in either MYO5 or
ACT1 that greatly diminished this
interaction, either in the two-hybrid and/or
the actin pelleting assays, did also affect
their function.
Previous experiments with the protozoal
type I myosins indicate that the second
ATP-independent actin binding site resides
within the TH2 domain (Brzeska et al.,
1988; Doberstein and Pollard, 1992; Jung
and Hammer, 1994; Rosenfeld and Rener,
1994). However, our data indicate that the
Myo5p tail-actin interaction detected in
either the actin-pelleting and the two-
hybrid assays resides within the SH3 and
the most C-terminal portion of the TH2
domain. The C-terminal fragment
containing the SH3 and the TH2c was
sufficient to reconstitute the Myo5p tail
footprint on the actin molecule and it was
necessary and sufficient to mediate the
Myo5p tail-actin interaction both in the
two-hybrid and pelleting assays. In
contrast, deletion of the N-terminal portion
of the TH2 domain did not affect the
interaction with actin in either assay.
Consistent with this, deletion of the TH2n
region in MYO5 did not disrupt its function
in endocytosis or in the polarization of the
actin cytoskeleton (Anderson et al., 1998).
The apparent discrepancy between
previous findings for the protozoal myosins
and our findings for the yeast type I
myosin could be explained in several ways.
It could be that the different results reflect
differences in the assays used to monitor
the interaction. Otherwise, there could be
evolutionary divergences in the structural
organization of the myosin tails. It is
possible that the region defined as a TH2
domain in Myo5p is not a bona fide TH2
domain. Glycines in this region are rare
when compared to the protozoal
counterparts and the percentage of alanine
and proline in the C-terminal region
downstream of the SH3 domain is
relatively low.
The requirement of the SH3 domain for a
physiologically relevant Myo5p tail-actin
interaction implicates intermediate proteins
in this event. Consistently, we found that a
protein that binds both the Myo5p SH3
domain (Anderson et al., 1998) and F-actin
(This manuscript and Vaduva et al., 1997),
Vrp1p, seems required to sustain this
interaction both in the two-hybrid and in
the actin pelleting assays. The functional
importance of this interaction is hinted by
the demonstration that point mutations in
either actin or the SH3 domain of Myo5p,
that strongly dimininshed the interaction
with Vrp1p, also disrupted the ATP-
independent actomyosin interaction and the
endocytic function.
The yeast type I myosins might trigger
localized actin polymerization at the
sites of endocytosis
It was demonstrated recently that in mast
cells transfected with a fusion protein
consisting of green fluorescent protein
(GFP) and -actin, endocytic vesicles
ignite a burst of actin polymerization at the
moment they pinch off from the plasma
membrane (Merrifield et al., 1999). This
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result suggests a direct involvement of
Apr2/3-dependent localized actin polym-
erization in some endocytic pathways in
mammalian cells. In yeast, mutations in
different subunits of the Arp2/3 complex
inhibit the uptake step of endocytosis
(Moreau et al., 1997; Schaerer-Brodbeck
and Riezman, 2000a) suggesting that a
similar mechanism might be involved. The
actin nucleating activity of purified Arp2/3
complex is moderate. It is believed that
different molecules, including the members
of the WASP family, locally activate the
Arp2/3 complex to fulfill distinct cellular
functions (Machesky et al., 1999; Madania
et al., 1999; Rohatgi et al., 1999; Welch,
1999; Winter et al., 1999; Yarar et al.,
1999). Our results suggest that the yeast
type I myosins may play a key role to
regulate Arp2/3-dependent actin polymeri-
zation at the sites of endocytosis.
Surprisingly, we observe that increasing
the cellular concentration of actin by
providing an extra copy of ACT1 partially
suppresses the ts endocytic defect of
myo5 mutant. Further, we could directly
demonstrate that the C-terminal domain of
Myo5p is able to trigger localized actin
polymerization in vitro and such activity
most likely depends on the presence of an
intact Arp2/3 complex. Type I myosins
bind acidic phospholipids with high
affinity via their TH1 domain (Mooseker
and Cheney, 1995; Pollard et al., 1991).
Besides, phosphatidic acid and
phosphoinositides have been implicated in
budding at the plasma membrane (Jost et
al., 1998; Schmidt et al., 1999). Thus, the
type I myosins could be recruited to sites
where these lipids are locally produced to
trigger localized Arp2/3 complex-
dependent actin polymerization.
An intact SH3 domain and Vrp1p might
be required to localize myosin-induced
actin polymerization
The C-termini of Myo3p and Myo5p share
homology with the C-terminal acidic
peptide of Las17p that greatly activates the
actin nucleating activity of purified Arp2/3
complex in vitro (Evangelista et al., 2000;
Lechler et al., 2000; Winter et al., 1999).
In our assay though, the carboxi terminus
of Myo5p (TH2c) containing the acidic
peptide does not suffice to trigger
accumulation of rhodamine-labeled actin
(data not shown). Rather, our data clearly
indicates that the SH3 domain of Myo5p is
also required in this process. A point
mutation in the SH3 domain completely
abolishes accumulation of fluorescence
onto the GST-(SH3,TH2) coated beads.
Interestingly, the same mutations also
abolished a physiologically relevant
interaction of the Myo5p tail with F-actin.
A view consistent with all these data is that
the SH3 domain of Myo5p is required to
bind the actin filaments that are being
nucleated by the Arp2/3 complex. Thus, in
essence, the SH3 domain would be
required to localize actin polymerization
rather than to activate nucleation. Since our
results indicate that Vrp1p is required to
mediate the Myo5p tail interaction with
F-actin this hypothesis would be consistent
with the observation that a cell extract from
a vrp1 strain is unable to sustain
accumulation of rodhamine-labeled actin
onto GST-(TH2, SH3) coated beads. This
possibility does not exclude that Vrp1p and
the carboxi terminal acidic peptide of
Myo5p work synergistically to promote
actin polymerization. Localized
accumulation of F-actin might for example
exponentially provide new sites for
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activation of the Arp2/3 complex
(Blanchoin et al., 2000). Additionally,
Vrp1p bears a WH2 (WASP homology 2)
domain that shares with members of the
WASP family including Las17p
(Machesky and Insall, 1998; Miki and
Takenawa, 1998). This domain binds
monomeric actin in vitro and has been
proposed to promote actin polymerization
by increasing the concentration of G-actin
in the proximity of growing barbed ends of
the filamentous actin.
Materials and Methods
Yeast, media, strains and genetic
techniques
Yeast strains used in this report are listed in
Table I with their relevant genotypes. Unless
otherwise mentioned strains that did not bear
plasmids were grown in complete media
YPUATD (2% glucose, 2% peptone, 1%
yeast extract, 40 /ml uracil (Ura), 40 g/ml
adenine (Ade) and 40 g/ml tryptophan
(Trp), 2 % agar for solid media). Strains
bearing plasmids were selected on SD
minimal media (Dulic et al., 1991).
Sporulation, tetrad dissection and scoring of
genetic markers were performed as
described by (Sherman et al., 1974).
Recombinant lyticase was purified from
E. coli as described in (Hicke et al., 1997).
Transformation of yeast cells was
accomplished by the lithium acetate method
of (Ito et al., 1983).
Strains SCMIG277 to SCMIG280 were
generated by integrating the corresponding
wt and mutant MYO5 genes as described in
(Geli et al., 1998). SCMIG37 and SCMIG40
were obtained by crossing RH1995 and
RH2892, respectively, to RH2884. Diploids
were selected in SD-His and subsequently
sporulated, dissected and segregants scored
for the appropriate markers.
SCMIG45, SCMIG48 and SCMIG286 were
obtained by plating SCMIG37, SCMIG40
and RH4166 respectively, on SD plates
containing 2 g/l of 5’-Fluoroorotic acid
(5’-FOA). Single colonies were restreaked
on SD+5’-FOA plates and all the markers
and the ts phenotype rechecked. Single
colonies with identical phenotype as those of
the original strains but unable to grow on
SD-Ura, were chosen. SCMIG308 to
SCMIG325 were constructed as follows: the
heterozygous diploids carrying the different
actin alleles linked to HIS3 (DBY5533,
5534, 5536, 5537, 5538, 5543, 5545, 5546,
5547, 5548, 5550, 5551, 5552, 5553, 5555,
5556, 5559 and 5562, respectively;
Wertman et al., 1992) were sporulated,
dissected and the segregants scored for the
different markers. Mat  act1-x haploids
were then crossed to RH422-8A (Mat a
ACT1 ade2 his3 leu2 ura3 trp1
vma2::LEU2 pVMA2::URA3 bar1). The
diploids were selected on SD-Ura-Leu,
sporulated, dissected and the segregants
scored for the appropriated markers. Mat a
act1-x his3 leu2 ura3 bar1 and either ade2
or ADE2 and trp1 or TRP1 were chosen to
perform the assays (SCMIG308 to
SCMIG325).
DNA Techniques and Plasmid
Constructions
All DNA manipulations were performed
according to standard techniques (Sambrook
et al., 1989) unless otherwise specified.
Restriction enzymes, Klenow and T4 DNA
ligase were obtained from Boehringer
Mannheim, New England Biolabs, United
States Biochemical or Stratagene Cloning
Systems. Plasmids were purified by the
Qiagen plasmid purification kit (Qiagen),
and transformation of E. coli was performed
by electroporation (Dower et al., 1988). All
PCR for cloning purposes were performed
with a DNA polymerase with proof reading
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activity (Pfu, Stratagene Cloning Systems)
and a TRIO-thermoblock (Biometra GmbH).
Oligonucletides were synthesized by
Microsynth GmbH or Interactiva. All
constructs were sequenced by Sequencing
service of the ZMBH (Im Neuenheimer Feld
282, D-69120 Heidelberg, Germany).
Plasmids used in this report and their
relevant features are listed in Table II.
Further details are available under request.
Immunoblots and antibodies
SDS-PAGE for protein separation was
performed as described (Laemmli, 1970)
using a Minigel system (Bio Rad
Laboratories). High and low range
SDS-PAGE molecular weight standards
(Bio Rad Laboratories) were used for
determination of apparent molecular weight.
Protein concentration was determined using
a Bio Rad Protein assay (Bio Rad
Laboratories). Total yeast protein extractions
were performed as and Western blots and
immunodetection were performed as
described in (Geli et al., 1998) using the
polyclonal EW and IK antibodies against
Myo5p C-terminal peptides (Geli et al.,
1998) the 9E10 anti-myc monoclonal
antibody (Roche Biochemicals) and the
C4 anti-actin monoclonal antibody (Roche
Biochemicals).
Yeast extracts
Yeast cells were grown in rich media to a
density of approx. 4 x 107 cell/ml. Cells
were harvested and washed twice with XB
(100 mM KCl, 2 mM MgCl2, 0.1 mM
CaCl2, 5 mM EGTA, 1 mM DTT, 1 mM
ATP, 10 mM Hepes pH 7.7 and 50 mM
Sucrose). 1/10 pellet volume of XB 50 mM
Sucrose was added and the cells glass bead
lysed in the presence of proteinase inhibitors
(0.5 mM PMSF, 1 g/ml aprotinin, 1 g/ml
pepstatin, 1 g/ml leupeptin). Unbroken
cells and debris were eliminated by
centrifugation at 2,500 g at 4°C. For low
speed pelleted (LSP) extracts, Sucrose was
supplemented to 200 mM, freezed in liquid
N2 and stored at –80
C until use in the
actin polymerization assay. Usually 30 to
40 mg of protein per ml of LSP extract was
measured using the BioRad protein assay.
For the high speed pelleted (HSP) or
cytosolic extracts, 100 l aliquots of the
LSP extracts were transferred to 1.5 ml
polyallomer tubes (Beckman Instruments)
and spun twice for 2 h at 45,000 rpm in a
TL100 Beckman table top ultracentrifuge
using a TLA-45 rotor. Supernatants were
then collected, supplemented to 200 mM
Sucrose, freezed in liquid N2 and stored at
–80
C until use in the pelleting assays.
About 10 to 20 mg of protein per ml of
HSP extract was measured using the Bio
Rad protein assay.
Recombinant GST fusion protein
purification
For purification of recombinant GST
fusion proteins, the corresponding pGST
plasmids were transformed into BL21
E. coli (Novagen). Cultures grown at 24
C
in minimal media (MM) (Sambrook et al.,
1989) supplemented with 50 mg/l
Ampicillin were induced at O.D. 0.7-0.8
with 0.1 mM IPTG (isopropylthio--
D-galactoside) for 2 h. For protein
purification, a GST Amersham-Pharmacia
purification kit was used (27-4570-01)
according to the manufacturer instructions.
For the actin pelleting assays, purified
GST-fusion proteins were supplemented
with 10 % glycerol, freezed in liquid N2
and stored at –80
C until use. For the actin
polymerization assay, GST fusion proteins
were freshly purified to a final
concentration of 2 mg of fusion protein per
ml of 50% glutahion sepharose.
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Table I. Yeast strains
Strain Genotype Reference
RH3375 Mata/Mat ade2/ADE2 his3/his3 myo3::HIS3/MYO3 myo5::TRP1/MYO5 (Geli and Riezman, 1996)
leu2/leu2 lys2/LYS2 trp1/trp1 ura3/ura3 bar1/bar1
SCMIG281 Mata/Mat ade2/ADE2 his3/his3 myo3::HIS3/MYO3 mycMYO5::URA3::myo5:: this study
TRP1/MYO5 leu2/leu2 trp1/trp1 ura3/ura3 bar1/bar1
SCMIG282 Mata/Mat ade2/ADE2 his3/his3 myo3::HIS3/MYO3 mycmyo5-TH2n::URA3:: this study
myo5::TRP1/MYO5 leu2/leu2 trp1/trp1 ura3/ura3 bar1/bar1
SCMIG283 Mata/Mat ade2/ADE2 his3/his3 myo3::HIS3/MYO3 mycmyo5-(SH3, TH2):: this study
URA3::myo5::TRP1/MYO5 leu2/leu2 trp1/trp1 ura3/ura3 bar1/bar1
SCMIG284 Mata/Mat ade2/ADE2 his3/his3 myo3::HIS3/MYO3 bar1/bar1 mycmyo5- this study
(TH2, SH3)::URA3::myo5::TRP1/MYO5 leu2/leu2 trp1/trp1 ura3/ura3
RH3975 Mata ade2 his3 leu2 trp1 ura3 bar1 (Geli et al., 1998)
RH2881 Mata his3 leu2 trp1 ura3 bar1 Riezman laboratory
RH2884 Mat ade2 his3 leu2 trp1 ura3 bar1 (Geli et al., 1998)
RH3977 Mat his3 myo3::HIS3 leu2 trp1 ura3 bar1 (Geli et al., 1998)
RH3377 Mata ade2 his3 myo3::HIS3 leu2 trp1 ura3 bar1 (Geli and Riezman, 1996)
RH3976 Mata ade2 his3 myo5::TRP1 leu2 trp1 ura3 bar1 (Geli et al., 1998)
RH3978 Mata his3 myo5::TRP1 leu2 lys2 trp1 ura3 bar1 (Geli et al., 1998)
SCMIG276 Mat ade2 his3 myo5::TRP1 leu2 lys2 trp1 ura3 bar1 this study
SCMIG277 Mata ade2 his3 myo3::HIS3 mycMYO5::URA3::myo5::TRP1 leu2 trp1 ura3 bar1 this study
SCMIG278 Mata his3 myo3::HIS3 mycmyo5-TH2n::URA3::myo5::TRP1 leu2 trp1 ura3 bar1 this study
SCMIG279 Mata his3 myo3::HIS3 mycmyo5-(SH3, TH2c)::URA3::myo5::TRP1 leu2 trp1 this study
ura3 bar1
SCMIG280 Mata ade2 his3 myo3::HIS3 mycmyo5-(TH2, SH3)::URA3::myo5::TRP1 leu2 this study
trp1 ura3 bar1
RH1995 Mata his4 leu2 bar1 end3::URA3 (Bénédetti et al., 1994)
SCMIG37 Mat ade2 his3 leu2 trp1 ura3 bar1 end3::URA3 this study
RH2892 Mata vrp1::URA3 his4 leu2 lys2 ura3 bar1 (Munn et al., 1995)
SCMIG40 Mat ade2 vrp1::URA3 his3 leu2 lys2 trp1 ura3 bar1 this study
RH4166 Mata ade2 arp3-62::LEU2 his3 lys2 leu2 trp1 ura3 bar1::URA3 B. Windsor
SCMIG286 Mata ade2 arp3-62::LEU2 his3 lys2 leu2 trp1 ura3 bar1::ura3 this study
SCMIG273 Mata las17::LEU2 his3 ura3 leu2 trp1 bar1 A. Munn
RH3392 Mat his3 leu2 lys2 trp1 ura3 bar1 end4::HIS3 pEND4::URA3 (Wesp et al., 1997)
SCMIG47 Mat his3 leu2 lys2 trp1 ura3 bar1 end4::his3::LEU2 this study
RH2600 Mata rvs161 his4 ura3 bar1 (Munn et al., 1995)
RH2950 Mata leu2 his4 ura3 trp1::URA3 rvs167::TRP1 bar1 (Munn et al., 1995)
RH2565 Mata sac6-::URA3 ura3 bar1 his3 leu2 (Kübler and Riezman, 1993)
RH4165 Mata arp2-2::URA3 ts GAL+ ade2 trp1 leu2 his lys2 ura3 bar1 B. Windsor
EGY48 Mata his3 trp1 ura3 leu2::lexAop6-LEU2 (Gyuris et al., 1993)
SCMIG45 Mat ade2 his3 leu2 trp1 ura3 bar1 end3::ura3 this study
SCMIG48 Mat ade2 vrp1::ura3 his3 leu2 lys2 trp1 ura3 bar1 this study
SCMIG308 Mata act1-101::HIS3 ade2 leu2 trp1 ura3 bar1 this study
SCMIG309 Mata act1-102::HIS3 ade2 leu2 ura3 bar1 this study
SCMIG310 Mata act1-104::HIS3 ade2 leu2 ura3 bar1 this study
SCMIG311 Mata act1-105::HIS3 leu2 ura3 bar1 this study
SCMIG312 Mata act1-108::HIS3 leu2 trp1 ura3 bar1 this study
SCMIG313 Mata act1-111::HIS3 ade2 leu2 ura3 bar1 this study
SCMIG314 Mata act1-113::HIS3 ade2 leu2 ura3 bar1 this study
SCMIG315 Mata act1-115::HIS3 ade2 leu2 ura3 bar1 this study
SCMIG316 Mata act1-116::HIS3 ade2 leu2 ura3 bar1 this study
SCMIG317 Mata act1-117::HIS3 ade2 leu2 trp1 ura3 bar1 this study
SCMIG318 Mata act1-119::HIS3 ade2 leu2 ura3 bar1 this study
SCMIG319 Mata act1-120::HIS3 leu2 ura3 bar1 this study
SCMIG320 Mata act1-121::HIS3 ade2 leu2 ura3 bar1 this study
SCMIG321 Mata act1-122::HIS3 ade2 leu2 trp1 ura3 bar1 this study
SCMIG322 Mata act1-124::HIS3 ade2 leu2 trp1 ura3 bar1 this study
SCMIG323 Mata act1-125::HIS3 ade2 leu2 ura3 bar1 this study
SCMIG324 Mata act1-129::HIS3 ade2 leu2 ura3 bar1 this study
SCMIG325 Mata act1-132::HIS3 ade2 leu2 ura3 bar1 this study
Actin pelleting assays
The actin pelleting assays performed with
the yeast strains expressing the myc tagged
wt and mutant Myo5p and HA tagged
VRP1 were designed based on (Wang et
al., 1998). Cells were grown either in rich
media or SD (for plasmid maintenance), to
a density of 2 x 107 cell/ml. For each
pelleting assay, 3 x 109 cells were
harvested. Half the volume of pellet of
3 x EB was added (EB = 20 mM PIPES
pH6.8, 100 mM sorbitol, 100 mM KoAc,
25 mM KCl, 0.5% Triton-X-100, 5 mM
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MgCl2, 1 mM ATP, 0.5 mM EGTA,
0.5 mM PMSF, 1 g/ml aprotinin, 1 g/ml
pepstatin, 1 g/ml leupeptin) on ice and the
cells glass bead-lysed. Unbroken cells and
debris were eliminated by centrifugation at
2500 g at 4°C. The supernatants were
transferred to a new tube and the protein
concentration adjusted to 15 g/l with
EB. Three 100 l aliquots of the protein
extract were transferred to 1.5 ml
polyallomer tubes (Beckman Instruments)
and spun 2 h at 45000 rpm in a TL100
Beckman table top ultracentrifuge using a
TLA-45 rotor. The supernatants were
collected into a fresh tube and 2 x 70 l
were transferred to polyallomer tubes
containing 10 l of 3 x EB and 20 l of
G buffer (5 mM Tris-HCl pH 7.5, 0.1 mM
CaCl2, 0.1 mM ATP) containing 2 mg/ml
actin (Sigma A-2522). 70 l were
transferred to a polyallomer tube
containing 10 l of 3 x EB and 20 l of
G buffer for the -actin control. After
2 hour incubation at 4
C, 0.2 u of apyrase
(Amersham Pharmacia Biotech) was added
to one of the samples containing actin for
the -ATP control. 10 min after incubation
at room temperature (RT), the samples
were centrifuged at 45,000 rpm for 2 h at
4°C in the TL100 Beckman tabletop
ultracentrifuge using the TLA-45 rotor.
The supernatants were discarded and the
pellet washed once with 100 l of EB
either treated (for the -ATP control) or not
with apyrase. The pellets were resuspended
in 30 l of SDS-PAGE sample buffer and
processed for immunoblot analysis. 14 l
of protein extract after the first
ultracentrifugation were loaded as total.
For the experiments performed with the
recombinant Myo5p fragments, 20 l of
the HSP fraction (adjusted to 10 mg/ml) of
the corresponding strain (see above) were
diluted with 60 l XB to bring sucrose
concentration to 50 mM, and centrifuged
2 h at 4°C at 45,000 rpm in the TLA-45
rotor. 70 l of the supernatant was
recovered and mixed with 4 l of G buffer
or 4 l of G-actin either 2 or 4 g/l. After
mixing, 3 l of the corresponding GST
fusion proteins adjusted to 0.5 M were
added and the samples incubated at 4
C for
2 h. After centrifuging 2 h at 4°C at 45,000
rpm in the TLA-45 rotor, the supernatant
was aspirated and the pellet washed with
100 l of XB 50 mM Sucrose. After
centrifuging further 2 h, the supernatant
was eliminated and the pellet resuspended
in 20 l of SDS-PAGE SB. 3 l of the
corresponding GST fusion proteins
adjusted to 0.5 M were brought to 20 l
with SDS-PAGE SB and the same amount
loaded on the gel as total for comparison.
Visual actin-polymerization assay
The actin polymerization assay was
designed according to (Ma et al., 1998a;
Ma et al., 1998b). Briefly, 7 l of LSP
extracts adjusted to 20 mg of protein/ml
with XB 200 mM sucrose or just buffer,
were mixed with 1 l of ARS (10 mg/ml
Creatine Kinase, 10 mM ATP, 10 mM
MgCl2, 400 mM Creatine Phosphate) and
1 l of 10 M rhodamine-labeled actin
(Cytoskeleton, Inc.). The polymerization
reaction was initiated by adding 1 l of
50% gluthatione sepharose beads bound to
2-3 g of the corresponding GST fusion
protein. Samples were incubated at room
temperature (RT) and visualized using
fluorescence Microscope Zeiss Axioskop
after 10-20 min incubation. Latrunculin
and DNase I were added to final
concentration of 10 M and 0.5 g/l
respectively, previous to the addition of the
gluthation sepharose beads.
-Factor uptake assay
[35S]-factor uptake assays were performed
as described (Dulic et al., 1991). A pulse-
chase protocol was used. Cells were grown
in YPUATD or minimal media at 24
C to a
density of 0.5 - 1 x 107 cells/ml, harvested
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and resuspended in ice-cold YPUATD
media for binding of -factor at 0
C for
45 min. Cells were harvested at 4
C to
eliminate unbound -factor, and
internalization was triggered by
resuspension in 37°C prewarmed YPUATD.
Samples were taken at the indicated time
points into pH 1 and pH 6 buffers.
Internalized counts were calculated by
dividing pH1 by pH6 resistant counts per
each time point. The internalization rates
were calculated as the percentage of counts
internalized per minute between 5 and
10 min (linear range). All uptake assays
were performed at least two times and the
mean and standard deviations calculated for
each time point.
Table II. Plasmids
Plasmid Yeast Yeast Insert Reference
Ori marker
Yeplac181 2 µm LEU2 - (Gietz and Sugino, 1988)
p181VRP1 2 µm LEU2 VRP1 this study
p181VRP13HA 2 µm LEU2 VRP13HA
pRS413 CEN HIS3 - (Sikorski et al., 1989)
p413ACT1 CEN HIS3 ACT1 this study
p33MYO5 CEN URA3 MYO5 (Geli et al., 1998)
p111VRP1 CEN LEU2 VRP1 this study
p111vrp1(9–200) CEN LEU2 vrp1(9–200) this study
p111vrp1(201–816) CEN LEU2 vrp1(201–816) this study
pINmycMYO5 - URA3 myc-tagged MYO5 this study
pINmycmyo5-(TH2n) - URA3 myc-tagged myo5-(TH2) this study
pINmycmyo5-(SH3,TH2c) - URA3 myc-tagged myo5-(SH3,TH2c) this study
pINmycmyo5-(TH2, SH3) - URA3 myc-tagged myo5-(TH2, SH3) this study
pJG4-5 2 µm TRP1 B42 (Gyuris et al., 1993)
pJG4-5ACT1 2 µm TRP1 B42ACT1 this study
pJG4-5act1-101 2 µm TRP1 B42act1-101 this study
pJG4-5act1-102 2 µm TRP1 B42act1-102 this study
pJG4-5act1-104 2 µm TRP1 B42act1-104 this study
pJG4-5act1-105 2 µm TRP1 B42act1-105 this study
pJG4-5act1-108 2 µm TRP1 B42act1-108 this study
pJG4-5act1-111 2 µm TRP1 B42act1-111 this study
pJG4-5act1-113 2 µm TRP1 B42act1-113 this study
pJG4-5act1-115 2 µm TRP1 B42act1-115 this study
pJG4-5act1-116 2 µm TRP1 B42act1-116 this study
pJG4-5act1-119 2 µm TRP1 B42act1-119 this study
pJG4-5act1-120 2 µm TRP1 B42act1-120 this study
pJG4-5act1-121 2 µm TRP1 B42act1-121 this study
pJG4-5act1-122 2 µm TRP1 B42act1-122 this study
pJG4-5act1-124 2 µm TRP1 B42act1-124 this study
pJG4-5act1-125 2 µm TRP1 B42act1-125 this study
pJG4-5act1-129 2 µm TRP1 B42act1-129 this study
pJG4-5RVS167 2 µm TRP1 B24RVS167 this study
pEG202 2 µm HIS3 LexA (Gyuris et al., 1993)
pEG202MYO5 2 µm HIS3 LexAMYO5 tail (aa 757–1219) this study
pEG202myo5-(TH2c) 2 µm HIS3 LexAmyo5-(TH2c) tail (aa 757–1181) this study
pEG202myo5-(SH3,TH2c) 2 µm HIS3 LexAmyo5-(SH3,TH2c) tail (aa 757–1091) this study
pEG202myo5-(TH2, SH3) 2 µm HIS3 LexAmyo5-(TH2, SH3) tail (aa 757–996) this study
pEG202(TH2, SH3) 2 µm HIS3 LexA(TH2, SH3) domain (aa 984–1219) this study
pEG202(SH3, TH2c) 2 µm HIS3 LexA(SH3, TH2c) domain (aa 1085–1219) this study
pEG202(TH2n, SH3) 2 µm HIS3 LexA(TH2n, SH3) domain (aa 984–1181) this study
pEG202TH2c 2 µm HIS3 LexATH2c domain (aa 1142–1219) this study
pEG202TH2 2 µm HIS3 LexATH2 domain (aa 984–1091) this study
pEG202SH3 2 µm HIS3 LexASH3 domain (aa 1085–1181) this study
pEG202myo5-TH2n 2 µm HIS3 LexAmyo5-TH2n tail (aa 757–996) + (aa1095–1219) this study
pEG202END3 2 µm HIS3 LexAEND3 this study
pSH18–34 2 µm URA3 8 LexA Op. LacZ (Gyuris et al., 1993)
pRFM-1 2 µm HIS3 LexAbicoid (Gyuris et al., 1993)
pGEX5X-3 - - GST
pGST-(TH2,SH3) - - GST-(TH2, SH3) domain (aa 984–1219) this study
pGST-(TH2,SH3)-W1123S - - GST-(TH2, SH3) domain (aa 984–1219)–W1123S this study
pGST-(SH3,TH2c) - - GST-(SH3, TH2c) domain (aa 1085–1219) this study
pGST-(TH2c) - - GST-TH2c domain (aa 1142–1219) this study
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Some thoughts about “complexity”
The last couple of years have brought an
enormous increase in the number of
organims whose genomes have been
sequenced. Scientific “Pet” organisms like
S. cerevisiae, D. melanogaster and
C. elegans have been sequenced and last
but not least also a working draft of the
H. sapiens genome is available. Using
sophisticated gene-prediction software the
approximate number of genes encoded by
the different genomes was determined and
of course the different species were
compared. To the big dissapointment of the
general public and especially of pharma-
ceutical and biotechnology companies, the
latest studies predict only about 30'000 to
40'000 genes for humans and not 70'000 to
100'000 as some previous studies had
predicted. There is a big disappointment
that humans are only about two times as
“complex” as worms and only about five
times as “complex” as yeast even though
no one can really say what the term
“complex” really means. Fortunately, the
focus seems to turn away from the mere
number of genes to what genes are actually
for: they mostly encode for proteins! DNA
is very important because it encodes almost
the whole properties of the cell (it is
believed that some membrane properties of
organelles are “inherited” to “daughter”
organelles and cannot arrise de novo).
However, the cell is mainly made of
proteins and lipids and proteins carry out
most of the activities going on in a cell.
Different cell types of the same organism
express different proteins even though they
have exactly the same genome. To further
complicate the whole system one gene can
encode for more than one protein because
alternative splicing and RNA editing can
produce from one precursor mRNA a large
number of “mature” mRNA’s encoding for
different proteins leading to an increase in
complexity. However, an increased number
of proteins per se does not necessarily
mean increased “complexity”. What really
determines the “complexity” of a cell are
the interactions among its proteins and
lipids that allow a cell to function properly.
The regulation of protein-protein
interactions networks and the integration
and fine-tuning of outputs from the diverse
networks are the key features that ensure
survival and allow a cell to pursue its tasks.
If we want to understand the smallest “unit
of life” (i.e. a cell) we need to understand
how it works at a molecular level by
unravelling its functional networks.
Anyways, the existence of life is such a
wonder that the classification in different
classes of “complexity” is pure semantics.
Especially because every single living
organism has proven to be the best suited
for its place in nature under the current
conditions.
Protein-protein and protein-lipid
interactions network
In this PhD thesis we have started to
unravel part of the interactions network
involved in the internalization step of
endocytosis on a molecular level. As
previously described in the introduction,
the different proteins required for this
process can be distributed to different
protein complexes based on genetic and/or
biochemical data. However, recent studies
from several groups (see introduction) and
work presented here in this thesis have
clearly demonstrated that the described
protein complexes are much more
interconnected than previously thought
leading to the notion that the whole system
is a complex network of interactions. (see
Figure 1). To further increase the
complexity, lipids add an additional level
of regulation and seem to work via
different mechanims to allow correct
working of the process. Sterols might
provide the proper membrane environment
to allow the endocytic machinery to be
recruited and/or to assemble at specific
sites. Another possible function might be to
modulate the biophysical properties of the
membrane to allow the proper membrane
Conclusions and Perspectives 98
curvature to build and/or to allow an
endocytic vesicle to pinch off. In contrast,
sphingoid bases seem to act as signaling
molecules controling a whole cascade of
protein kinases starting with Pkh1p and
Pkh2p and required for the internalization
step (this thesis). Previous data (Friant et
al., 2000) and work presented in this thesis
suggest that one of the roles of this
sphingoid base-mediated signaling cascade
might be to regulate the actin cytoskeleton.
Our initial studies have identified two
possible effectors of this signaling pathway
(Rvs167p and Pkc1p) and we can assume
that there will be more (e.g. Yck2p).
Therefore we propose that this signaling
cascade will affect endocytosis directly and
not only via regulating the actin
cytoskeleton.
Figure 1. Protein-protein interactions network involved in the internalization step of endocytosis
Schematic drawing of the new connections (big double-headed arrows) between the four protein complexes
described in detail in the introduction.
Proteins that have been shown to interact biochemically and/or in the two-hybrid system are drawn near each
other. Synthetic lethal interactions are shown by a dashed line, and an arrow marks phosphorylation of a protein
by a kinase. Las17p might be part of three complexes and therefore connections are drawn by double-headded
arrows.
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We have provided preliminary data
suggesting that the phosphorylation of
Rvs167p by Pkh2p is required for its
endocytic function but maybe not for its
actin function (see third section of the
results). However, we cannot exclude that
the immunofluorescence assay used to
monitor the actin cytoskeleton is not
sensitive enough to monitor subtle
changes. Furthermore, we do not know
which actin structures are really required
for endocytosis. Interestingly, recent
studies have identified two new proteins,
Myo5p and Abp1p, that activate the actin
nucleation functions of the Arp2/3 complex
(Evangelista et al., 2000; Goode et al.,
2001; Lechler et al., 2000; this thesis).
Myo5p has been shown to be involved in
the internalization step (Geli and Riezman,
1996) and Abp1p has a redundant
endocytic function with the central coiled-
coil domains of Sla2p (Wesp et al., 1997).
Therefore, both proteins could be involved
in initiating and/or regulating the actin
structures required for internalization.
However, in the case of Abp1p the in vivo
relevance of its role in Arp2/3 complex
acitvation has not been thorougly adressed,
yet. In the case of Myo5p the evidence
supports a physiologically relevant
interaction with actin.
Rvs167p is one of the two yeast
amphiphysin homologs. Members of this
protein family have been implicated in
endocytosis. Work presented in this thesis
and several other studies have suggested a
high degree of similarity in terms of
regulation and binding partners between
Rvs167p and amphiphysin (Floyd et al.,
2001; Lee et al., 1998; Lombardi and
Riezman, 2000; Navarro et al., 1997;
Rosales et al., 2000; Wigge et al., 1997).
Amphiphysin I interacts with amphiphysin
II as does Rvs167p with Rvs161p.
Rvs167p is phosphorylated by Pho85
kinase as is amphiphysin by the
mammalian Pho85 homolog Cdk5
suggesting that at least part of the
regulation has been conserved through
evolution. We have shown in this thesis
that Pkh2p phosphorylates Rvs167p and
have identified a PDK2 consensus
phosphorylation site in amphiphysin I.
Given the striking similarities between
Rvs167p and amphiphysin I we propose
that PDK2 might phosphorylate and thus
regulate amphiphysin I. Furthermore, it
might be interesting to investigate a
possible role of PDK-kinases in clathrin-
mediated endocytosis in mammalian cells.
Outlook
It is very clear, that we have just started to
unravel the interactions network acting at
the internalization step of endocytosis.
There are still a large number of proteins
missing and even more protein-protein
interactions to be discovered. However,
what is almost completely missing is
knowledge about the actual functions of
the proteins involved in this process.
Up to now, the type I myosin Myo5p was
the only protein where a direct role in force
generation and/or rearrangement of actin
filaments could be postulated. However,
now several studies (Evangelista et al.,
2000; Lechler et al., 2000; this thesis) have
unravelled an additional function of Myo5p
in actin polymerization suggesting that
Myo5p might not behave as a normal
motor protein carrying its cargo from A to
B. Myo5p might be able to induce the actin
filaments it needs to move and/or generate
additional force by polymerizing new actin
filaments at the sites of internalization by
activating the Arp2/3 complex. As
mentioned previously, we don’t know
which actin structures are involved in the
internalization step. However, the actin
patches are most likely not the sites of
internalization (Mulholland et al., 1999)
suggesting that a more specialized actin
structure not visible by conventional
fluorescence microscopy might be
required.
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For the rest of the proteins we don’t have
any concrete idea about their role in
internalization. Most of them affect the
actin cytoskeleton and therefore it would
be interesting to determine if their
endocytic defect is solely due to the actin
defect or if they have a more direct role in
the process. One obvious approach would
be to generate mutants and determine if the
two phenotypes can be genetically
separated. Furthermore, one could deter-
mine if they work on actin directly by
investigating how they affect actin
polymerization and/or the stability of
F-actin.
However, the most usefull tool to
understand the role of the different proteins
in the internalization process would be an
in vitro endocytosis assay. This would
allow to dissect at which step a certain
protein is involved by interfering with the
protein function and determining where the
process is blocked. Furthermore, the
minimal requirements to build and pinch
off an endocytic vesicle might be
determined giving a hint which factors are
absolutely necessary, which factors
increase the efficiency and which factors
are involved in regulation.
Another major issue is to understand how
internalization is regulated. There are now
several kinases identified to be required for
the internalization step (Pkh1p, Pkh2p,
Pkc1p and Yck2p; Friant et al., 2000; this
thesis). Two other kinases, Ark1p and
Prk1p, have been shown to be involved in
regulating the actin cytoskeleton and might
be linked to the Pan1p complex (see
introduction, section 3.2.4.). However,
there is no report about a possible role in
endocytosis. Sphingoid bases have been
shown to activate a whole signaling
cascade including at least three of these
kinases (Pkh1p, Pkh2p and Pkc1p; Friant et
al., 2000; Zanolari et al., 2000; this thesis).
We have identified Rvs167p as a down-
stream effector of Pkh2p but we don’t
know what targets Pkc1p regulates.
Furthermore, we don’t know if Yck2p is
also part of this sphingoid base-mediated
signaling cascade or if it defines another
signaling pathway involved in regulating
internalization.
We are far away from understanding the
internalization step of endocytosis at a
molecular level but we have started to
design a rough sketch on which to build up.
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